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Abstract
In 1999, a proposal was put forward for a pilot project to sequence a region of the 
medically important pathogenic fungus Aspergillus fumigatus to determine whether a 
whole genome sequencing project was viable. This thesis reports on the generation of 
a Bacterial Artificial Chromosome library and the sequencing and annotation of a 
1Mb region surrounding the niaD gene cluster. Identification of the BAC containing 
the niaD gene was achieved through hybridisation and the clones “walked” out from 
this. The final minimal tiling path contig used for sequencing consisted of 16 
overlapping clones. The total sequence completed was 921,539bp which, after 
annotation, was shown to contain 341 predicted putative protein coding genes and 8 
tRNA genes with a GC content of 50.6%. Of significance was the synteny found in 
the qut/qa gene cluster between A. fumigatus and A. nidulans. There was complete 
conservation of this cluster between the two, except for the inversion of two regions, 
facC  and trpC. An aroM gene was also found, which has a known involvement in 
aromatic compound synthesis and could be a good candidate for possible drug targets.
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1. Introduction
The Mycology of pathogenic fungi was largely a science based on observation. This is a 
laborious process but with the advance of molecular biological techniques this has 
changed. There are indications that the identification, diagnosis and treatment of fungal 
infections are relying more on modem molecular systems. This research is aimed at 
analysing the DNA sequence of the mould Aspergillus fumigatus, a clinically important 
Ascomycete.
Classification of fungi has traditionally been through the particular unique sexual 
structure of that organism. Therefore, there are many fungi in the Aspergillus group that 
are related only because of the lack of an identifiable sexual stage. A. fumigatus is a 
filamentous fungus and the hyphae specialise to form conidiophores, which produce the 
organism’s spores, termed conidia. Most fungi grow exclusively as moulds or yeasts thus 
Aspergillus will only grow as hyphae and Candida glabrata will only grow as yeast. 
Fungi can show both morphological forms in different stages of their life cycle and this 
may be influenced by the medium.
An increasing number of fungi sequencing projects are underway, with several complete 
such as the sequence for Saccharomyces cerevisiae and Schizosaccharomyces pombe. 
Projects on Candida albicans, Neurospora crassa, Candida glabrata, Cryptococcus 
neoformans, Pneumocystis carinii, Aspergillus fumigatus and Magnaportha grisea are all 
underway or first drafts have been published. A resource for the fungal genomics can be 
found in a recent review by Yoder and Turgeon, published in 2001. There is a proposal 
by Fink with the collaboration of a number of eminent fungal researchers, to sequence the
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genome of 15 medically and agriculturally important fungi at the rate o f approximately 
one a month. Known as the FGI, or Fungal Genome Initiative, it will give excellent 
insight into eukaryotic evolution as well a massive resource on fungal genomes. The FGI 
realise that the increase o f fungal infections is having a very significant impact on human 
disease numbers, as well as being highly damaging in agriculture. If this proposal is to be 
funded, then a vast amount of information will be available within two years 
('http://www-genome.wi.mit.edu/seq/fgi)
There are more than 200,000 identified species of fungi and of these about 200 have 
pathogenic properties in humans. Pathogenicity of these fungi can be separated into two 
types: 1) Opportunistic which tend to cause disease in patients that already have 
abnormal immune systems and cannot fight against the fungal invasion. Due to increased 
incidences o f immunosupression in patients for varying reasons such as AIDS, 
transplantation, neutropenia and leukaemia, fungi that were never previously seen as 
pathogenic are being isolated from patients with varying degrees of immunosupression. 
Opportunistic fungi do not usually cause disease in immunocompetent patients, but there 
are exceptions. A. fumigatus is one of these exceptions. 2) Dimorphic fungi can also 
cause disease in immunocompetent patients. They exist in two morphological forms. In 
the wild, they produce infectious conidia and form hyphae. Yet, in the body, with 
increased temperature, the conidia proliferate as yeast-like structures. The conidia can 
easily overcome the host’s defences. Most dimorphic fungi also have geographical 
restrictions e.g. Coccidioides immitis is found only in southwest America and Mexico. 
This thesis focuses on the pilot-sequencing project o f Aspergillus fum igatus , an 
increasingly important pathogen, especially in immunocompromised patients.
2
1.1 Project background
Dr David Denning o f the University o f Manchester put forward a proposal to the Sanger 
Institute for a pilot project to study the feasibility of sequencing the genome Aspergillus 
fumigatus in i999. This proposal was accepted and I was available to carry out some of 
the research. Relatively little research had been done on A. fumigatus at a genetic level 
and there were few sequenced genes in the public databases to access and study. At the 
time of writing, there were 34 A. fumigatus sequenced genes in the Swiss-PROT database 
(http://srs6.ebi.ac.uk/srs6bin/cgi-bin/wgetz), (compared to 478 sequenced genes o f its 
relative, A. nidulans). A fumigatus is a significant clinical problem due mainly to the 
increase in opportunistic fungal infections. Complications arise in HIV infections, post 
transplant immunosupressant treatment, severe bums and various other conditions that 
decrease immune response. There are a number o f fungi that take advantage o f these 
conditions to invade and cause damage to varying degrees, but there are no other fungi 
that are as prevalent, virile and damaging as that of Aspergillus fumigatus.
1.2 An introduction to A. fumigatus
Aspergillus fumigatus is now known to be the most common mould causing invasive 
infection worldwide. It is a thermophilic fungus and can grow well at over 40°C and up 
to 50°C on decomposing organic material. It was first described by Micheli in 1729. He 
described the conidial head of the fungus, with the spore heads around the central
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structure, and named it Aspergillus after what he thought resembled aspergillum, the 
perforated tool for the sprinkling of holy water. Various attempts have been made to 
classify the whole genus, which is closely related to the Penicillium genus. The naming 
of the first species, A. flavus, was in 1809 by Link. There are a large number of the 
Aspergilli that are pathogenic and cause aspergillosis. Aspergillosis is a general term, 
which covers the infection by m y Aspergillus species. A. flams, A. niger, A. terreus and 
A.nidulans are all highly prevalent and pathogenic, but it is Afumigatus that is the most 
predominant in pathogenicity, accounting for over 90% of invasive aspergillosis 
(Denning, 1998). The most common and effective drugs administered to patients with 
Aspergillus infection are the azoles. There are significant species differences in response 
to drug therapies, so species identification is critical for effective treatment (Denning, 
unpublished data) and any molecular approach to Aspergillus clarification will be 
beneficial.
1.2.1 History of infection
The first infection was described in 1815 by Mayer, who saw the infection in the air-sack 
of a jackdaw. Later in 1842, Bennett in 1842 described an aspergilloma in man in a 
hospital in Edinburgh. An aspergilloma is a fungal ball that establishes itself typically in 
pre-existing cavities in the lungs. There were recorded cases by Rayer (1842) and by 
Gairdner (1856) of similar infections, but the organism was unidentified. Virchow then 
described a number of cases of aspergillosis in 1856. Many more cases have been 
reported between 1890 (Wheaton) and 1947 (Cawley). The first allergic reaction due to
4
Aspergillus was recorded in London in 1952 (Hinson et al, 1952) and the first fatal 
invasive infection of a known immunocompromised patient was recorded in the British 
Medical Journal in 1953 for a patient found in Gloucester (Rankin, 1953). Appendix 1 is 
a table of dates that mark out the history of aspergillosis.
1.3 Biology
1.3.1 Reproduction
Asexual sporulation is the most widespread form of reproduction for fungi. Reproduction 
is carried out by conidiation, a complicated process of temporal and spatial regulation of 
gene expression, intercellular communication and cell specialization. Detailed studies on 
the mechanisms of this process have not been carried out on A. fumigatus, but have been 
studied in other fungi. In general terms, the reproductive cycle has three observed stages: 
1) A growth phase that allows the cells to acclimatise, adapt and to respond to induction 
signals; 2) initiation of the development pathway; 3) processes leading to sporulation.
1.3.1.1 Formation and establishment of the colony
Growth in the initial stage is vegetative leading to germination of a spore and 
subsequently hyphal formation, which grow by apical extension in a polar form. This 
then forms a network of multiple hyphae called a mycelium. Although seemingly 
vegetative in nature, it is clear that the hyphae must communicate to produce an ordered
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network, where each hypha has a definite role in the uptake of nutrients from its 
environment. There also has to be some kind of interaction to help time the formation of 
the various reproductive tools that the fungus will need. Sixteen hours after germination, 
the centre of the colony starts to form hyphal branches that form conidiophores, the 
structures that produce the spores. The formation of the hyphae to the formation of the 
first spore (conidium) takes between 6 and 8 hours, with a total of approximately 24 
hours from first spore germination to reinitiation of the asexual cycle. The colony 
continues to form with the older conidiophores in the centre and newer formations 
moving to the edge of the colony.
1.3.1.2 Conidiophore formation
This is a complicated process that has several distinct steps. The formation begins with 
the growth of a stalk that elongates by apical extension (Figure 1).
Figure. 1 Scanning electron micrographs o f  the different stages o f  conidia formation. 1) Early 
conidiophore stalk 2) Vesicle formation 3) Metulae development 4) Phialide development 5) Mature 
conidiophores with chains o f  conidia (Adams and Wieser, 1999)
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This is different to the vegetative hyphae in three ways. There is a thick walled foot cell 
that anchors the stalk to its growth medium. It is also wider than the vegetative aerial 
hyphae and the hyphae rarely branch, with the growth length being relatively uniform. 
This conidiophore stalk then stops growing and the tip swells to a “vesicle” of about 
10pm. Nuclei align around this vesicle in large numbers and divide in unison, producing 
buds at the same time. This layer of buds is called the metula. There are approximately 60 
metula on the conidiophore head. The metula then bud again and produce another 
uninucleate layer and these are known as phialides, which then form the uninucleate 
spores called conidia. Each phialide forms 100+ spores and generates over 10,000 spores 
in total on one conidiophore.
Key developmental regulatory pathways in conidiation have been studied extensively in 
A. nidulans. The null mutants of the brlA gene are known as “bristle” as these mutants get 
blocked in early development and do not make it to the polar growth stage of the 
conidiophore stalk to the swelling of the conidiophore vesicle. The mutants control 
growth of the conidiophore stalks in an erratic way, where the stalk grows 20-30 times 
taller than the wild type and the whole colony has a “bristly” appearance. brlA is thought 
to activate expression of development specific genes at the very start of conidiophore 
vesicle formation, including abaA and wet A (Marshall and Timberlake, 1991).
Although the processes of function of conidia formation are thought to be similar to those 
of A. fumigatus, the timescales and conditions in A. fumigatus may differ. Further study
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of the genetic mechanisms and processes will be more freely obtainable by the genome 
project.
1.3.2 Pathogenesis
Depending on the medium used, A.fumigatus spores take between 5 and 12 hours to 
germinate at 37°C (Ng et al 1994). Most species of Aspergillus cannot grow at 37°C and 
this is an important characteristic that separates the pathogenic species from the non- 
pathogenic species. The growth rates of the various Aspergillus species also differ quite 
markedly, the most rapid grower being A.fumigatus. A major marker for the 
pathogenicity may well be this rapid onset of growth, shown vividly by experiments in- 
vitro with physiological and pharmacological concentrations of hydrocortisone, where 
A.fumigatus has been known to accelerate growth up to 40%. It has a doubling time of 48 
mins and a hyphal extension rate of l-2cm/h in these conditions (Ng et al 1994). Another 
factor in Aspergillus pathogenicity may be the small spore size, allowing the spore to 
penetrate deep into the lungs. The spores are hardy, being able to survive extreme 
atmospheric conditions. This is thought to be due to the conidial hydrophobic protein 
coat, which may also protect the spores from host defence mechanisms. The hydrophobic 
surface allows them to stay airborne, even in damp conditions and they are prevalent in 
the environment, accounting for 0.3% of spores (Schmitt et al, 1991). Surveys have 
shown that that most humans would inhale several hundred conidia from the environment 
per day (Chazalet et al 1998, Goodley et al 1994). A.fumigatus has the added factor that it 
also efficiently binds laminin (Tronchin et al 1993) and fibrinogen (Bouchara et al 1993)
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more strongly than the other species facilitating adhesion of the spores to the airways to 
allow invasion.
There are other virulence determinants thought to be instrumental in the pathogenicity of 
A.fumigatus. Experimentally, these have shown to be various proteases (Monod et al 
1995, Markaryan et al, 1994 and Reichard et al, 1997), ribotoxin (Arruda et al 1992, 
Latge et al 1991 and Smith et al 1993), phospholipases (Birch et al 1996), a hemolysin 
(Ebina et al 1994), gliotoxin (Mullbacher et al 1985, Sutton et al 1996 and Waring 1990), 
aflatoxin (Denning 1987), phthioic acid (Birch et al 1997) and various other toxins 
(Frisvad and Samson, 1990 and Moss 1994). A. fumigatus also produces at least four 
phospholipases (Birch et al 1996) may have a role in invasive aspergillosis. Certain 
Clostridium and Pseudomonas species produce phospholipases and their mechanisms of 
cell destruction are very similar to that of A. fumigatus. Gliotoxin is known to reduce 
phagocytosis by reducing macrophage and neutrophil numbers (Mullbacher et al 1985) 
and it can promote programmed cell death (Waring 1990). Granuloma formation may be 
due to the small amounts of phthioic acid produced by A. fumigatus, but it is not thought 
to be a major factor in virulence of the species. The organism itself also seems to be very 
well protected due to the mannitol (Birkinshaw et al 1931, Wong et al 1989 and Megson 
et al 1994) and catalases (Heam et al 1992, Takasuka et al 1997, Calera et al 1997) that it 
produces. These may well protect the organism from free radicals produced by 
phagocytes that work in attacking “normal” invaders. The most infamous illness caused 
by A. fumigatus is Farmer’s Lung, where the lung becomes infected after repeated 
exposure to the fungus from ploughing soil and moving hay bales. These symptoms
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would also commonly be found in long term mine workers. Patients suffering from cystic 
fibrosis in rural regions tend to have a higher incidence of Aspergillus invasion.
However, urban locations are also good environments for the prolification of A. 
fumigatus. Cellars, potted plants and spices (Staib 1984) are all good environments for 
the fungus as well as unfiltered marijuana smoke, which may well yield large quantities 
of the organism (Denning, 1998).
The first barrier against infection is the macrophage found in the lungs and nasal cavities. 
These are capable of destroying the spores. The hyphae are killed by neutrophils, which 
are dysfunctional in AIDS patients (Schaffner et al 1982, Diamond et al 1978) and also 
by monocytes (Roilides et al 1994). Hyphae are generally too large to be ingested by the 
defence mechanisms and killing occurs extracellularly. Histological responses range from 
a small, granulatomous response to an invasion of necrotised tissue. Neutropenia and, in 
AIDS patients, dysfunctional neutrophils are also important risks in invasive 
aspergillosis.
The pathogenesis of the organism is increased by the release of lytic enzymes and toxins. 
Research has been carried out into what individual factors relate to the pathogenicity of 
the organism, but so far, little has been discovered. What is important is the dosage of 
conidia taken in and how it relates to the damage of the defence mechanisms available to 
the host. In humans, the defence is primarily the removal of the conidia from the lung via 
ciliar transport and secondarily phagocytosis by the alveolar macrophages. If the primary 
defence is damaged or fails, then chronic colonisation can occur, such as in cystic fibrosis
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(Wojnarowski et al 1997). If secondary defences are damaged, then invasive infection 
can become established if the phagocytic ability of the neutrophilic granulocytes is 
limited, for example in leukaemia (Schaffner et al 1982). Advanced colonisation results 
in invasion of areas such as blood vessel walls, organ cartilage borders and can lead to 
haemorrhaging. Aspergilli are among the most mycotoxic species known (Samson 1992). 
This pathogenicity, as mycotoxins, can be readily ingested with food, especially grain or 
dairy products. A.fumigatus produces a number of toxins, such as gliotoxins, which can 
act as an immunodepressants (Sutton et al 1996), aflatoxins, which are thought to have a 
role in hepatic cancer in patients with Hepatitis B (Pitt 1994), and ochratoxins, which are 
thought to have a role in renal failure (after large scale exposure to the fungus) (Di Paolo 
et al 1993).
1.3.3 Epidemiology
A recent study of invasive aspergillosis in a German hospital found that case frequency 
increased approximately 14-fold from 1978 to 1992 and in the last year of study 4% of 
the patients had invasive aspergillosis at autopsy (Groll et al 1996). It has taken over 
candidiasis as the most frequent fungal infection detected in patients after death. In Japan, 
a study of autopsies between 1970 and 1995 showed that the frequency of invasive 
aspergillosis had increased from 0.4% to 1.4%. The reasons for the increase include the 
worldwide increase in HIV infection (up to 40 million cases by the year 2000 with a 
potential estimated number of 1.4 million cases of aspergillosis), particularly in the third 
world, the development of newer and more sophisticated chemotherapy methods for
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malignant tumours and the large increase in worldwide organ transplants (up to 500,000 
each year). Linked to this is the large increase in immunosuppressant drugs for transplant 
anti-rejection and for the treatment of autoimmune diseases such as systemic lupus 
erythematosus, plus the ineffectiveness of Itraconazole and AmB. The patients at most 
risk are those with chronic granuloma disease, a defect in the white blood cell (25-40%), 
lung transplant patients (17-26%), allogeneic bone marrow patients (4-30%), neutropenic 
leukaemia patients (5-25%), heart transplant patients (2-13%), pancreatic transplant 
patients (1-4%), kidney transplant patients (~1%) and AIDS, multiple myeloma and 
combined immunodeficiency patients (~4%) (Denning, 1998). It can be clearly seen that 
the combat of invasive aspergillus infection is of a high priority to the medical world. The 
mortality of invasive aspergillosis, if untreated is approximately 85%, and falls to 50% 
with treatment (Denning, 1996).
Aspergillus also causes a number of other diseases in man. These include aspergilloma (a 
fungal ball that infects and proliferates in existing lung cavities), sinusitis, allergic 
bronchopulmonary and sinus infections, keratitis, which can present itself as blindness, 
and post-operative infections in normal, non-immunocompromised patients.
Aspergilloma cases are predicted to rise because of the notorious difficulty of treatment 
and the widely reported increase in the number of cases of tuberculosis worldwide. There 
is also an increase in the number of cases of cystic fibrosis, which is also seen to be a 
further contributor to the increasing numbers of aspergilloma. The fact that 40% of 
patients with aspergilloma are not expected to live beyond 5 years from diagnosis is also
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seen as another factor for the rapid increase of research into this extremely common and 
virile fungus.
1.3.4 Treatment
Until 2001, there were only two major treatments licensed for Aspergillosis, and these 
were the antibiotics Amphotericin B (AmB) and Itraconazole. Despite reasonable success 
of these two drugs in vitro, in-vivo success is low and hence the mortality rate from 
invasive aspergillosis is still high. After 30 years of AmB anti-fungal therapy, it is still 
not fully understood how the drug works, although it probably binds to membrane sterols, 
opening transmembrane channels and resulting in increased permeability to monovalent 
cations (Bolard 1986). It inhibits proton ATPase pumps, decreasing cell energy levels as 
well as inducing membrane fragility by increasing lipid peroxidation (Brajtburg et al, 
1985). It is insoluble in water and to make it biologically active, the drug has to be 
solublised first. Bristol-Myers-Squibb were the first company to try and overcome this 
problem with Fungizone, the first marketed AmB formulation, wherein it was solublised 
in the detergent deoxycholate. The drug is highly toxic to the patient (Clements and 
Peacock, 1990). The side effects are severe, with increased nephrotoxicity, which is 
increased in the presence of cyclosporin. The AmB does damage the fungal cells, but also 
damages some of the cells surrounding the infection. This effect may be due preferential 
binding of the drug to ergosterol, which is found in fungal membranes rather than 
cholesterol found in mammalian cells. It is also thought that AmB has a role in binding to 
serum lipoprotein and then being internalised through lipoprotein receptors to promote
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toxicity, but this has not been widely studied (Vertut-Doi et al 1994 and Wasan et al 
1993).
The mode of action of the triazole itraconazoles are much better understood to those of 
AmB. It works by having its free azole nitrogen bind to the catalytic haem iron atom of a 
cytochrome P-450. Inhibition of the P-450 14a-demethylase prevents production of 
ergosterol in fungal membranes. This in turn alters membrane fluidity, the relationship 
with various membrane enzymes and thus an altered synthetic pathway predominates 
with increased accumulation of phospholipids and unsaturated fatty acids occuring within 
the fungal cells. Itraconazole only weakly binds to mammalian cytochrome P-450 and 
therefore the drug is not as toxic as AmB. Despite its reduced toxicity to that of AmB, 
Itraconazole still has major drawbacks. Firstly, no intravenous preparation is 
commercially available. This becomes a problem when treating patients that have 
swallowing difficulties or have impaired bowel absorption. For itraconazole to work 
effectively, it needs good absorption and distribution within the body. Secondly, the 
absorption rate varies markedly in different patients. Constant monitoring of the patient 
with respect to itraconazole concentrations needs to be undertaken. It is more effective in 
patients who have previously not responded favourably to AmB (Denning 1996, Denning 
et al 1994, Dupont 1990). Thirdly, resistance strains are now beginning to be identified 
(Denning et al 1997). Resistance mechanisms have not yet been fully researched, but it 
may be mediated by one of a number of mechanisms, such as energy-dependant efflux 
mechanisms, increased expression of the sterol 14a-demethylase and altered affinity of
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the enzyme for the drug (Tobin et al 1997). There may be interference with metabolism 
of other drugs e.g. phenytoin, carbamazepine, via the P-450 system of the patient.
To summarise, mti-Aspergillus therapy still remains inadequate. Success of AmB in 
invasive aspergillosis is about 34% (Denning 1996). Not only that, infection can occur in 
patients who have been treated with AmB for other unrelated illnesses. This highlights 
the deficiency of drug treatment against A.fumigatus and shows that there is a desperate 
need for new, innovative therapies to be developed. Hence the Aspergillus genome 
sequencing project is of utmost importance as it should facilitate the development of 
novel drug therapies.
1.4 Genetics
There are five components to the fimgal genome: chromosomal genes, mitochondrial 
genes, plasmids, mobile genetic elements and fungal virus genes.
1.4.1 Chromosomes and chromosomal genes
There are a number of factors that impinge on accurate chromosomal analysis. Firstly, 
fungi can alternate between a haploid and a diploid somatic phase. Some yeasts, such as 
C. albicans, are permanently diploid and some fungi are polyploid, for example 
P. infestans. Secondly, the haploid stage is not conducive to microscopic observation. It 
is impossible to observe chromosomes in their natural state using conventional
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microscopy. Thirdly, fungal chromosomes are small, tightly wound and highly 
condensed and the nuclear membrane remains during most of the mitotic cycle, further 
reducing the capacity to observe the chromosomes with a conventional microscope. Some 
fungi have had chromosomal counts performed on them using a combination of 
techniques such as genetic linkage analysis, pulsed-field electrophoresis and cytology. 
Table 1 shows the haploid chromosome count for a number of fungi.
Table 1
ORGANISM  
Basidiomycota 
Coprinus cinereus 
Puccinia kraussianna 
Shizophyllum commune 
Chytridiom ycota 
A.javanicus 
Allomyces arbuscula 
Oomycota 
Saprolegnia spp.
Achlya spp 
Pythium
Phytophthora spp 
Ascomycota 
Aspergillus nidulans 
Neurospora crassa 
Saccharomyces cerevisiae
C H R O M O SO M E NUM BER
13
30-40
11
14 (but can vary to polyploidy) 
16
8-12
3,6,8
Usually 10 or 20 
9-10
7
17
In A.fumigatus the confirmed number of chromosomes is seven. However, in 
unpublished reports, some laboratories have managed to separate a total of eight 
chromosomes, the same as the close relative, A. nidulans. This may be due to the
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chromosomes running as “doublets”. The only published report of note regarding 
A.fumigatus having eight chromosomes is by Amaar and Moore (1998), in which a 
comparison is made using the niaD gene and comparing chromosomal position to that of 
A. nidulans by hybridisation. Their estimate is done by chromosome size, not by 
visualisation; hence confirmed evidence is still not forthcoming.
Fungal nuclear genomes are smaller than other eukaryotes for instance, Saccharomyces 
cerevisiae is 13.5Mb, compared to that of Drosophila at 165Mb and the human genome 
at 3000Mb. One of the reasons is thought to be that there is very little reiterated DNA. It 
accounts for only 7% of the DNA in A. nidulans, and even then most of this codes mainly 
for cell components, which are required by the organism in large amounts, such as 
ribosomal RNA, transfer RNA and chromosomal proteins. One notable exception to this 
is Bremia lactucae, which is highly repetitive, where 65% of its 5Mb genome is 
repetition. S. cerevisiae is thought to transcribe as much as 50-60% of its genome. 
Therefore it can be deduced that fungal genomes have very little non-coding DNA. 
Moreover, fungal introns are very short and they are usually between 50-200bp compared 
to that of higher eukaryotes that have introns sizes that can be lOkb or more.
1.4.2 Mitochondrial genes
Fungal mitochondria contain a small, circular molecule of DNA. It is comparable in size 
to that of other eukaryotes, with a genome size between 19kb and 121kb.
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Fungal mitochondrial DNA is known to be important in aging in several filamentous 
fimgi, including Aspergillus. A single mutation in a single mitochondrion can be 
responsible for the premature aging (senescence) of an entire fungal colony. Eventually, 
the mutant gene will displace the mitochondrial DNA of the wild type (Esser 1990, 
Bertrand 1995). The fungi Podospora can be maintained with the senescence phenotype 
indefinitely with the right conditions and media. However, the cultures need to be kept 
young by repeated subculturing, as the cultures will die if they are kept growing 
continuously for more than 25 days. The mutants are brought about by an extra nuclear 
“infective factor”. Non-senescent strains can “acquire” the ability to senesce when their 
hyphae anastomose (connect) with strains that already have the ability. It was shown that 
senescence could be switched off indefinitely by dosing growing strains with sub-lethal 
amounts of mitochondrial DNA or protein synthesis inhibitors.
1.4.3 Transposons and Plasmids
Plasmids have been found in a number of fungi e.g. S. cerevisiae. This plasmid is seen to 
have a 2pm length when viewed under an electron microscope. It has a length of 6.3kb, 
up to 100 copies and is found in the nucleus of the organism (Deacon, 1998). The 
plasmid has no known function, but has been manipulated extensively and forms the 
basis of many yeast vector systems. Fungal plasmids are usually found in the 
mitochondria of the organism. Neurospora crassa plasmids have been extensively 
studied (Galagan et al 2003). The plasmids themselves are a linear piece of DNA that 
shows a degree of sequence similarity to mitochondrial DNA. It is thought that these
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plasmids, because of the homology, are defective, excised elements of the mitochondrial 
genes. N. crassa also has circular plasmids within the mitochondria. These elements have 
very little or no homology to that of the mitochondrial genome. Their length can vary 
between 3 and 5kb and sometimes occurs in tandem to make larger repeat elements.
These fungal plasmids have no known function as yet. This is a marked contrast to that of 
the plasmids found in bacteria, where the majority have a function conferring to antibiotic 
resistance or pathogenicity determinants (Oliver and Schweizer, 2001).
Transposons are short elements of DNA that integrate within the chromosome and they 
replicate by producing RNA copies of themselves, which is translated to DNA via 
transposon encoded reverse transcriptase. These are rare in fungi and have had little 
research carried out on them.
S. cerevisiae have transposable elements that are involved with switching mating type. 
This is a process that ensures that there will always be a mixture of two mating types 
within the population. This mating type switching has not been found in N. crassa, so is 
not necessarily a general feature of ascomycetes.
1.4.4 Fungal genetic variation: Non-sexual variation and Heterokaryosis
Fungi are often haploid and are the only major eukaryotes to be so. Fungal hyphae have 
an unusual organisation and this tends to make it more difficult to study them in respect 
to other organisms. Haploid organisms tend to express all of their genes and this in turn 
brings continual selection pressures, with mutations that occur in any gene swinging the
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fitness of the organism either to the detriment or the good of the organism. But another 
phenomenon, called heterokaryosis, allows fungi to exist with multiple nuclei that are all 
genetically different in their hyphal cytoplasm. This can arise by mutation in one of the 
multiple nuclei or from anastomosis. This phenomenon has significance for DNA 
sequencing and it is necessary to bear this in mind with interpreting the data.
1.4.5 Clinical Manifestations
An outline of the major diseases caused by A. fumigatus is shown in appendix 3. It 
describes the kind of diseases that can occur when Aspergillus fumigatus is taken in by 
the host and the effects it can have upon the host depending upon varying factors such 
immunocompetence, general health and mode of intake. It is interesting to note that most 
immunocompetent patients do not develop invasive aspergillosis, but this does not make 
them immune to the effects of the fungus. Immunocompetent patients can contract an 
invasive aspergillus related disease, but this is a much more rare occurrence. Because 
some of these diseases overlap in their effects, it is difficult to divide them into the 
immunocompromised and immunocompetent variants.
1.5 Genomics, Comparative Genomics and Post genomics
Genomics and comparative genomics is a growing science, which is going to prove 
invaluable in the fungal arena for gene analysis, the development of new drugs and 
interpretation of pathogenicity. This section outlines the main molecular background to
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mapping and the methods used in the project. It additionally reviews some of the current 
methodology in comparing sequences and gene expression.
1.5.1 Mapping
Genome mapping is a tool that helps the determination of relative positions of genes on a 
DNA molecule. There two broad categories of genome mapping; genetic mapping and 
physical mapping. Both of these methods give a good indication of the likely order of 
genes along a chromosome and are used to “guide” the scientist to a certain gene. 
Physical maps show an accurate estimate of the distances between genes along a 
chromosome. A physical map will help the scientist “home in” on a particular gene of 
interest far more easily than the information from genetic mapping alone.
1.5.1.1 Genetic mapping
Genetic maps rely solely on genetic markers. “Marker” is a very broad term for 
describing any observable variation that is a result of mutation or alteration at a specified 
genetic locus. Commonly used genetic markers include 1) Restriction length 
polymorphisms (RFLPs), VNTRs, or variable number of tandem repeat polymorphisms, 
Microsatellite polymorphisms and single nucleotide polymorphisms (SNPs).
Genetic Linkage Analysis is a statistical based analysis, which infers likely crossover 
patterns of genes and therefore the order of the markers involved. The markers are often
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seen to co-segregate with certain genes and it is this information that is used to infer gene 
order from the linkage analysis. Genetic maps are also used to form the scaffold that is 
required to help build more detailed genome maps. These detailed “physical” maps 
further clarify the DNA sequence between genetic markers, and are essential to the rapid 
identification of genes.
1.5.1.2 Physical Mapping
There are three main forms of physical maps; chromosomal maps, radiation hybrid maps 
(RH maps) and sequence maps. Each form has a varying degree of resolution. The lowest 
resolution of these is chromosomal mapping. RH and sequence maps are much more 
detailed. Breaks are induced using radiation to determine the distance between two 
markers. DNA is exposed to a calculated dose of radiation. This type of mapping is able 
to isolate almost any genetic marker, as well as other genomic fragments, to a highly 
accurate map position. Its usefulness is especially significant in positioning markers in 
regions where highly polymorphic genetic markers are scarce. RH mapping has also been 
used as a bridge between linkage maps and sequence maps.
Sequence mapping, or sequence tagged site (STS) mapping relies on the phenomenon of 
short sequences of DNA that are shown to be unique and the location of this unique site 
must already be identified. The unique site must be nowhere else on that particular 
chromosome or genome if the fragment happens to cover the entire genome. Expressed 
sequence tags, or ESTs, are short sequences of DNA that are identified by the analysis of
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complementary, or cDNA clones. ESTs can be used as a marker only if the STS comes 
from a unique gene and not from a gene family member where the genes all have similar 
sequences. Simple Sequence Length Polymorphisms (SSLPs) are arrays of repeat 
sequences that vary in length. SSLPs that are polymorphic and have previously been 
mapped by linkage analysis are highly regarded as they provide a good link between 
genetic and physical maps. Random genomic sequences can be used either by sequencing 
random pieces of cloned genomic DNA, or by looking at and determining the use of 
sequence already deposited in a database.
To use STSs for mapping, the DNA is cut into smaller fragments using a restriction 
enzyme and this breaks down overlapping DNA fragments from a region of DNA of 
interest. To form the map from this, it must be known which fragments contain which 
STSs. To do this, copies of the DNA fragments are made using standard molecular 
cloning to form a library.
These copies are pieced back together in the correct order by looking at clones that 
contain overlapping DNA fragments via end sequencing and computer methods to 
identify overlaps. This is what is known as a contig. The clones are archived in freezers 
and the sequence data is stored on computers and used as starting information for 
generating continuous DNA sequence. The STSs serve to anchor the sequence onto a 
physical map.
STS-based mapping does have limitations. There may be gaps in clone coverage or 
clones may become lost or mapped to a wrong position. DNA fragments can break. 
Deletion of DNA fragments can also occur during the replication process. Clones that
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have two distinctly different regions of DNA can be replicated. This would give DNA 
segments that are widely separated in the genome being mistakenly mapped to adjacent 
positions. There is also the risk of the cloned DNA getting contaminated with host DNA. 
To try and lessen the effects of these problems improve the mapping accuracy, 
comparison and integration of STS-based physical maps with genetic, radiation hybrid, 
and cytogenetic maps is frequently undertaken. This comparison, or “cross-referencing” 
helps enhance the usefulness of a given map, confirms the STS order, and helps 
orientation when building contigs. The comparison of genetic and physical maps can be 
very laborious, so computers and dedicated software align the maps and speed up the 
process.
The mapping for the Aspergillus project has been mainly to set out the framework from 
which the genome sequencing could commence. There has been input from both genetic 
and physical mapping but the physical mapping has taken priority, as initially a particular 
gene was the starting point. Once found, the information could be used to continue to find 
the next piece of the puzzle. Radiation hybrid mapping was used to find the niaD gene 
and a combination of some of the techniques, or variations of them, to continue the 
project.
1.5.2 Annotation
Gene annotation takes raw DNA sequence and adds useful information so that the 
downstream user can interpret the information. The annotator will always strive to be as 
correct and accurate as possible, but even with careful observation, it is extremely 
difficult to get everything 100% correct, so constant checks with other annotators and
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other interpretations would be made continuously to maintain the high standards. 
Genome annotation falls broadly into two sections. The first is the prediction of the 
position and start site of all of the genes and the second is to discern the function of the 
gene products.
In a given genome, a number of software programs can predict the majority of genes in a 
genome with a relatively high degree of accuracy and consistency. However, the nature 
of a genome will always throw up regions within the genome where gene prediction is 
particularly difficult and the programs will therefore never become 100% efficient. It 
might be good for a program to be accurate to 97% and well understood in other working 
areas, but for a genome scientist, it is usually the other 3% of unknown quantity that hold 
the regions of interest. Therefore the outputs of the prediction programs still need to be 
closely looked at and the results interpreted according to the investigator’s knowledge. 
Table 3 shows a few of the programs that are used for gene prediction.
Table 3. Gene prediction programs
Program
Glimmer
Orpheus
GeneMark
GeneMark.hmm
CRITICA
Source
http://www.tigr.org/softlab/glimmer/glimmer.html
http://pedant.gsf.de/orpheus/
http://opal.biology.gatech.edu/GeneMark/
Reference
Delcher et al (1999) 
Frishman et al (1998) 
Borodovsky and 
Mclninch (1993), 
Lukashin and 
Borodovsky (1998) 
http://geta.life.uiuc.edu/~gary/programs/CRITICA.html Badger and Olsen
(1999)
(Parkhill, 2002)
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Gene prediction is concerned with the determination of the open reading frames (ORFs) 
that begin with a start codon and ending in an in-frame stop codon, using software tools 
to predict these from the DNA sequence. What is essential with gene prediction is 
deciding which of the ORFs actually are coding regions of sequence. Also, it is obvious 
that all the genes in an organism will not be identical. There is a high likelihood that 
some sets of genes within a given genome will vary from the normal rules that those 
genes may adhere to in other organisms for example, genes that encode small basic 
ribosomal proteins or largely hydrophobic proteins or repetitive proteins. The gene 
finding programs will not always see these genes, as they do not always conform to the 
model of the genes within that organism. There are also other reasons, such as horizontal 
transfer of genes in recent evolution in a genome and there may be non-typical genes 
such as RNA genes, DNA repeats and psuedogenes that all contribute to gene prediction 
programs either not seeing genes or over-predicting genes in non-coding sequences. 
These all have to be removed or edited manually.
Following prediction, genes are given putative roles using databases such as FASTA 
(Pearson and Lipman, 1988) and BLAST (Alstchul et al 1990). It is likely the databases 
will give slightly different hits because of the differing calculation methods of the 
databases and it is therefore useful to run both searches to determine best hits according 
to the context of the sequence. The database searches are not 100% accurate or infallible 
though and therefore this step still requires further human intervention to ensure that 
there is a high degree of accuracy to function assignment. Comparison with biologically 
characterised function is always much more accurate than comparison with previous 
annotation as this can lead to mistakes and chains of wrongly annotated genes. To avoid
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problems of wrongly assigned functions, there is a further step of looking at protein 
families or motifs. This is done by identifying sequences or patterns that are common to 
all members of a particular protein family and then this information can be used to 
identify new member of that family. This can be a more accurate way of assigning 
function or structure as proteins usually have a modular structure and this can sometimes 
confuse the similarity based searches like BLAST and FASTA as different domains can 
match different sets of database sequences. PROSITE (Bairoch, 1991) looks for motifs 
and residue patterns in a protein. Short functional motifs such as enzyme active sites as 
easily found by this program, but although the method is highly specific, the program 
lacks the ability to identify larger and more diffuse features such as entire protein 
domains and has recently been modified to include profile information (Falquet et al 
2002). Further refinements of functional assignment do exist. The most useful of these is 
orthology and paralogy. These give very good insights into the mechanisms of functional 
transfer of information from one genome to another. Orthologues are equivalent genes in 
two organisms directly descended from the same gene in the two organisms direct 
ancestor. Paralogues are genes related through a gene duplication event in either the 
parent organism or in one of the descendants. Orthologues are usually seen to serve the 
same function yet paralogues have either usually perform the same function yet lead to 
functional redundancy or have diverged to perform a different function or act on different 
substrates. Therefore, if orthologues and paralogues of a given functionally characterised 
gene can be identified, the functional description of the characterised gene can be 
transferred to the novel gene (Figure. 2)
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a b c
A>B
A B A B
Figure. 2 The ovals at the top represent the ancestral species and the bottom ovals represent the descendant 
species. A and B represent given genes. A and A are orthologues in the descendant species and A  and B are 
paralogues in the descendant species. In (a), this illustrates a simple descent, (b) shows gene duplication o f  
A and B in ancestral species and (c) shows a gene duplication o f  A to B in one lineage only.
(Parkhill, 2002)
Looking for what is called reciprocal best matches between gene sets computationally 
helps the identification of orthologues. A gene is compared from one genome against all 
of the genes in a second genome. If a best match is found then this best match is then 
compared back against all the other genes in the original genome. If the second match 
identifies the original match from the first comparison, then it is known as the reciprocal 
best match. This can only be done to identify orthologues in two complete genomes of 
the organisms if the comparison is known. But this method is not always free from 
mistakes and some paralogous genes can be identified as orthologues. Careful manual 
checking has to be done at this process.
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Orthology can be checked by looking at synteny in related genomes. Synteny is the 
conserved gene order and orientation in a genome. Orthologues will tend to be found in 
areas of high conservation and in the same context as other orthologues in compared 
genomes. Any differences found needs great care in assignment of orthology.
Similarity based methods such as those just described can assign function to a gene 
putatively with a relatively high degree of accuracy, but it is only in the lab that a definite 
function can be ascribed to a particular gene.
It is imperative that an annotator is aware of what they are working on and should be 
vigilant of any potential problems that may arise. The information that is gleaned from 
the sequence is going to be new and novel and therefore the annotator must have a good 
biological understanding of both the bioinformatic analysis and the biological processes 
within the organism. The programs and techniques are good and they facilitate the 
tedious groundwork, but the full understanding and interpretation of the genomic 
information is the purview of the annotator.
1.5.3 Comparative Genomics
The use of comparative genomics will be an essential tool in analysing the sequence 
generated by the A. fumigatus project, especially the data from the closely related A. 
nidulans species. To date, little data have been released from the A. nidulans project, 
although the sequencing is virtually complete. A target date of Spring 2003 has been set 
by the Whitehead Institute to release annotation data
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(http://www-genome.wi.mit.edu/annotation/funRi/aspergillus/).
A number of important organisms, both related and unrelated to A. fumigatus have 
recently been sequenced and analysed and comparative genomic techniques applied to 
the findings. Here, I will review some of the more recent, relevant and more important 
aspects of current comparative analysis.
1.5.3.1 Characteristics in Neurospora crassa sequence
Neurospora crassa paved the way for modem genetics in the early 20th century and the 
sequence and annotation data was published by the Whitehead Institute in 2003 (Galagan 
et al 2003). It too, like the Aspergilli, is a multicellular filamentous fungus that has 
helped us understand concepts such as genome defence mechanisms, DNA methylation, 
circadian rhythms, DNA repair, post-transcriptional gene silencing and mitochondrial 
gene importation. It is also a good model for other eukaryotic organisms.
The assembled genome is approximately 40Mb in length. A total o f 10,082 protein- 
coding genes were predicted, with 9,200 longer than 100 amino acids in length. This is 
approximately twice the number as predicted in S. pombe and almost as many as the 
D. melanogaster. The genes were found to cover over 44% of the genome and a gene 
could be found approximately every 3.7kb. Gene length was found to be slightly longer 
than that o f S. pombe (1.67kb and 1.4kb respectively). Table 4 shows that Neurospora 
has a greater number of introns than S. pombe in its genes and this accounts for the longer 
gene length (on average, 1.7 introns per gene, each averaging at 134 nucleotides).
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Feature
G eneral
Size (bp)
Chromosomes 
G+C content (%)
Protein-coding genes 
Protein-coding genes >100 amino acids 
tRNA genes 
5S rRNA genes 
% coding 
% intronic
Average gene size (bp)
Average intergenic distances (bp)
Predicted protein-coding sequences
Identified by similarity to known sequences
Conserved hypothetical proteins
Predicted proteins (no similarity to known sequences)
Value
38,639,769
7
50
10,082
9,200
424
74
44
6
1,673 (481 Amino Acids) 
1,953
1,336(13%)
4,606 (46%) 
4,140(41% )
Table 4. Neurospora crassa genome features (Galagan et al 2003)
4,140 (41%) of Neurospora proteins do not match known proteins from public databases. 
5,805 (57%) of the proteins have no match to any genes in that of either S. pombe or 
S. cerevisiae. Only 14% (1,421) genes match either plant or animal genes. This indicates 
that its biology is not likely to be homologous to yeasts, but may have some homology 
with other filamentous fungi and higher eukaryotes.
Additionally, studies on repeat sequences over 200bp long with 65% similarity showed 
that 10% of the genome consists of repeat sequences (Kelkar et al 2001). This 
emphasises a phenomenon that is unique to fungi called Repeat-induced point mutation
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(RIP). This is a process that was originally detected in Neurospora crassa and is a highly 
efficient genome defence mechanism. Occurring during the haploid stage of the 
Neurospora sexual cycle, the method can detect and mutate both copies of a sequence 
duplication. Within the duplicated sequence, CG to TA is mutated at a 30% rate during 
the sexual cycle. It has been proposed as a mechanism for defence against mobile or 
selfish DNA. When the sequence was analysed, it was seen that 81% of the repetitive 
sequence in Neurospora had been mutated by RIP. Repetitions of over 400bp are most 
susceptible to RIP, with over 97% of the genomic repeats being RIP mutated. The 
hypothesis that RIP acts a defence mechanism is supported by the fact that there were no 
intact mobile elements identified in the sequence and 46% of repetitive nucleotides could 
be identified as mobile element relics.
Neurospora photobiology has been studied for a number of years because blue light has 
major implications in developmental circadian rhythms. The genome sequence has shown 
that there are a number of sequences that show similarity to blue light sensing genes and 
also homologous with Aspergillus nidulans velvet gene, which has been implicated in 
both red and blue light responses. This was unexpected, as no red light photobiology has 
been described for Neurospora crassa before. Arabidopsis has recently been shown to 
have phytochromes that associate with cryptochromes that have a role in blue light 
sensing and signalling (Devlin and Kay, 2001), therefore the two phytochromes and the 
velvet homologue may have a role in regulation of this aspect of Neurospora 
photobiology.
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MAPK (Mitogen-activated protein kinase) pathways integrate signals from multiple 
receptor pathways including two-component signalling systems. This mechanism is 
conserved, as the nine MAPK proteins identified in Neurospora are also found in both 
S. pombe and S. cerevisiae. In addition, Neurospora has a complement of 11 histidine 
kinases, compared to one in S. cerevisiae and three in S. pombe. A  third of these genes 
are similar to proteins found in A. fumigatus and A. nidulans that affect conidiation 
(unpublished data). The functions of the rest of the genes are unknown, although seven 
contain PAS/PAC domains, which would implicate them in light and oxygen responses. 
The number of histidine kinases is thought to show that they have a larger role than 
thought and shows that filamentous fungi are more similar to plants than animals, where 
two-component systems are less abundant.
The sequence has also shown that the pathway for macroconidiation differs in both 
Neurospora and A. nidulans. Components of the pathways have been found in both 
species and some signalling proteins are known to be conserved upstream. But in 
contrast, there is little conservation downstream between the two fungi. Neurospora 
requires the acon-2, acon-3,fld and f t  genes for conidiation. A. nidulans requires the 
FlbC, FlbD, BrlA, AbaA and WetA gene products to perform the same function. The 
Neurospora sequence has not revealed any FlvC, BrlA or AbaA homologues, with only a 
weak similarity in one protein that has 100 amino acids of the carboxy terminus of the 
WetA gene. This shows that the mechanics of similar functions of the two fungi are very 
different.
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Although Neurospora is a saprotroph, the sequence contained a number of genes required 
for plant pathogenesis, identified in other fungal pathogens. It contains a number of genes 
that code for a wide range of extracellular enzymes that digest plant material, although 
there is no observed cutinase homologue, which is the enzyme that breaks down cutin 
found in many other plant pathogens. It also contains a number of cytochrome P450 
enzymes that help in the detoxification of plant anti-fungal compounds. The sequence 
also shows that all the known signal transduction components used in ascomycete 
pathogenesis are present in Neurospora even though Neurospora is not known to be a 
pathogen.
1.5.3.2 Comparative Genomic Analysis of Vibrio cholerae
In 2002, Dziejman et al published an analysis of Vibrio cholerae, the causative bacteria 
of the disease cholera. The majority of their studies used the technique of microarraying 
to carry out the comparisons of a number of strains relating to endemic and pandemic 
outbreaks of the disease. The study was originally set up to analyse the evolution of 
V. cholerae as a human pathogen and environmental organism. The complete sequence of 
the “El Tor” 01 Strain N 16961 from the 7th pandemic was used as a starting point for 
comparison. Another serogroup, 0139, shares locality with the 01 strain in many areas 
and are thought to be closely related, with the 0139 evolving from the 01 strain using 
various molecular typing methods such as ribotyping, RFLP analysis and sequence 
analysis and comparison of homologous housekeeping genes. The El Tor strains can be
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distinguished from “classical” strains that have caused previous pandemics by their 
haemolytic properties and agglutination with erythrocytes, as well as antibiotic resistance, 
The comparison of the El Tor strain was done against a classical strain, pre-pandemic El 
Tor strain, another pandemic El Tor strain and two non-toxigenic strains to find unique 
genes in N 16961.
The analyses found a high degree of genetic similarity between the strains that had been 
isolated over the past century, but some genes were found to be unique in the El Tor and 
0139 strains. It is these unique genes that may have contributed to the success of these 
two strains.
The array analyses identified 143 genes that were absent from the eight of the nine test 
strains compared to N16961 (Table 5).
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Table 5.
Strain Origin Y ear Isolated Biotype, serogroup No. g en es;
N16961 Bangladesh 1971 El Tor, 01  (7th N/A
2740-80 G ulf Coast, US 1980
Pandemic) 
Environmental, non- 49
NCTC 8457 Saudi Arabia 1910
toxigenic El Tor 01  
El Tor 01  (Pre­ 39
MAK 757 Celebes Islands 1937
pandemic)
El Tor 01  (pre- 49
569B India 1948
Pandemic) 
Classical, 01 46
0395 India 1965 Classical, 01 36
NIH41 India 1940 Classical, 01 48
HK1 Hong Kong 1961 El Tor, 01  (7th 0
C6709 Peru 1991
Pandemic)
El Tor, 01  (7th 1
MO10 India 1992
Pandemic)
El Tor, 0139 47
(From Dziejman et al 2001)
Strain HK1 seemed to be identical to N16961. C6709 was missing only 1 gene. The 
remaining seven strains all were missing between 36 and 49 genes, an approximately 1% 
difference between the genomes of the test strains and N 16961. In comparison to studies 
done on S. aureus and Helicobacter pylori, this is a marked difference. Approximately 
12% of the genes were missing within different strains of S. aureus and 6% with
H. pylori. This suggests high genomic conservation between strains over the past century, 
a remarkable feat. The identified genes fell into 4 main groups (Table 6).
36
Table 6.
G roup  S tra ins w here genes a re  absent No. o f genes absent*
Group I 0395 7
Genes present in El Tor but not classical 569B 7
strains NIH41 7
Group II 2740-80 14
Genes present only in strains able to cause NCTC8457 14
epidemic disease (absent from MAK757 2
environmental and pandemic El Tor)
Group III 2740-80 22
Genes present only in 7th pandemic strains NCTC8457 22
HK1, C6709 and MOIO MAK757 22
0395  22
569B 22
NIH41 22
Group IV MOIO 42
Genes uniquely absent from a single strain N IH41 14
MAK757 15
* Genes identified by array, PCR and/or Southern analysis 
(from Dzeijman et al 2001)
Some genes could differentiate the classical biotype strains from those of the El Tor 
biotype strains. The genes would be in all strains except classical. The microarray 
technique would not allow the researchers to identify the genes only in classical strains as 
the microarray itself was constructed from N16961. The “non-classical” strains were all 
El Tor strains of diverse origin and all contained a pathogenicity island coding for the
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TCP pili of the CTX bacteriophage that encodes the cholera toxin in the bacterium. 
Therefore, it could be deduced that they are all potentially pathogenic.
Genes were identified in only pandemic strains, including the classical strains (group 2).
iLOther genes that were found to be specific to the 7 pandemic strains, including epidemic 
and endemic El Tor 01 and closely related 0139 strain MO 10.
1.5.3.3 The genome sequence of Plasmodium falciparum
The human malaria parasite Plasmodium falciparum is responsible for hundreds of 
millions of cases of malaria and kills over 2,700,000 people worldwide every year. 
Despite many years of research, it is becoming more and more prevalent in tropical and 
sub-tropical regions.
In 2002, a consortium consisting mainly of the Institute for Genome Research in the USA 
and The Sanger Institute published the genome sequence and its subsequent genomic 
findings (Gardner et al 2002). Here I will give a brief overview of the findings made.
Using whole genome shotgun technology, the sequence was assembled using YACs to 
assist contig ordering and gap closure and using sequenced tagged sites (STSs), 
microsatellite markers and HAPPY mapping to orientate the contigs. A very high A+T 
content made the gap closure very difficult as this makes the genome much more unstable 
and making it less conducive to standard sequencing techniques.
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The genome consists of 22.8Mb along 14 chromosomes that range in size from 0.6Mb to 
3.3Mb. This is nearly twice the size Schizosaccharomycespombe. The A+T content is 
approximately 80% and was found to rise to over 90% in introns and intergenic regions. 
Various computer programs predicted protein encoding genes and these were then 
manually curated. There were approximately 5,300 protein encoding genes identified, 
which was approximately the same as that found in S. pombe (Table 7). This infers a gene 
density of one gene per 4,338bp. Introns were predicted in 54% of P. falciparum, which 
equates to being similar to that found in both S. pombe and Dictyostelium discoideum, but 
much higher than that found in Saccharomyces cerevisiae, which has only 5% of genes 
containing introns. The mean length of the gene, excluding introns, was 2.3Kb, much 
higher than that found in other organisms, which are usually between 1.3 and 1.6Kb. 
There were also a much higher proportion of genes that were over 4Kb in length (15.5%). 
S. pombe and S. cerevisiae have 3.0% and 3.6% respectively. Many of these larger genes 
encode for uncharacterised proteins that are thought to be cytosolic proteins as there are 
no recognisable signal peptides. There were also no transposable elements identified, so 
the reason for this increased length of these genes still a mystery.
Table 7.
Feature P. falciparum S. pombe
Size (bp) 22,852,764 12,462,637
G+C content (%) 19.4 36.0
No. o f  genes 5,268* 4,929
Mean gene length 2,283 1,426
(bp)
S. cerevisiae D. discoideum+ A.thaliana
12,495,682 8,100,000 115,409,949
38.3 22.2 34.9
5,770 2,799 25,498
1,424 1,626 1,310
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Gene density (bp 
per gene)
% coding
Genes with introns
(%)
Exons
Number 
No. per gene 
G+C content (%) 
Mean length (bp) 
Total length (bp) 
Introns
Number 
G+G content (%) 
Mean length (%) 
Total length (bp)
4,338
52.6
53.9
12,674
2.39
23.7 
949
12,028,250
7,406
13.5
178.7 
1,323,509
2,528
57.5
43.0
ND
ND
39.6
ND
ND
4,730
ND
81.0
383,130
2,088
70.5
5.0
ND
NA
28.0
ND
ND
272
NA
NA
ND
2,600
56.3
68.0
6,389
2.29
28.0
711
4,548,978
3,587
13.0
177
643,899
4,526
28.8
79.0
132,982
5.18
ND
170
33,249,250
107,784
ND
170
18,055,421
Intergenic regions
G+C content (%) 13.6 ND ND 14.0 ND
Mean length (bp) 1,694 952 515 786 ND
RNAs
No. oftR N A  genes 43 174 ND 73 ND
No. o f  5S rRNA 3 30 ND NA ND
genes
No. of5.8S, 18S 7 200-400 ND NA 700-800
and 28S rRNA 
units
ND, not determined, NA, not applicable
*70% o f  genes matched ESTs or encoded proteins detected by proteomic analyses
+ “No. o f  genes” is figure for Chr 2 only. Genome still yet incomplete, therefore some figures extrapolated 
for whole genome. Other genomes stated here are complete.
(Gardner et al, 2002)
40
Over half of the genes predicted (52%) were detected in samples taken from several 
stages of the life cycle of the parasite. 49% of these genes with 97% identity over lOObp 
overlapped with expressed sequence tags (ESTs) which were also taken from different 
cell cycle stages. At the time of their writing, the group had not completed proteomic and 
EST studies to a depth enough to back some data up, but it could be assumed that the 
annotation process identified large proportions of most genes. But to fully predict 
correctly, the identification of the 5’ ends of genes and genes with small exons is very 
difficult without the support of EST and protein evidence. It was suggested by the 
consortium that further studies into ESTs and full length complementary DNA sequences 
would be required to develop more intuitive training sets for gene finding programs to 
verify predicted genes.
60% of the 5,268 predicted proteins (3,208 hypothetical proteins) did not have the 
required similarity to proteins in other organisms to assign functions. It was therefore 
proposed that nearly two thirds of the proteins are unique in the organism, which is much 
higher than found in previously sequenced eukaryotes. This may be down to the greater 
evolutionary distance between Plasmodium and other sequenced eukaryotes. This is 
magnified by the much higher A+T content of the genome, which will decrease the 
likelihood of sequence similarity in other organisms. 5% of the proteins (257) had 
significant similarity to hypothetical proteins in other organisms. 1,631 (31%) predicted 
proteins contained one or more transmembrane protein domain and there were putative 
signal peptide and signal anchors found in 911 (17.3%) of the predicted genes.
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The Gene Ontology (GO) database (Ashbumer et al 2000) was used to describe the roles 
of genes and gene products in the P. falciparum genome. GO terms were assigned to 
2,134 gene products (40%). A comparison from the paper between P. falciparum and 
S. cerevisiae can be seen in Figure 3. There are higher values for nearly all categories in 
S. cerevisiae than in P. falciparum, which is due to the larger proportion of the genome 
being characterised. Two exceptions to this are related to the parasite cell life cycle. It 
was found that at least 1.3% of the genes in P. falciparum are involved in cell-to-cell 
adhesion or invasion of the host cells. There are 208 (3.9%) genes in the genome that are 
known to be involved in host immune system evasion. This is indicated by the number of 
gene products designated “physiological processes” in P. falciparum compared to that of 
S. cerevisiae.
Highlighting the reasonable lack of knowledge of P. falciparum compared to other 
organisms such as S. cerevisiae is the number of areas that are under-represented in the 
P. falciparum genome. For instance, the GO terminology had very few assignments in the 
areas of sporulation and cell budding, which are included in “other cell growth and/or 
maintenance”, but this was to be expected. But it was also found that very few genes in 
P. falciparum were designated in “cell organisation and biogenesis”, the “cell cycle” or 
“transcription factor” compared to that of S. cerevisiae.
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Figure. 3 Gene Ontology classifications. Classification o f  P. falciparum proteins according to the 
“biological process” (a) and “molecular function” (b) ontologies o f  the Gene Ontology system.
(Gardner et al, 2002)
When subjected to comparative genome analysis with other sequenced eukaryotes, the 
research showed that in overall genome content, P. falciparum is most closely related to 
Arabidopsis thaliana. But the affinity that seems apparent between Arabidopsis and 
Plasmodium may not show the true phylogenetic history of the P. falciparum lineage.
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Any vaccine produced from these studies must induce a protective immune response that 
is better than those provided naturally. Up to the point of the publication date, 
approximately 30 antigens had been identified using conventional techniques and some 
have been tested in clinical trials, with one giving partial protection in field settings. The 
genome publication will hopefully stimulate research into hundreds more potential 
antigens which could be scanned for properties such as surface expression or limited 
antigenic diversity. Combined with stage-specific expression data from microarrays and 
proteomics, potential antigens from one or more stages of the life cycle could be 
identified. But for the genome to have an impact on vaccine development, high 
throughput immunological assays that can identify novel candidate vaccine antigens that 
are targets of protective humoral and cellular immune responses in humans needs to be 
developed. Also, new methods in to maximise the longevity and quality of the immune 
response will have to be developed to produce effective malaria vaccines. These kind of 
studies will be carried out at the completion of the whole genome sequencing project, but 
the pilot project may give a small glimpse of what to expect. A more in depth analysis of 
the findings of this sort are discussed further in chapter 4.
1.5.3.4 Genomic approaches to fungal pathogenicity (and related studies)
The previous sections provide examples to illustrate that genomics will be invaluable in 
understanding pathogenicity as conventional genetic and biochemical methods are very 
limited, especially in pathogenic fungi.
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Lorenz published a review in 2002 (Lorenz 2002) outlining the techniques that are used 
to characterise pathogenicity traits in fungi. Mutagenic techniques have been staple 
techniques for many years in genomic studies, with the isolation and analysis of mutants 
providing good information in many projects. Genomic approaches make identification 
of mutated loci and the creation of mutant pools much easier. Signature tagged 
mutagenesis (STM) for bacterial pathogens was developed by Holden (Hensel et al,
1995) and was used for Aspergillus fumigatus. Holden tested 4648 STM strains in a 
mouse model of aspergillosis and found that two insertions were reproducibly defective. 
One of these was upstream of the pabaA gene, which encodes for /rara-aminobenzoic 
acid (PABA) synthase. There were no known in vitro phenotypes but a growth defect was 
detected in the absence of PABA. Moreover, it was markedly avirulent unless the mice 
were fed PABA supplements. The presence of PABA had never before been associated 
with virulence in fungi.
Microarray analysis has been used successfully in Vibrio cholorae as described in 1.6.3.2. 
In C. albicans, exposure to itraconazole was used to induce expression changes in 296 
genes on a slide from Incyte Genomics containing 6,600 Open Reading Frames (ORFs), 
ESTs and genomic fragments. The upregulated genes included most of the ergosterol 
biosynthesis pathway, which is a known target for triazole compounds.
A consortium, led by the laboratory of Braun published data (Braun et al 2001) on the 
construction and use of a 2000 gene filter based array. They used the array to study 
morphogenesis by profiling C. albicans strains in the TUP1 and NRG1 genes. ScTUPl is
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known to be a transcriptional repressor targeted to specific genes by ScNRGl. Mutations 
is tupl and nrgl code for filamentation. With this, CaTUPl and CaNRGl co-regulate a 
number of genes involved in yeast-hypha transition, including HWP1, ECE1, ALS3 and 
ALS8. They also have promoter regions similar to those found to bind to NRG1 in vitro. 
CaTUPl is also targeted to promoters by CaMIGl protein, which co-regulate genes 
unrelated to morphogenesis.
A two-hybrid system, developed by Fields (1989) was used to good effect to study 
protein-protein interactions. Requiring in frame fusions with ORFs, hundreds of 
thousands of clones were screened for the small fungal genome. Uetz et al (2000) 
systematically cloned 6000 ORFs into both fusion constructs. Transformants were pooled 
and 962 interacting pairs were found. Alternatively, they arrayed 6000 strains, each 
expressing one fusion and screened against 192 selected “bait” proteins, which identified 
281 pairs. It was simpler, but interference was higher; only 20% of initial interactions 
were confirmed. This needs to be optimised, but it shows that the genomic approaches 
have advantages.
Snyder et al designed protein arrays with 5800 yeast proteins, expressed in yeast and 
purified as glutathione-S-transferase (GST) fusions. Control experiments using an anti- 
GST antibody found 93.5% of the spots were detectable. The array was then probed with 
a biotinylated calmodulin which identified six known and 33 unknown calmodulin- 
binding proteins. The array was also used to identify liposome-binding proteins that 
contain various phosphotidylinositol compounds. It was also used to study kinase
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specificity (Zhu et al 2000). As this shows, it would be easy to adapt this to pathogenic 
fungi, to find host factor binding proteins for example.
Pathogen information will be improved by the systematic examination of every gene in a 
pathogenic organism to uncover the overall expression patterns. Microarrays could also 
provide information on drug responses in those organisms. Gray (1998) used microarrays 
to measure the effects of kinase inhibitors on the whole of the yeast genome. This was 
done by measuring changes in mRNA levels before and after treatment.
Genomics will bypass the traditional challenges in fungal pathogens and present a good 
opportunity to look at virulence. Some technologies have not yet been applied to 
pathogenic fungi, as there are still a lot of fungal pathogens to be sequenced. When this 
occurs, we will see rapid and productive applications of genomics in this field.
With respect to transcriptomics and proteomics, Gavin et al (2002) performed a large- 
scale study of the multiprotein complexes in Saccharomyces cerevisiae using Tandem- 
affinity purification (TAP) and mass spectrometry. 1739 genes were tagged. 1143 of 
these had human orthologues. There were also 589 purified protein assemblies. The 
analysis of the assembly data showed 232 different multiprotein complexes and from 
those showed that 344 proteins had new, previously unknown cellular roles. From those, 
231 had no previous functional annotation in the databases. There was seen to be 
conservation across species between human and yeast complexes, from single proteins to 
their molecular environment.
47
Patterns that could identify genetic regulatory networks or gene groups that are similar 
have been demonstrated on human cell lines and yeast (Tavozoie et al 1999, Spellman 
et al 1998). The Spellman group found 800 S. cerevisiae genes whose transcripts 
alternate through one peak per cell cycle. The 800 genes were identified using objective, 
empirical models of cell cycle regulation, but with an arbitrary threshold. Below this 
threshold, it was not known if there were genes whose expression was truly periodic or 
the periodicity might even have biological significance.
1.6 In conclusion
Aspergillus fumigatus is fast becoming a very important, medically significant organism. 
It is unusual in that it is an opportunistic pathogen. It can affect both 
immunocompromised and normal hosts in a variety of ways, from skin lesions to eye 
infections to full blown lethal lung and central nervous system invasion. Because of the 
highly opportunistic nature of A. fumigatus, immunocompromised host groups are at very 
high risk of infection. As the worldwide incidence of HIV/AIDS, organ transplants and 
other immunocompromising illnesses increase, the combat against A. fumigatus becomes 
more and more important. A. fumigatus infection is now the most common mould causing 
infection worldwide and is the most prevalent and virile of the known aspergillosis 
causing aspergilli. It is extremely resistant to virtually all known anti-fungal drugs, with 
many of them having little or no effect. Of the dmgs that do have limited effect, these 
usually have severe and highly unpleasant side effects for the host.
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So far, little study on the genetic mechanisms of A. fumigatus has been carried out. In 
fact, little is known about its genetic make-up at all. So far, there are only a small number 
of genes in the public databases that can be accessed. This is compared to A. nidulans, its 
closest relative, where there are over 400 genes in the databases. It is still not known what 
the definitive chromosome number is for A. fumigatus.
This study was initiated to determine the feasibility of sequencing the entire A. fumigatus 
genome on a small and manageable scale. The proposal was to sequence 1Mb and if this 
was successful, then the sequence would be annotated to determine what information the 
sequence carried. The thesis describes this sequencing, the strategies used and the 
background to the choice of vectors and technology. It is broadly divided into three parts: 
BAC library construction, physical mapping and annotation. Once this was complete and 
was determined then the whole genome sequence could be undertaken, with the process 
scaled up to achieve this. The sequence could be used in comparative and post genomic 
studies to determine factors such as the mechanisms to its pathogenicity and virulence, as 
well as its other biological mechanisms to give a much greater understanding of how the 
fungi works at a genetic level. This information would hopefully lead to more successful 
drug therapies and development of more specific host and organism-targeted drugs.
Genomics and post genomics are going to play a large part in the understanding of 
A. fumigatus. As in the examples of other organisms such as Plasmodium falciparum, as 
well as related organisms such as the yeasts S. cerevisiae and S. pombe, the genomic 
approach can determine large amounts of very useful information about the organism.
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At the time of writing, the whole genome sequencing of Aspergillus fumigatus is well 
under way.
2. BAC library construction
2.1 Introduction
2.1.1 History of Vector development
Until the mid 1980’s, genomic research relied on approaches that used DNA vectors such 
as plasmids, cosmids and bacteriophage X. Stable, large inserts could not be generated. 
Cosmids were developed in 1978 by Collins and Hohn. These are plasmid/bacteriophage 
hybrids (ColEl) that carry cohesive ends (cos) of X and can be packaged in vitro, using a 
system developed by Hohn and Murray (1977). They can be manipulated to accept inserts 
of 35-45kb and as they are multi copy, a high yield of DNA can be generated. However, 
the vector itself cannot carry inserts over the stated size the cosmid needs to be packaged 
into the Bacteriophage X head with the physical size of the insert being the limiting 
factor.
In 1979, Sternberg published data on the development of the PI vector. This worked in 
similar way to that of the cosmid, but could be packaged into a much larger 
Bacteriophage PI head increasing the possible insert size from the 45kb of a cosmid to
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lOOkb in the PI. PI also has the added advantage that it was a single copy vector. This 
factor inherently gave the DNA much better stability than was found in cosmids.
Cosmids and PI became the vectors of choice for a number of years. This was because of 
their ease of use and no special laboratory requirements were needed. They also 
efficiently produced high yields of DNA. But genome research became more intense and 
larger regions of DNA from more complex organisms were of interest to scientists. The 
limitations of insert stability and size became more and more apparent.
In 1987, Burke et al developed the Yeast Artificial Chromosome (YAC). It promised the 
possibility of being able to routinely clone inserts of up to 1MB and could change the 
face of genome mapping and analysis. It was envisaged that even the largest genomes 
could be analysed with fewer clones covering regions of interest, genome wide. Whole 
genes or gene clusters could be studied without the need for manipulation to reconstruct 
the region of interest.
Unfortunately, as work geared up to make full use of this new cloning vector, it was seen 
that there were some serious drawbacks with this method. The construction of a YAC 
library was very labour intensive and complicated. New techniques had to be developed 
and learned, followed by protracted periods of careful production. This would involve 
duplicating procedures repeatedly to generate a large enough number of clones to create a 
library to cover a genome. YAC clones were therefore seen as expensive, time 
consuming and difficult to master. Only a few laboratories were able to invest in the 
technique. Moreover, YAC clones had high levels of chimerism and insert rearrangement 
(Burke 1990; Neil et al 1990; Green et al 1991; Venter et al 1996). These clones were 
thus considered unusable for sequencing large genomes and with too much effort targeted
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into eliminating chimeras and rearranged inserts. What was required was a vector that 
would allow easy and efficient cloning of insert sizes that were big enough to allow 
relatively deep coverage of genomes and gene clusters, as well as the ability of the clones 
to be easily manipulated and stored. This would allow the distribution of clones and 
libraries to other laboratories and thus in turn widen the study and approach by the 
scientific community.
In the early 1990s three vectors were developed. Firstly, Kim et al (1992) developed the 
Fosmid. This was a modified form of a cosmid based on the F factor replicon of E. coli. It 
is a low copy vector and because of this it has inherent stability. One major advantage 
was the generation of libraries of certain DNA that previously had been unclonable in 
E. coli because of high copy number. Fosmids allowed the maintenance and propagation 
of unstable and unclonable genomic segments and allowed the construction of libraries 
with a more comprehensive representation of the genomes under study. But the 
disadvantage was that the insert size was not much larger than that of a cosmid. The 
development of the Bacterial Artificial Chromosome (BAC) (Shizuya et al, 1992) from 
the fosmid and then the PI Artificial Chromosome (PAC) (Ioannou et al, 1994) has 
revolutionised cloning.
The vector of choice for large-scale genome analysis and mapping is the Bacterial 
Artificial Chromosome (BAC) (Cai et a l 1998). The basic structure of most BAC vectors 
is not strictly artificial but is based on the E. coli F factor. This incorporates some 
essential genes that provide stability and are also involved with copy number.
An important reason for using a BAC, as opposed to using PI Artificial Chromosome 
(PAC) is the actual size of the vector. BAC cloning has superseded PAC cloning because
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PAC vectors are often around 16kb long, whereas BAC vectors are usually no more than 
8-9kb. Working with BACs therefore becomes much easier. Also, pBACe3.6 contains 
several unique cleavage and modification sites that other BAC vectors do not have.
The F-factor in E. coli is a ~100kb plasmid which codes for more than 60 proteins that 
are involved in replication, partition and conjugation. The F-factor is usually present in a 
closed circular, double stranded form, with maybe 1-2 copies per cell. It can insert 
randomly into 30 or more sites on the E. coli chromosome.
BAC vectors now utilise only minimal sequence needed for autonomous replication, 
partitioning of the plasmid and copy number control. The genes that code for the proteins 
to do this are derived from the F-factor and are listed as thus: oriS, is the origin of 
replication and is unidirectional; repE encodes for a protein called RepFIA protein E that 
is autoregulatory and is required in replication from oriS; parA, parB and parC are 
required for ParFLA partitioning and parB and parC are required for compatibility with 
other F factors.
2.1.2 Technical considerations for library production
The development of BAC and PAC vectors mentioned in 2.1 allowed the rapid analysis 
of large genomic regions, complete genes and provided the tools for large-scale genome 
analysis. Whole libraries with very deep coverage (greater than xlO) of the human 
genome could be gridded out onto Nylon filter membranes and used in hybridisation 
experiments providing unlimited shelf life for storage. BACs allow insert sizes of up to 
300kb, with most libraries regularly having average insert sizes of 80-200kb. Although
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insert sizes are much bigger than that of cosmids, the inserts are still nowhere near the 
sizes of those cloned into YACs. However, BACs are easier to manipulate in culture and 
bacterial cultures tend to grow more rapidly than yeast. They are also easier to grid and 
handle. The growth is denser, which in turn allows better screening. But probably the 
most important factor is that pure DNA from bacterial clones can be extracted in high 
yield using simple plasmid preparation techniques.
The most important aspect of a genome study is to simplify the logistics of the project to 
save time and cost. The proportion of the genome represented in the library needs to be 
maximised. This can be done by increasing the overall depth of the library. Increasing the 
library size significantly increases the chance of creating contiguous pathways of 
overlapping clones. Whole genomic regions can be spanned in this way. It also 
maximises the chance of finding a clone that has a locus of interest within it. Determining 
overlap of clones is important in three ways. It allows correct orientation with respect to 
other clones, as they would be in the genome. It also helps identify the path of clones 
across a genomic region of interest and provides proof that the clone belongs to the 
genome of study. The larger the library size, the greater the chance of a sizeable overlap. 
It might be preferable to be able to make libraries as large as possible, but there are other 
constraints that have to be considered in financial and practical terms.
Secondly, creating a library with larger average insert sizes means fewer clones overall to 
cover a region under study. Insert size is an important part of genome analysis as it 
determines the genome coverage in the library. If markers are known in the genome at 
lOOkb spacing, there is no point having a library of insert sizes of 50kb as it will rarely 
link two markers together. Other methods such as walking or fingerprinting would be
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needed to complete the genome “map”. Whereas a library with insert sizes of 150kb will 
allow contiguous overlapping of clones. But there are inherent problems with this 
approach. If the sizes of the clones themselves are too large then this could cause 
problems with the computer assembly.
Ideally when a library is constructed, the total amount of DNA in the library, represented 
by summing the sizes of all the inserts, is usually a factor bigger than the total amount of 
DNA in the whole genome of the organism of study. The ratio of DNA in a library to that 
of the DNA in the genome of study is known as the depth of coverage, or redundancy. 
There are a number of factors in determining the depth of coverage and quality of a 
library when constructing a library for the first time: genome size, desired number of 
clones, vector only clones or empty wells and the average insert size. Genome coverage 
of a library can be calculated using the following formula: 
c (genome coverage) = (total number o f clones-non contributing clones)x average 
insert size/haploid genome size.
The coverage value gives an indication of the number of clones that contain a gene or 
locus of interest that will be in the library. But it is only an indication. Some genomes 
contain loci that are very difficult to clone (high number of repeats, chimeric DNA etc). 
These regions may not be represented in the library. There may also be certain areas in 
the genome that are not represented well purely because of the uneven spread of clones 
across the library. Some regions may be over represented in the library. If it is assumed 
that the library is random, probabilities of loci being present in the library follows a
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Poisson distribution if the coverage is between 0.5 and lOx. It also has to be assumed that 
the genome size is 100 or more times larger than the average insert size (see Table 8)
Table 8.
Probability of having one or more clones/loci with a library as a function of library 
size.
Library Size 
(genome coverage) P (%)
0.5 39.3
1 63.2
2 86.4
3 95.0
4 98.2
5 99.3
6 99.75
7 99.91
8 99.97
9 99.99
10 99.995
The probability o f  finding x clones from a library o f c coverage is calculated as:
P(x) = CVxl x e c 
(Dunham et al, 1997)
Although it is assumed with these calculations that the cloning has occurred randomly, 
the calculation is actually an overestimation. Some genomic regions are not equally well 
adapted as other regions for cloning. From the large number of factors that create cloning 
bias, two are most prominent. Firstly, the sites that restriction enzymes work on are not
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evenly spread across the genome. Secondly, certain regions in genomic DNA are lethal to 
the E. coli host. To counteract this, library construction must have a depth that is larger 
than that predicted by the Poisson distribution. If a genome is small or if only a few 
clones per loci are required, then a lOx coverage library would be of good use, but would 
be economically unfounded. But if a walking or mapping strategy is to be utilised, where 
each clone needs to be verified, then there are going to be regions where there will be a 
greater probability of there being no clones present for the next step. So constructing 
larger libraries with greater depth will increase the probability that contigs can be 
contiguously built over large areas of the genome, but can also allow a much higher 
flexibility in selecting clones that will provide a minimal tiling path for sequencing 
(i.e. the coverage that takes the least number of clones to cover the region). Therefore, 
with these considerations in mind, the number of clones required in a library can be 
calculated.
When constructing libraries that have large depth of coverage, a large number of clones 
need to be generated and handled. Because of this, the logistics of handling, storage and 
manipulation become a lot more complicated. The table below shows numbers of clones 
required for a 7.5x coverage of organisms of differing genome sizes (see Table 9)
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Table 9.
Haploid Average Library size
genome size insert size
o f  organism o f  clones no. o f  clones no. o f  384 well
(Mb) (Kb) plates
20 50 3000 8
1000 100 7500 20
3000 50 450,000 1172
3000 150 150,000 391
(Dunham et al, 1997)
This illustrates that there are a number of factors in combination that determine how large 
a library should be, clearly shown by the discrepancy between the genomes that are both 
3000Mb long, yet with a larger insert, the number of plates to handle is vastly reduced.
2.1.3 The Vector
The vector that was used for the Aspergillus fumigatus library was pBACe3.6. It has a 
number of other features within its genotype that make it highly conducive to accepting 
large inserts of DNA and maintaining them with a high degree of stability. The wildtype 
loxP site is retained as well as including an additional mutant loxP511 site. loxP stands
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for “locus of crossing over o f PI phage” and is involved with the CrQ-loxP 
recombination. Cre is the enzyme that catalyses the reaction. An animated illustration of 
how this mechanism works can be seen at
fhttp://www.clontech.com/products/families/creator/popups/creloxanimation.shtml). The 
mutation loxP511 is a recombination proficient mutation with regards to other mutations, 
but is less proficient than the wild type loxP. Incorporated into the loxP511 mutation is 
the Pl-Scel site. Pl-Scel is a “homing endonuclease” usually found in eukaryotes, 
prokaryotes and archaebacteria and is coded for by a kind o f parasitic DNA element that 
is highly proficient at replicating itself. Pl-Scel is produced by an autocatalytic protein 
splicing reaction from a precursor protein and works enzymatically on the cleavage of the 
DNA at a defined position. By doing this, it initiates the recombination of its own gene 
into a genome that does not have it (Frengen et al 1999). Close to this site is a Tn7att site, 
which is present to aid downstream manipulation such as gene knockouts. It retrofits 
DNA by utilising the specificity of the Tn7 within the genome and without affecting the 
insert in any way.
Positive selection for inserts containing BAC clones is achieved through inclusion o f the 
sacBII gene from Sternberg's PI vector (Pierce et al. 1992,). Possession o f this gene is 
lethal to E. coli when it is grown on sucrose containing medium. This is because the gene 
codes for levansucrase, which converts sucrose to levan, which is highly toxic to the 
cells. If an insert disrupts this gene, then the cell will grow, as the gene has been 
disrupted and no levansucrase is expressed.
The sacB selection that is built into the genotype of the vector helps this enormously.
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As shown in figure 4, the vector has a split mutli-cloning site either side of the stuffer 
fragment. This allows the insertion of inserts that are cut with a number of restriction 
enzymes. pBACe3.6 will accept inserts cut with BamRl, SaclI, EcoRl, Sad  and Mlul. 
This versatility allows the investigator much more freedom in the enzymes that they use. 
A full review of this vector can be read in the paper by Frengen et al (1999) and the full 
sequence can be found in GenBank Accession No: U80929.
The parental form of the vector has a 2.7kb pUC plasmid, or “stuffer fragment” inserted 
into the sacBII gene. The “stuffer fragment” is removed in the preparation of the vector. 
The stuffer fragment is inserted into the sacBII so to leave the cloning site within the 
gene when the stuffer fragment is removed. If an insert does not incorporate, then the 
gene is fully functional and therefore becomes lethal to the cell in the presence of 
sucrose. The “stuffer fragment” is there for another reason: it increases the copy number 
of the vector to ensure large quantities of DNA during propagation and preparation of the 
vector. It is preferable to have as few colonies that do not contain inserts as possible.
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Figure 4. A diagrammatic map o f pBACe3.6 (http://bacDac.chori.org/vectorsdet.htm)
2.1.4 DNA Source
The cells (Af293) that were used for this project are pathogenic and they come from a 
well-maintained cell line that was isolated from the lung of a 57 year old woman patient 
from Shrewsbury in 1993 and cultured at the Public Health Laboratory o f The Royal 
Shrewsbury Hospital, Shrewsbury, England. High purity DNA was important to 
eliminate any contamination that could hamper the ligation process. Any small, spurious 
DNA fragments will compete with the larger, required inserts and bring the overall insert 
size and coverage down. Other contaminants may also inhibit enzymatic activity. For the 
pilot project, it was initially envisaged that 1MB would be sequenced since we were
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working from a set starting target with an unknown genomic position. Therefore a library 
needed to be generated from the whole genome to include all regions of the genome. The 
integrity of the DNA was important, as this would make the job of creating large inserts 
easier. Low quality DNA in smaller fragments would make it difficult to control the size 
of the fragments during digestion and bias the library towards smaller inserts. There 
needed to be enough DNA to work with, so concentration was also important. Both a 
high and low concentration of DNA tends to bias the library towards smaller inserts but 
can allow a high enough concentration for the ligations to work, as we found out. For 
BAC library construction, the DNA is prepared in agarose plugs, allowing isolation of 
very large fragments of DNA that can be manipulated in situ following restriction 
enzyme digestion and Pulsed Field Gel Electrophoresis. Fragments hundreds of kilobases 
in size can be generated and isolated. The DNA can be “cleaned” by a “pre­
electrophoresis” step which removes the cellular debris, as well as smaller fragments of 
DNA and some RNA that may be present and hinder the downstream processes used to 
generate the library.
2.1.5 Bacterial Host Strain
DH10B was selected, due to the presence of the deoR gene. deoR and CytR regulate the 
deo operon which is involved in the uptake and catabolism of nucleosides and 
deoxyribonucleosides. The operon regulates the cluster to allow the cell wall to “open” 
much more readily and accept large pieces of DNA. Without this mutation, plasmids 
>10kb are only transformed with very low efficiency. Some DNA loci are difficult to
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clone or maintain. Whilst A. fumigatus has little repetitive DNA it is advantageous to use 
DH10B cells that can cope with DNA instability.
To prevent degradation of DNA with high levels of methylated cytosine and adenine, 
DH10B cells have mutations and deletions in the genes coding for the restriction systems 
McrA, McrB (which both restrict DNA containing methylated cytosine residues) and Mrr 
(which restricts DNA containing methylated adenine residues). The mcrA gene has been 
mutated and the mrr-hsdRMS-mcrBC region has been deleted entirely. The mcrA gene 
encodes for proteins that are important in the restriction systems. Not having these genes 
allows DH10B to accept foreign methylated DNA much more readily. Fungal DNA is not 
highly methylated, with Neurospora crassa having no more than 2-3% of its cytosines 
methylated. It can also be assumed that this is the case for A. fumigatus, although this is 
not clear, as little investigation has been done in this area. Therefore, DH10B cells were 
used to prevent any library bias if A. fumigatus DNA turned out to have a higher degree 
of methylation than expected.
DH10B cells have other characteristics that make them much more amenable to accepting 
and propagating foreign DNA; recAl, which increases the stability of the inserts by 
involvement in homologous recombination; hsd encodes for a protein subunit that has 
specificity to a number of proteins (if mutation occurs in this gene, the cell is unable to 
carry out methylation and mutation); endAl improves the quality of the DNA from mini- 
preps by keeping it stable. The strain also contains a O80d/acZAM15 marker that 
provides a a-compliment to the P-galactosidase gene from pUC or similar vectors for
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blue/white selection. With a combination of all of these factors, DH10B was our host 
strain of choice for the BAC library.
2.2 Materials and Methods
The construction of the BAC library for A. fumigatus took almost a year to perfect. The 
experimentation and methodology was based closely on that set out in the methods of 
Osoegawa et al (1998).
2.2.1 BAC vector preparation
In order to ensure that the vector preparation was sufficient for library preparation and 
high quality ligation, the following methods were used:
• A caesium chloride gradient to remove and purify the vector DNA from the cells 
it is supplied in (section 2.2.1.1)
• removal of the “stuffer” fragment to open up the cloning site, preparation of X 
DNA for use as a control for the ligations (section 2.2.1.2)
• a cloning site check to ensure that the site is of a good integrity and allow 
ligations to occur (section 2.2.1.3)
2.2.1.1 Caesium chloride gradient 
Materials and Equipment
• Sorval RB5C centrifuge with GSA or SS34 rotor
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• Mistral 3000 centrifuge
• Beckman Optimal TL Ultracentrifuge with TL100 rotor
• Bench top microfuge capable of 13,000rpm
• Minigel equipment and power pack
• Chloramphenicol (20pg/ml in Ethanol) (Sigma)
• GTE (see appendix 2)
• LB Broth (see appendix 2)
• Sodium Dodecyl Sulphate/Sodium Hydroxide (SDS/NaOH) (see appendix)
• Isopropanol
• 3M Sodium Acetate
• TE (10:10) (see appendix 2)
• TO.IE (see appendix 2)
• Ethidium Bromide (Sigma) stock solution: lOmg/ml ethidium bromide in TE 
10:10
The vector was supplied in DH10B cells by Pieter de Jong (Children’s Hospital Oakland 
Research Institute, USA) (http://bacpac.chori.org/pbace36.htm).
CsCl gradient purification is still the most efficient way of removing the host 
chromosomal DNA from the solution, leaving only the purified vector to be recovered 
and is described below.
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1. E. coli cells containing the vector were spread from an agar stab onto an agar 
plate containing 20pg/ml chloramphenicol and grown at 37°C overnight.
2. A single colony was inoculated into 200ml of LB broth containing 20pg/ml 
chloramphenicol (x4) and grown 37°C overnight.
3. Cultures (4x200ml) were harvested in 250ml tubes and put into a GSA rotor and 
spun at 5000rpm for lOmins at 4°C.
4. Each pellet was then washed in 10ml of GTE. The suspensions were then 
combined and re-spun to pellet the cells.
5. The cells were then re-suspended in 10ml GTE and left at room temperature for 
lOmins.
6. The suspension was split (2x5ml) into Oakridge centrifuge tubes and 10ml of 
SDS/NaOH was added to each. The tubes were then mixed gently by inverting 
slowly and left at room temperature for lOmins.
7. Sodium Acetate (7.5ml) was added to each tube. The tubes were mixed and left 
on ice for 30mins.
8. The cell debris was pelleted by centrifuging the tubes at 10,000rpm for 20mins at 
4°C in a SS34 rotor.
9. The supernatants were poured off gently and put into clean tubes. Isopropanol 
(12ml) was added and left for 15mins at room temperature.
10. The nucleic acid was pelleted by spinning at 15,000rpm for 30mins.
11. The supernatant was decanted off and the pellets washed in 70% ethanol.
12. The ethanol was decanted and the pellets left to air dry.
13. The pellets were resuspended in 2x4.6ml TE (10:10) for 2 hours.
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14. Into two 50 ml Falcon tubes, 4.78g of Caesium Chloride (CsCl) were weighed 
out. The DNA solution was then added to each tube and the tubes swirled gently 
to dissolve the CsCl.
15. To each tube, 462pl of ethidium bromide stock solution was added.
16. The tubes were spun at 3000rpm at RT for 12mins to pellet the debris.
17. A 16G needle was attached to a 5ml syringe. The supernatant was recovered using 
the syringe and the contents emptied into a 5.1ml Beckman ultracentrifuge tube. 
The meniscus had to reach the base of the spout of the tube.
18. A metal sealer was placed on the top of the tube and a heated Beckman adaptor 
tool was placed on the top of this. With pressure and heat, the tube would seal by 
melting down the collar of the neck. Once the neck was sealed, a cooling tool 
would be placed on top of the metal sealer for a few seconds. All tools should be 
either provided with the centrifuge or the tubes.
19. The tubes were then places into a rotor with spacers and the rotor was placed into 
an ultracentrifuge.
20. The tubes were then spun at 70,000rpm for 24 hours at 20°C.
21. When the spin was finished, the tubes were carefully removed from the rotor and 
placed in a rack.
22. The tubes were then illuminated with long wavelength U/V light. This would 
show up the bands that contained the vector and the cellular debris. Figure 5 
describes how the vector was removed:
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Figure 5.
The tube was pierced 
with a  needle here
A 20G needle 
was fitted to a 
syringe inserted 
into the tube just 
below the broad 
vector band. The 
flat edge at the 
end of the needle
Cellular debris
23. The removed vector was then placed back into a fresh, clean Beckman tube and 
the liquid topped up with stock CsCl and ethidium bromide/TE solution and the 
tubes sealed again.
24. The tubes were then spun overnight at 20°C and 70,000rpm.
25. The DNA was removed as before, but then split between two eppendorf tubes. 
There should be approximately 2x600pl.
26. An equal volume of isobutanol was added to each tube. The tubes were then 
vortexed and then spun in a microfuge for lmin at 13,000rpm. This was repeated 
by multiple isobutanol extraction until both layers colourless.
27. The lower layer containing the vector DNA was removed with a pipette and 
placed into a dialysis bag.
28. The bag was dialysed against 250ml TO.IE at 4°C, changing the TE every hour 5
times.
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29. The vector DNA was recovered from the bag and placed into an eppendorf tube.
30. Added to this was 1/10 volume of sodium acetate then 2 volumes of ethanol.
31. This was then incubated overnight at -20°C.
32. The tube was then spun at 13,000rpm in a microfuge for 30mins to pellet the 
DNA. The supernatant was removed and the pellet allowed to dry.
33. The DNA was then resuspended in 120pi TO. IE.
34. A small amount of this was then run on a agarose minigel (0.8%) to check the 
yield.
2.2.1.2 Stuffer fragment removal 
Materials and Equipment
• Calf Intestinal Alkaline Phosphatase (CLAP) (Boehringer Mannheim, 0.03U/pg)
• BamRl restriction enzyme (New England Biolabs, 20U/pl)
• BamHl enzyme specific buffer
• lOxBovine Serum Albumin (New England Biolabs, lOmg/ml)
• 0.1MEDTA
• Proteinase K (Roche, 14mg/ml)
• TBE of various concentrations (see appendix 2)
• High Gelling Temperature Agarose (Invitrogen)
• Ficoll loading dye SeaKem GTG Agarose (BMA Products)
• Low Range Pulsed Field Gel Marker (New England Biolabs, 25pg/ml)
• 3A Dialysis tubing (Invitrogen)
• Polyethylene Glycol (PEG) 8000 (Sigma)
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• CHEF gel apparatus (see appendix 2)
1. A reaction was set up to remove the 2.8kb pUC stuffer fragment that was inserted 
in the vector. The reaction was set up in bulk as follows:
CLAP (final concentration 0.03U/pg DNA) 7.5pl
DNA (5xD) 20pl
lOxBamHl Buffer 20pl
DDW 135pl
BamHl 5pl
lOxBSA 20pl
2. This was incubated at 37°C for 1 hour. The reaction was stopped by adding 26pl 
of 0.1M EDTA and 5pi of 14mg/ml Proteinase K and incubated at 37°C for
1 hour.
3. A lpl amount was run on a small check gel, lxTBE to determine if digestion had 
worked.
4. The whole vector digest was then loaded with loading dye into a 1% CHEF gel in
0.5xTBE and run at 14°C for 16 hours, 6V/cm and a 0.1 to 40secs switching time. 
Also loaded onto the gel, in the side lanes was a Low Range Pulsed Field Gel 
Marker. The gel was removed from the apparatus and the flanking marker lanes 
were removed, taking a small, but minimal amount of the vector portion. These 
lanes were then stained in Ethidium Bromide for 15-20 mins to detect the position
70
of the vector and stuff fragment. The lanes were visualised under U/V light and 
small “nicks” were made where the position of the vector band was. The lanes 
were then reassembled with the main body of the gel containing the unstained 
vector and the gel slices cut from the main portion, using the flanking, stained 
portions as a guideline.
5. The gel slice was then placed into a 3A inch dialysis tubing and the tubing was 
clipped at one end. The “bag” was then filled with sterile 0.5xTBE and then 
clipped at the other end to seal. The bag was then placed into a small 
electrophoresis tank filled with 0.5xTBE and electroeluted at 3V/cm for 3 hours. 
The current was reversed for 45 secs at the end of the run to detach any DNA 
from the walls of the dialysis bag.
6. The bag still containing the gel slice was dialysed over night at 4°C against
0.5xTE. The solution was then concentrated down to approximately 600pl by 
dialysing in 0.5xTE (containing 30% PEG). The vector was recovered and 
concentrated by ethanol precipitation. After centrifugation the pellet was 
resuspended in lOOpl of TO. IE.
2.2.1.3 X DNA for use as a control in ligations 
Materials and Equipment
• X DNA (New England Biolabs, 250pg)
• BamHl restriction enzyme (20U/pl)
• BamRl restriction enzyme buffer
• EDTA
71
• Proteinase K (14mg/ml)
• TO. IE
• CHEF gel apparatus (see appendix 2)
To check the vector and ligation conditions a positive control insert was prepared from 
bacteriophage X. X DNA is 48,502bp in length and a BamHl digestion produces fragments 
of 5.5kb (x2), 6.5kb, 6.8kb,7.2kb and 17.3kb. It was the largest of these fragments that 
was purified and used as the positive control. The digestion was set up as follows:
X DNA (500ng/pl) lOpl
lOx BamHl buffer lOpl
DDW 75pl
BamHl 5pl
1. This was incubated at 37°C for 3 hours and the reaction was stopped by adding 
13pl of 0.1M EDTA and 2.5pl of 14mg/ml Proteinase K and incubated at 37°C 
for 1 hour. This was run on a CHEF gel and the 17.3kb top band removed and 
extracted as described in section 2.2.1.2.
2. The X DNA was resuspended in 60pl TO.IE. This could be then used as the 
positive control insert DNA.
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2.2.1.4 Cloning site check 
Materials and Equipment
• Polyethylene Glycol (PEG) 8000
• 1M MgCl2
• T4 DNA ligase (Roche, 5U/|xl)
• T4 DNA ligase buffer
• T4 polynucletide kinase (Roche, 5U/pil)
• 0.5MEDTA
• Proteinase K (Roche, 14mg/ml)
The cloning site needed to be examined to ensure that the dephosphorylation had been 
efficient and the cloning site had been undamaged. The DNA had previously been treated 
with Calf Intestinal Alkaline Phosphatase (CLAP) (described in section 2.2.1.2) to remove 
the phosphate group from the 5’ ends of the DNA and prevent it from re-ligating. Kinase 
treatment replaces the phosphate and allows the linear molecule to re-ligate. When run on 
a gel, linear and circular DNA have different migration properties, so is a good indicator 
of whether or not the vector has been prepared correctly and is usable.
1. The test was done by setting up two ligation reactions, one with T4
Polynucleotide Kinase (PNK) (Roche 5U/ptl) and one without. The two ligations 
were set up as follows:
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Vector DNA 0.5pl Vector DNA 0.5pl
20% (w/v) PEG 8000 5.0pl 20% (w/v) PEG 8000 5.0pl
1M MgCl2 0.1 pi 1M MgCl2 O.lpl
lOx ligation buffer 2.0pl lOx ligation buffer 2.0pl
T4 Ligase 0.2pl T4 Ligase 0.2pl
T4PNK O.lpl DDW 12.2pl
DDW 12.1pl
The ligations were incubated at 37°C for 2 hours.
2. EDTA (2pl of 0.5M) and 0.5pl of Proteinase K were added and incubated at 37°C 
for 15mins to stop the reaction
3. A small amount (1 pi) was checked on a 0.8% agarose gel to determine whether or 
not most of the ends could still be ligated depending on kinase treatment (Larin
et al 1996).
2.2.1.5 Self ligation 
Materials and Equipment
As the previous section, but without the T4 Polynucleotide Kinase
• Bench top microfuge capable of 13,000rpm
• 1M Sodium Chloride
• 1:1 Phenol/Chlorophorm (Applied Biosystems)
• 96% Ethanol
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• Loading mix (see appendix 2)
1. Once it was determined that the ends could be ligated, a bulk ligation was set up 
to remove a minor, yet significant background of non-dephosphorylated vector 
ends. This was set up as follows:
Vector 50pl
20% (w/v) PEG 8000 lOOpl
0.1M MgCl2 lOOpl
lOx ligation buffer 40pl
T4 Ligase 20pl
DDW 90pl
This was incubated overnight at 16°C.
2. NaCl (50pl) was added and the ligation extracted with an equal volume of 
phenol/chloroform.
3. After centrifugation at 13,000rpm in a microfuge for lmin to separate the layers, 
the top layer containing the vector was removed and placed into another 
eppendorf tube.
4. Ethanol (1ml) was then added and incubated at either -70°C for 2 hours or at 
-20°C overnight. The tube was spun at 13,000rpm for 30mins and the ethanol 
discarded and the pellet dried.
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5. The pellet was then resuspended in lOOpl loading dye. The vector was then 
purified in the same way by CHEF gel electrophoresis and electroelution, as 
described in 2.2.1.2.
2.2.1.6 Control ligations
Materials and Equipment
The same as section 2.2.1.4 but without the T4 Polynucleotide kinase.
• Phenylmethylsulphonylfluoride (PMSF, 40mg/ml in isopropanol)
• Microfiltration discs (Millipore, 50mm, 0.025pm pore size)
• 0.5xTE
• ElectroMax DH1 OB cells (Life Technologies)
• Life Technologies CellPorator equipped with a voltage booster
• Chloramphenicol (Sigma)
1. A series of ligations (designated A, B and C) were set up to ensure that the
ligations were working correctly. The basis of the ligations were set up as follows:
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Vector 2.5jla1
DDW 8.25pl
Positive control insert 20pl
30% PEG 8000 12.5pl
0.1M MgCl2 1.25pl
lOx Buffer 5pl
T4 DNA Ligase 0.5pl
The A ligation contained no control insert DNA
The B ligation contained no control insert DNA and no ligase
The C ligation contained control insert DNA from the large BamHl digested X fragment 
prepared in 2.2.1.3
2. These were incubated at 16°C for 5 hours. The ligation reaction was stopped by 
adding 2.5pl 0.5M EDTA and lpl Proteinase K.
3. This was then incubated at 37°C for 1 hour and then lpl of PMSF was added to 
kill the Proteinase K.
4. The ligations were then dialysed by placing on the surface of microfiltration discs 
that were floating on 30ml 0.5xTE in a Petri dish at 4°C. These were left for 4 
hours. The ligation was then recovered and stored at 4°C until transformation.
5. The transformations were done using 2pl of the ligation with 20pl of cells and the 
electroporator set to 400V, 25 pF and 1000Q, fast charge rate.
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6. The cells were then plated out onto agar plates containing 20pg/ml 
chloramphenicol and left at 37°C overnight.
2.2.1.7 Miniprep 
Materials and Equipment
• Bench top centrifuge capable of 2000g
• Bench top microfuge capable of 13,000rpm
• New Brunswick Scientific Innova 4300 shaking incubator
• LB broth (see appendix 2)
• Chloramphenicol (12.5pg/ml, Sigma)
• GTE (see appendix 2)
• 3M Potassium Acetate
• Isopropanol
• 70% ethanol
• TO. 1E (see appendix 2)
1. Colonies from the plates were inoculated into 5ml of LB broth containing 
chloramphenicol and incubated with shaking at 37°C for 18-20 hours.
2. The culture was centrifuged at 2000g at 4°C for 15mins using a bench top 
centrifuge.
3. The supernatant was poured off and the pellet was resuspended in 0.2ml of 
ice-cold GTE.
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4. The suspension was transferred to a 1.5ml microfuge tube and 0.4ml (freshly 
prepared) 0.2N NaOH/1% SDS was added. The solution was mixed by inversion 
gently several times. This was left at room temperature for 5mins.
5. Potassium acetate was added and the tube inverted gently to mix. The mixture 
was then spun at 13,000rpm on a bench top microfuge for 15mins.
6. Supernatant was removed (0.75ml) without disturbing the pellet and transferred to 
a clean microfuge tube. Ice-cold isopropanol (0.45ml) was added and the tube was 
spun at 13,000rpm for 15mins to pellet the DNA.
7. The supernatant was removed and the pellet rinsed with 1ml of cold 70% ethanol. 
The ethanol was removed and the pellet was dried in the tube upside down until 
the pellet became transparent.
8. The pellet was then resuspended in lOpl of TO. IE.
2.2.1.8 Ligation check 
Materials and Equipment
• Bovine Serum Albumin (lOOx lOmg/ml, New England Biolabs)
• lOx NEB Buffer 3 (New England Biolabs)
• Notl restriction enzyme (lOU/pl, New England Biolabs)
1. A Notl enzyme digest was set up to determine if the insert had been incorporated 
into the vector and to ensure that there were no problems with the cloning site.
The digestion was setup as follows:
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Vector/Insert DNA 4pl
Buffer 3 1  J L l l
lOxBSA lpl
Notl 0.5pl
DDW 3.5pl
2. This was incubated at 37°C for 1 hour and the reaction stopped by incubating at 
65°C for 20mins. lpl was run on a 0.8% agarose gel to determine if the insert had 
been excised from the vector.
2.2.2 Insert DNA preparation
Dr Michael Anderson from Manchester University supplied Aspergillus fumigatus Af293 
DNA in agarose plug form. This is because the organism is highly virulent and the 
Sanger Institute does not have the facilities or the capabilities to harvest the fungus in a 
safe environment, so the DNA was extracted and supplied on our behalf.
2.2.2.1 Size fractionation 
Materials and Equipment
• Sau3 AI restriction enzyme (1 OU/pl, New England Biolabs)
• 10xiSVzw3 AI restriction enzyme buffer (New England Biolabs)
• Bovine Serum Albumin (lOOx lOmg/ml, New England Biolabs)
• Proteinase K (14mg/ml, Roche)
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• 1MEDTA
• TO. 1E (see appendix 2)
• Ethidium Bromide (lOmg/ml aqueous solution, Sigma)
• CHEF apparatus (see appendix 2)
A high concentration of Aspergillus DNA was required in the correct size ranges for the 
BAC library to be successful. Partial digestion with an enzyme and CHEF gel separation 
was used to achieve this. Firstly, a concentration of enzyme had to be determined to 
provide the correct amount of partial digestion of the DNA in the plug without the 
digestion going to completion. The enzyme chosen was Sau2> AI, because its cut site was 
compatible with that of the cut site of BamHl.
1. An enzyme concentration series was set up in order to determine the amount of 
enzyme required to meet the parameters stated above. The DNA plugs were 
digested in 1.5ml microfuge tubes as follows:
1 2 3 4 5 6 7
Sau3Al buffer (pL) 50 50 50 50 50 50 50
SauSAl (pi) 5 pi 
1/100
lpl
1/10
2pl
1/10
3 pi 
1/10
0.5pl 0.7pl lpl
1M Spermidine (pL) 1.3 1.3 1.3 1.3 1.3 1.3 1.3
BSA lOOpg/ml (pL) 2.5 2.5 2.5 2.5 2.5 2.5 2.5
DDW (pL) 441.2 445.2 444.2 443.2 445.7 445.5 445.2
Units 0.5 1 2 3 5 7 10
These were incubated on ice for 2hrs and then at 37°C for 20mins.
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2. The digest was stopped by incubating plugs with Proteinase K and EDTA at 37°C 
for 1 hour, as described in 2.2.1.6. The plugs were then removed from the reaction 
mixture and washed in TO.IE to remove any excess enzyme. The plugs were then 
loaded onto a 1.0% CHEF gel and run under the same conditions as those stated 
in section 2.2.1.2.
3. From this, the gel was visualised by staining with Ethidium Bromide and viewing 
under U/V light. From these digests, an optimal enzyme concentration for partial 
digestion was chosen. This was done by visually deciding which of the plugs had 
given the highest, cleanest yield of DNA fragments in the correct, required size 
ranges.
4. Once the correct and most suitable enzyme concentration had been determined, 
the conditions for this digestion were then used to digest a large number of plugs 
(approx. 6-8 plugs). These plugs, once digested were then placed into another 
CHEF gel and a pseudo double sizing procedure was used to help remove the 
smaller fragments of DNA in two steps and using the same gel. Smaller fragments 
need to be removed to improve the library, as smaller fragments tend to ligate 
much more easily and would compete with the larger fragments in the ligations, 
reducing the overall average insert size of the library. This is difficult to achieve 
as the smaller fragments can stay in the gel due to a phenomenon called 
“trapping”. This is where much smaller fragments of DNA are “trapped” by larger 
fragments of DNA as the DNA migrates through the gel. When the required size 
DNA is extracted from the gel, the smaller, unwanted fragments are also removed
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with them and cause problems previously mentioned and gives an overall poor 
representation of the genome. Figure 6 describes the process in detail.
Markers (Low 
range PFG)
Run 1 to remove debris and small DNA
DNA in plugs loaded with markers flanking 5 V/cm, 6hrs, 15sec pulse time, 14°C
New marker added
s'
i
5 V/cm, 6hrs, 15sec pulse time, 14°C 
Run 2
6V/cm, 16hrs, 0.1 -40s switch time, 14°C 
Run 3 Size Fractionation
Figure 6. Diagrammatic representation o f  the pseudo double size fractionation o f  the partially digested 
DNA. The flanking marker lanes are removed when the fractionation has finished and stained separately to 
measure the marker distances, as not to damage the DNA in any way.
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5. The gel was initially orientated so that the DNA ran towards the nearest edge of 
the gel. Using the conditions in the Osoegawa paper as guidelines, the smaller 
fragments of digested DNA and cellular debris, along with the smaller fragments 
of marker, were run off the edge of the gel without removing the larger, more 
useful size range fragments. The gel was then turned 180° and run under the same 
conditions as the first run to bring back the remainder of the DNA to the well 
from where the DNA started. The third run was run under normal conditions to 
separate the fragments more evenly for easier extraction of the correct sizes. As a 
guideline, a further marker lane was added to the gel to provide indication that the 
DNA had correctly run and that there was no debris or smaller fragments.
6. Once the pseudo double sizing had been completed, the flanking marker lanes 
were removed and stained separately and then visualised under U/V light to 
determine where the DNA had run. The size ranges required were marked and the 
flanking regions then placed back at the main body of the gel and the size ranges 
cut out.
2.2.2.2 DNA Extraction: Electroelution 
Materials and Equipment
• 3A inch dialysis tubing (Invitrogen)
• Small electrophoresis tank and power pack
• 0.5xTE (see appendix 2)
• 30% Polyethylene glycol (PEG) (Sigma)
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1. The DNA was removed from the gel slices by a process called electroelution. 
Similar to electrophoresis, but the gel slice and therefore the DNA itself is 
contained within dialysis tubing so the DNA migrates out of the gel and into the 
tubing to be recovered.
2. The gel slices were placed into separate % inch dialysis tubing, which were 
clipped at one end to seal. The tubes were then submerged in 0.5xTBE and the 
other end clipped to seal, removing all air bubbles at the same time. The tubes 
were then placed across the flow of current in a small gel tank filled with
0.5xTBE and the power was run at 3V/cm for 3 hours. At the end of the run, the 
current was reversed for 30-45secs to detach any DNA from the walls of the 
dialysis tubing.
3. The tubes were then removed from the gel tank and placed, still sealed and 
containing the gel slice, into 900-1000ml of 0.5xTE (not TO.IE). The tubes were 
then dialysed in this at 4°C overnight, with gentle stirring on a magnetic stirrer.
4. The tubes were then placed into 0.5xTE containing 30% PEG8000 and dialysed 
for 1 hour to concentrate the solution to about 300pl. The solution was then 
removed from the tubes using a wide bore pipette to prevent damaging the DNA 
and placed into an eppendorf 1.5ml tube.
5. A small amount of each size range (lpl) was run on a 0.8% check gel for 45mins 
to check the recovery efficiency of the electroelution.
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2.2.3 Ligation, transformation, plating and gridding 
Materials and Equipment
• 30% Polyethylene glycol (PEG) (Sigma)
• ImM MgCl2
• T4 DNA ligase (5U/pl, Roche)
• T4 DNA ligase buffer (Roche)
It was important to optimise the ligation to a 1:10 molar ratio of insert: vector to reduce 
the number of non-recombinant clones and maximise cloning efficiency. A number of 
attempts were made, all with varying degrees of success and as there were a number of 
insert DNA preparations, the concentration of DNA recovered did not always remain the 
same. So, the ligation conditions changed very slightly every time a ligation was set up, 
depending on the concentration of the insert DNA to maintain the 1:10 molar ratio. The 
ligations were set up as follows:
pBACe3.6 Vector 2pl
DDW to make up to 50pl
Insert DNA 1 to 20pl*
30% PEG8000 9pl
MgCl2 lpl
Buffer 5 pi
T4 DNA Ligase lpl (of a 1/10 dilution)
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* Amount dependant on concentration of insert DNA to maintain insert: vector ratio. 
Incubated at 16°C overnight. The ligations were then transformed using the same 
protocol already described in section 2.2.1.3 and plated out and incubated as also 
described in that section.
1. An A, B and C control was also set up to compare with to determine whether or 
not the ligation had worked. These were set up in the same way, but the A control 
had no DNA in it, the B control had no DNA or ligase and the C control had both 
ligase and the X DNA fragment as its control DNA.
2. DNA was extracted from a number of colonies as described in section 2.2.1.3. 
Clones were analysed be digesting thesis minipreps with Notl and separating the 
digests by CHEF electrophoresis as previously described.
2.2.4 Replication and gridding 
Materials and Equipment
• LB Broth (see appendix 2)
• Chloramphenicol (20mg/ml)
• 96 well, deep well boxes (Beckman)
• Polythene plate sealers
• Flat bottomed microtitre plates (Beckton and Dickinson)
• Pre-cut 78x119mm Nytran N nylon filters (Schleicher and Schuell Bioscience)
• 3MM filter paper (Whattman)
• 10% SDS (see appendix 2)
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• 0.5M NaOH
• 1.5M NaCl
• 0.15MNaCl
• 0.5M Tris-HCl (pH7.4)
• 50mM Tris-HCl (pH7.4)
• 2xSSC (17.53g Nacl, 8.82g Hydrated Trisodium Citrate to lltr with DDW)/0.1% 
SDS
To allow for easy screening of the library by hybridisation the clones were gridded out on 
a nylon filter. All picking of colonies and media aliquoting was done in sterile conditions 
in a fume hood to minimise contamination.
1. LB broth (1ml) containing 20mg/ml chloramphenicol was added to 36x96 deep 
well boxes. Then, using toothpicks, single colonies were picked from the plates 
and placed into every well of all 36 boxes in a random order. This was now the set 
order for the clones.
2. The boxes were sealed with a cellophane plate sealer and each well punctured 
with a small hole to let air in. The boxes were grown overnight at 37°C in a 
shaking incubator at 300rpm.
3. Culture from each well (70pl) was added to 36x96 flat bottomed microtitre plates, 
and glycerol was added to a final concentration of 7.5%. These were then stored 
at -70°C until needed. Overall, 6 copies of the library were made for either 
archiving.
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4. From the remaining culture, the library was sent to be gridded out onto labelled 
nylon filters robotically, using a specialised machine built in house and according 
to the specific protocol of that machine. The arrays were set out in the same form 
described in chapter 3, section 3.2.1.1. The filters with freshly printed and inked 
colonies were grown at 37°C overnight on agar plates.
5. Two large sheets of filter paper were placed on 2 large trays. One tray was 
saturated with 10% SDS and the second tray was saturated with 0.5M 
NaOH/1.5M NaCl. The bubbles were removed from the paper by rolling out with 
a glass roller. Excess solution was then drained. Filters were then placed colony 
side up on the first tray for 5mins, ensuring no solution is washed onto the upper 
surface of the filter.
6. The filters were then removed and any excess SDS was blotted onto tissue. The 
filters were then placed onto the second tray, ensuring no air bubbles for lOmins.
7. The filters were removed from the solution and then placed onto a dry piece of 
filter paper for 10-20mins, ensuring no over drying.
8. The filters were neutralised by submerging fully, colony side up, in 0.5M Tris- 
HCl pH7.4/1.5M NaCl. The solution was changed and replaced and then the 
solution containing the filters was placed on an orbital shaker for 5mins at low 
speed. This step was repeated once more.
9. The solution was replaced with 1 litre of 50mM Tris-HCl pH7.4/0.15M NaCl and 
placed on the shaker for 5mins.
10. The solution was drained and the filters rinsed in 1 litre of 2xSSC/0.1% SDS for 
5mins, shaking.
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11. The solution was drained and the filters rinsed in 2xSSC for 5min, shaking.
12. The filters were then rinsed twice in 1 litre of 50mM Tris-HCl pH7.4 for 5mins, 
shaking.
13. The filters were then air-cooled colony side up on chromatography paper for 4-5 
hours. The filters were then U/V cross-linked colony side down for 2mins to fix 
the DNA to the membrane.
2.3 Results
2.3.1 Stuffer fragment removal
The stuffer fragment was removed to liberate the cloning site and make the vector 
amenable to ligation, as described in section 2.2.1. The digestion reaction to remove the 
stuffer fragment was checked to determine whether the reaction had worked. A small 
amount was run on a small agarose gel (Figure 7).
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Figure 7. Agarose gel o f  Bam\\\ digest o f pBACe3.6, showing the 8.7kb vector band and the 2.8kb 
“stuffer” fragment clearly defined and separated
8.7kb
2.8kb " "  w
23,130
9416
6557
4361
2322
This shows that the digest had worked successfully with no miscellaneous banding or 
smearing. The digested vector was then run on a CHEF gel once the check had shown the 
digestion had worked (Figure 8).
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Figure 8. One edge o f  a CHEF gel containing the marker and a small amount the vector band. The vector 
band in the gel slice glows with Ethidium Bromide staining and the distance from the well the band has 
migrated is measured. This is recorded and used to locate the band in the main central section o f  the gel, 
which contains the main body o f the vector band. The same distance from the well is then measured and the 
band can be cut from the gel without staining the main section.
Well at 25-27 mm
Vector band at 85-91mm
When the location of the bands had been completed, the linearised vector was cut from 
the main body o f the gel from the corresponding positions that were identified on the 
marker sections. (Figure 9)
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Figure 9. This is an image o f the central section o f the gel. The linearised vector fragment was excised and 
the remaining gel sections stained to check that the vector had been removed cleanly and from the correct 
location.
Well
8.7kb 
vector 
band
2.8kb 
stuffer 
fragment
2.3.2 Cloning site check
If the removal o f the stuffer fragment was successful, the cloning site should be o f good 
quality and amenable to ligations, as previously described in section 2.2.1.
The kinase reaction would show whether or not the vector could be ligated. If the kinase 
treatment works, then the vector can then self-ligate again. Running the DNA on an 
agarose gel takes advantage o f the differing migrations properties that this causes.
Figure 10 shows that this is exactly what had happened and proves that the cloning site is 
good and usable.
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Figure 10. Here the image shows a check o f the ligated DNA with and without kinase treatment. The 
ligations with kinase treatment did not migrate easily through the gel and have remained near the top o f  the 
gel. The ligations not treated with kinase have migrated further down the gel. The brighter bands are 5pl o f 
the non-ligated vector to check quantities recovered by electroelution. Here, the band is bright and strong, 
suggesting the recovery had been efficient.
Marker
5^1 of
recovered
electroelution
Once it had been determined that the vector could be ligated, a bulk ligation was set up 
and run on a CHEF gel to remove the non-dephosphorylated DNA (Figure 11)
+ kinase
- kinase
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Figure 11. CHEF gel containing vector band after bulk ligation to remove any non-dephosphorylated 
DNA that may still be present. Here, the gel was treated in the same way as before, with the outside marker 
lanes being removed with a small amount o f  vector, stained and the distance from well noted and then the 
band removed from the main body o f the gel.
Marker 
in gel 
slice
Small 
fraction o f 
vector band V -
Gel sections containing the main body 
of the vector band
The DNA was recovered from the gel slices by electroelution and a final check was done 
to ensure a good recovery by running ljil o f elute on a check gel (Figure 12).
F igure 12. A good recovery o f the vector was made. The relative brightness o f  the vector band compared 
to the top band o f the marker gave an indication o f the quantity o f recovered DNA as well as the quality.
Recovered
vector
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2.3.3 Size fractionation
The enzyme digestion gradient gave good results. The general trend was as expected, 
with the amount o f digestion increasing with the amount o f enzyme. But one or two plugs 
either did not digest or digestion was insufficient, possibly due to the inconsistent 
concentration or quality o f DNA in the plugs. Figure 13 shows the digestion pattern.
Figure 13. Trial partial digestion o f Aspergillus plugs with increasing Sau3A  concentration.
Low Range PGF 
marker (kb)
Increasing enzyme concentration 
as described in section 2.2.2.1
6 7 Non­
digested 
control
From the evidence in Figure 13, the optimal digestion conditions were taken from 2 of 
the digests. Lane 4 (3U enzyme) had good strong DNA and a high yield in the size range
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required. Lane 7(1 OU enzyme) also had very good results. The fact that there is a large 
difference in the concentration of the enzyme must mean that there was possibly a 
different yield o f DNA in each of the separate plugs, regardless o f the fact they were 
prepared at the same time. Lane 7 does also appear to have a much higher concentration 
of smaller fragments than lane 4. This may be due to the increased digestion received by 
this plug from the higher concentration of enzyme.
A full digestion was then done on a number of plugs using the conditions from these two 
digests. H alf were digested with the conditions from lane 4 in the series and half were 
done with the conditions from lane 7 in the series (Figure 14).
Figure 14. Gel showing large scale partial digestion o f Aspergillus plugs with desired insert 
fragment sizes removed
Digestion ____
conditions 
from lane 4
Band size in Kb
Digestion 
conditions 
from lane 7
242.5 
194
145.5 
97 
48
PFG marker 
lanes
High yield o f partially 
digested DNA with the 
fragments removed
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Figure 14 also shows that the pseudo double sizing step was successful in removing 
smaller fragments of DNA. It can be seen that the bottom of the digests have clean, 
straight cut off points and that the smaller fragment of the outside markers are also 
missing. This is a good sign as it means that there is a reduced possibility of DNA 
trapping, as the smaller fragments will have been removed before the larger fragments 
have migrated in the gel.
2.3.4 Electroelution
The electroelution process itself was straightforward. At the electroelution and recovery 
stage, the large DNA fragments were concentrated by dialysis against 30% PEG. This 
posed a few problems. Not only was the solution containing the DNA very difficult to get 
out of the dialysis tubing, it was invariably of differing volumes with each attempt. The 
length of time it took to reduce the volume to a given amount for each attempt also 
fluctuated wildly. The results ranged from a few minutes for a complete reduction in 
volume to a few hours just to reduce it a few microlitres. There was no way of knowing 
how quickly or how slowly the volume reduction was going to take, even when all 
conditions were reproduced. Nonetheless, a careful, watchful eye was a kept to ensure the 
bags did not dry out and the DNA was recovered after maximal concentration.
There was a good, consistent concentration in all of the plugs and more than adequate 
DNA in the 80-3OOkb size range. DNA was cut at the required size ranges, extracted and 
5 pi run on a small check gel to determine yield and quality of DNA (Figure 15).
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Figure 15. 1 jul aliquots o f DNA recovered from each o f the size ranges excised from the gel.
H in d llU  80- 100- 125- 150- 200-
/pBR322 B stl 100kb 125kb 150kb 200kb 300kb
Marker
The yield from each size range was good and the integrity o f each appeared excellent.
2.3.5 Ligation
The aim was to achieve an average insert size of between 125-150kb, but achieving this 
proved difficult. Eventually one ligation gave an average insert size o f 74kb. This was 
still well below the size ranges of the fractions that were removed from the gel, but was 
usable for a BAC library and was not prohibitively small for sequencing. This ligation 
had a DNA volume o f 10pl in a total ligation volume of 50pl to try and optimise the 
frequency of high molecular weight inserts over smaller inserts and non-recombinants. 
To try and reduce the amount of enzyme that would be there generating non­
recombinants, the enzyme was diluted 1:10 with lOxBSA. The ligation reactions were 
set up to try and optimise maximum cloning efficiency for large insert sizes, using the 
conditions recommended in the Osoegawa paper as guidelines. There was 25ng of 
pBACe3.6 vector (approx) and up to 65ng o f insert DNA that gave a recommended ideal
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1:10 molar ratio of insert to vector. Overnight ligations were done instead of 4hr 
ligations. A series of ligations were carried out at 4 hours, but this seemed to give a very 
low titre. When ligations of at least 16 hours were done, the titre increased to levels that 
were much more usable.
lOgl of DNA was used in the ligation and lpl of the ligation used to transform the 
DH10B cells. Three ligations from the successful size fractionation step were done, 
designated B28, B29 and B30. These represented the size fractions removed from the gel 
in 80-100kb, 125-150kb and 150-200kb respectively (see Table 10)
Table 10.
Expected insert Vol. DNA (pi)
size from gel
excision(kb)
B28 80-100 10
B29 125-150 10
B30 150-200 10
Plated Colonies Ave. Insert Size
(pi) (after Notl
digestion)
1 600 73.5 kb
1 380 24kb
1 400 33.9kb
Figure 16 indicates that the ligation had worked with the correct size inserts being 
present. The Notl digest gave an average insert size of 73.5kb. This was not an ideal size 
as the ligation was from the 80-1 OOkb size range, but nonetheless, it was a usable, 
workable size range and was much better than the other size ranges and previous attempts 
at making the library. Sizes ranged from 12kb to >150kb.
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Figure 16. The final check gel after digestion with Notl that confirmed that the ligation had worked 
sufficiently to continue to generate the library.
145kb
97kb48kb
23kb
L Average insert 
I size73.5kb
9kb Vector
2.4 Discussion
Although Osoegawa used EcoKL to remove the ‘stuffer’ fragment and therefore, EcoRl 
was used as the ‘cloning’ enzyme, the use of a six base cutting enzyme, such as EcoRl, 
may bias the digestion and therefore bias the library. BamHl was decided upon because 
of its multiple compatibility with other enzymes. It has a 6-base recognition sequence but 
has compatible cohesive ends with Sau3Al. Sau3AI has a four base cutting enzyme 
which was thought would give a more random digestion in an unknown genome.
The insert preparation process was the most problematic area of the library construction. 
This was mainly due to a poor DNA concentration in the DNA plugs supplied by the 
University of Manchester. The aim was to obtain as clean and as high a yield of DNA as 
possible from the stock in agarose plugs that was sent to us. Originally following the 
methodology in the Osoegawa paper as closely as possible, a number of attempts were 
made from the plug stocks we had available. Most were unsuccessful and it was very
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puzzling. There did not seem a logical explanation until another step (pre-electrophoresis) 
that was not used in the final library production method brought the problem to light. The 
DNA impregnated plugs were placed into a gel and run between 1 and 6V/cm, lsec 
switching time, 14°C for any length of time between 1 and 6 hours to remove the very 
small DNA and RNA fragments that may be present in the plug, as well as any left over 
cellular debris that may have had a detrimental effect on the library production. 
Unfortunately, when the pre-electrophoresis stage was carried out, it seemed that it took a 
sizeable amount of good DNA with it, reducing the overall amount that could be used for 
digestion. In addition to this, it showed that the concentration of the DNA that was in the 
plugs was not that high in the first place. It was fortunate that some DNA did come out of 
the plugs under some conditions because otherwise it would have been quite difficult to 
spot that the DNA concentration was actually quite low. Moreover, in theory it was a 
good idea to remove the unwanted material, but every batch of plugs that were sent to us 
did not respond as expected at this step. On a number of occasions, there was evidence to 
suggest that the conditions had been optimised and that the debris was being removed 
with minimal DNA removal, (Figure 17a) and consequent examination on a CHEF gel 
would show that there was a lot of what seemed good quality DNA left behind. But this 
was not to be the case. As digestions were done after the pre-electrophoresis stage, it was 
soon evident that the quality of the DNA, as well as the amount being recovered, was far 
removed from the standards that were required to generate a library. (Figure 17b). A 
number of further attempts were made on several batches of plugs. All had the same 
result.
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Figure 17a
Debris
An example o f  a pre-electrophoresed plug run at 1 V/cm, 2 hours, 1 sec switching tim e and 14°C. It plainly 
shows banding o f  what could be either debris or RNA at high concentrations.
Figure 17b
Plug in
The same plug run at digestion conditions (6v/cm, 16 hours, 15 sec switching tim e and 14°C. This shows 
that there is still, even after pre-electrophoresis, a large concentration o f debris. This was detrimental to the 
downstream techniques we were using to create the library as the smaller fragments o f DNA would 
compete against the larger fragments, as well as the non-DNA/RNA debris would contaminate the ligations 
and prevent good sized inserts for the library.
The digestions conditions themselves were sometimes problematic. Various batches of 
DNA plugs were sent to us from Manchester. Digestion conditions remained the same 
with every batch, yet the results were very variable. Some plugs would go to complete
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digestion with the minimum amount of enzyme; others would not digest regardless of 
enzyme concentration. Digestion times were varied, with mixed success. These findings 
were communicated and plugs with the desired quantity requested from Manchester 
University. The new plugs seemed to have more consistent digestion and gave good DNA 
yields. After consultation, the plugs from Manchester were of high DNA concentration 
and with a much better quality o f DNA. Even with the pre-electrophoresis stage being 
used only as an indicator to the quality o f the DNA, it showed that there was very little 
debris in the plugs (Figure 18).
Figure 18. Pre-electrophoresis stage showing good quality DNA being left behind in the plug, yet there is 
little debris and the RNA can clearly be seen to have travelled cleanly from the plugs.
Bands o f  RN A
Plugs in wells with 
good, clean quality 
DNA remaining
The size fractionation was much more controlled after digestion, so there was consistency 
at this stage with all plugs. The rotation o f the gel through 180° made sure that there were 
as few small fragments o f DNA as possible. It became clear that the methodology was 
sound and when the quality of the starting material was improved, success was achieved 
after two attempts. The first attempt ascertained the conditions to digest at and to 
determine the quality of the DNA. The second attempt was to generate the library. It was
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also less contaminated with debris and consequently there was less of the small size DNA 
that could compromise the ligation reactions. It can be concluded that the successful 
outcome of the experiment was probably due to the much higher quality of DNA 
provided, with less smaller size DNA being “trapped” with the larger size DNA and co- 
migrating with it during electrophoresis.
The “pseudo” double run was designed to help the removal of the smaller fragments and 
cellular debris and was relatively successful. There are other methods, most notably the 
“double run” method, described by Peterson et al (2000). This method is relatively 
efficient at purifying the DNA, but is much more time consuming and also uses more 
resources. In this method, DNA is run through a gel, side by side with markers. The 
markers are removed and visualised, noting where the desired fragment sizes are and then 
these are compared back to the main body of the gel. The fragment sizes required, using 
the marker gel slices as a guide, are then removed from the main body of the gel. This is 
then cut into three equal sizes corresponding to the three different size fractions desired 
and then placed into the wells of another gel. The fragments are then run again to remove 
any small, trapped fragments of DNA that had migrated with the larger fragments in the 
first gel. The principle is repeated, where the markers are stained and the fragment sizes 
noted and compared back to the main body of the gel and the correct, “double purified” 
fragments are cut out and the DNA extracted.
The method that was used for the A.fumigatus project was chosen due to its higher 
recovery of DNA, its efficiency of removing the smaller fragments of DNA, is more
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conducive to being used with smaller concentrations of DNA and is also more practical 
as the DNA remains in one gel throughout the process. As we expected small amounts of 
DNA, a method like this was ideal, as the Peterson method would have a high level loss 
of DNA due to the extra purification steps. The method we used only ran DNA off the 
end of the gel, removing the unwanted smaller fragments completely, yet leaving the 
main fractions of DNA untouched in the gel, with little loss overall (Figure 14). Although 
both methods are designed to achieve the same results, we thought that with the possible 
constraints we might have with this project (low DNA concentration, low DNA integrity 
etc), the method described in the Osoegawa paper seemed to be the logical choice.
Electroelution was used to recover the large DNA fragments from the excised gel slices 
after the size fractionation for two main reasons. It has been shown by Strong et al (1997) 
that the high molecular weight DNA can be recovered with a higher degree of integrity 
compared to that of enzyme based agarose digestion for extraction of the DNA. The 
study showed that the integrity of the DNA before and after extraction by comparing the 
size of the DNA was better when electroeluted and not enzyme digested from the 
agarose. Enzyme digestion requires a number of steps that may be detrimental to the state 
of the DNA, such as heating, pipetting and agitation. Small fragments of DNA may be 
broken off and these can the ligation. Electroelution uses the same principle to get the 
DNA out as it does to get the DNA into the gel. Direct manipulation of the DNA is kept 
to a minimum, as well as using wide bore pipettes to prevent shearing of the DNA. This 
reduces the risk of breaking the DNA into smaller fragments. Also, electroelution allows 
the use of high melting point agarose, rather than low melting point agarose that enzyme
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digestion works best on. This increases resolution of separation and helps when handling 
the gel, as high melting point gels are much stiffer and less prone to shearing than low 
melting point gels.
The running buffer used was the same as the Osoegawa paper methodology, with 
0.5xTBE as the main buffer. It has been noted that borate ions may inhibit ligations 
further downstream (Ioannou et al 1994; Strong et al 1997), so they were removed by a 
dialysis step against TE after elution. This allows the running of the gels to be in 
0.5xTBE, as TBE buffer allows the best resolution of the size fragments during size 
fractionation (Osoegawa et al 1998).
There also seemed to be differences in the times that PEG concentration took to reduce 
volumes within the tubing that could sometimes be inconvenient. Some PEG dialysis 
would take no more than a few minutes, while some would take hours with little or no 
discernible difference in internal volume. A possible explanation for this inconvenience is 
the differences in starting volumes in the dialysis tubing. If there were a lot of liquid to 
start, then it would possibly take longer for the PEG to remove the water. Also, as the 
water component was removed by the PEG, it could cause localised dilution of the PEG, 
reducing the osmotic gradient between the tubing contents and the PEG, which will in 
turn increase the time to remove more water. If there were low volumes of starting liquid 
in the dialysis tubing, then this effect was reduced, as there would be less liquid to 
remove at the start and also, as a consequence, less localised dilution of the PEG, so
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maintaining the osmotic difference for longer and removing the water component much 
more quickly.
There is a combination of factors that make for a good library. Large average insert size, 
low background of non-recombinant clones and high titre are essential to making a good 
library. Table 10 in section 2.3.5 showed that the highest efficiency of the ligations was 
from the ligation with the smallest insert size. This is expected to a degree, as the larger 
the DNA becomes, the harder it would be to transform into the cell. But there were 
sufficient numbers to generate a library. What is harder to explain is the insert size 
fluctuation. Although B28 had an insert average size that was reasonably close to that of 
the original excised size, it was still some way below what was expected. What was 
stranger was the large reduction of average insert size in the other two ligations. Not only 
were they much reduced over that of the B28 ligation, they were just a fraction of the size 
of what they should have been. The reason for this the phenomenon of DNA trapping.
On a number of occasions after size fractionation had been optimised to a more reliable 
methodology, excising the insert from the vector after ligation would instantly show that 
the ligation, although successful, had not worked in obtaining the largest possible average 
insert size. Figures 19a and 19b shows that although there were inserts that had been 
excised, they were small and very sparse. This kind of thing happened on numerous 
occasions when it was thought that there would be a possibility of success.
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Small
inserts
4 8 k b ---------------
9 k b __________   Vector
band
Deleted
F igure 19a An example o f  one o f  the failed ligations. Digested with Not I enzyme to excise the insert.
Two good inserts (approx 60-70kb)
Vector
bands
Figure 19b Example o f a ligation that nearly worked, as there were two inserts that were over the required 
size, but as it was only two from the library, it was deemed unusable.
Although numerous attempts were made over the course o f approximately a year, each 
attempt gave a greater degree of success until a single methodology was settled upon that 
gave a good usable insert size to generate a high quality, stable library. This would 
hopefully pave the way for relatively easy sequencing, making interpretation o f the 
sequence much easier. More o f this is discussed in the following chapters.
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3. Physical M apping and Fingerprinting
3.1 Introduction
Physical mapping o f a genome provides an invaluable resource in a number o f ways. It 
gives the location of physical clones and markers across a genome. It also makes possible 
the selection of clones to be sequenced, ensuring minimal sequencing redundancy and 
providing the maximum coverage possible of the genome. It localises clones with respect 
to other clones that may have already been sequenced. Also, when fingerprinting clones, 
sizing o f the clones enables verification of the accuracy of shotgun sequencing o f each 
clone that is identified.
There have been a number of mapping projects that relate to the A. fumigatus project, 
namely the Aspergillus niger project fhttp://www.aspergillus-genomics.org). the
S. pombe project fhttp://www.sanger.ac.uk/Proiects/S pombej . using cosmids and the 
model fungus Aspergillus nidulans utilising BACs. The latter also used plasmids and 
fosmids and although they are relatively reliable, the number o f clones required for 
genome coverage is high. Ideally, the clones used would be as large as possible to create 
a minimal tiling path (the least number of overlapping clones to cover the entire genome). 
Plasmids and fosmids have small insert sizes making the logistics problematic and 
interpretation difficult.
O f most relevance to this study is the closely related organism, Aspergillus nidulans 
sequencing project of
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(www-genome.wi.mit.edu/annotation/flmgi/aspergillus/background.html). A. nidulans 
and A. fumigatus have similar genome sizes (approx 30Mb) and it is thought that they 
both have 8 chromosomes. A. nidulans is used as a model for cell biology, gene 
regulation and fungal genetics. It is additionally important for carbon and nitrogen 
regulation studies. The Whitehead Institute for Genome Research (WICGR) is in 
collaboration with Monsanto to produce a lOx genome sequence coverage for A  nidulans
i.e. a genome library that represents the genome of the organism up to 10 times over. 
They are aiming to achieve this by using a shotgun sequencing strategy and incorporating 
both BAC and Fosmid end sequences into the assembly, to provide linking information. 
This information will then be integrated into existing physical and genetic maps. So far, 
Monsanto have contributed a 3x coverage consisting of 16,144 contigs over 
29,123,109bp. The estimated genome size is approximately 31Mb and is thought to 
contain up to 12,000 genes. 432 genes have already been mapped to a locus. 254 of these 
genes are cloned and sequenced.
But work at WICGR has continued apace and exceeded the original aim alone, already 
producing whole genome shotgun sequence from 4kb and lOkb plasmids, 40kb Fosmids 
and 1 lOkb BACs. These were assembled with Monsanto’s reads and the result is a 13x 
assembly that was made public in March 2003, 3x more than was originally aimed for. 
The aim was to make the annotation public by spring 2003, but this is still ongoing and 
not yet fully available. What information that is available is primarily used for BLAST 
searching and downloading by the fungal genetics community.
For the shotgun strategy, the genomic DNA was shattered into small fragments of 4, 10 
and 40kb. The fragments were then ligated into either 4 or lOkb plasmid vectors or 40kb
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Fosmids. An external collaborator supplied the 1 lOkb BAC library. The ends o f the 
fragments were then sequenced to give paired sequencing reads. Software was used to 
pair the reads and generate contigs and these contigs were then linked to supercontigs 
using the read pair information already generated in other contigs.
The total genome length is 30,068,514bp and there are 248 contigs that are longer than 
2kb and there are 89 supercontigs covering the genome. The average contig length is 
121kb and the average supercontig length is 338kb. A clickable overview o f the physical 
map can be found at http://aspergillus-genomics.org/phvsical.fls/overview.html.
Other projects, such as the C. elegans (http://www.sanger.ac.uk/Projects/C e 1 egans) and 
the S. cerevisiae fhttp://www.sanger.ac.uk/Projects/S cerevisiae/1 sequencing projects 
have also used clone-based maps and have been completed using this information. The 
C. elegans project was one of the first “large scale” genomes to be sequenced (Waterson 
and Sulston, 1995). The project pioneered various different approaches to physical 
mapping. The physical map constructed consisted mainly o f overlapping cosmids and 
YACs. At the time of the construction, these two methods were thought to be the best 
techniques available. YACs were used because o f the large inserts, the ease of 
propagation in yeast, the fact that, long range continuity was more achievable and DNA 
that was unclonable in cosmids could be cloned. Cosmids were used as they gave a much 
higher resolution locally and were technically more amenable. A number o f techniques 
were used to construct the map. Restriction enzyme fingerprinting was used to generate 
cosmid contigs; YAC-cosmid hybridisation to grid the arrays; sequence tag site (STS) 
assays were used to detect YAC-YAC overlaps; and hybridisation to C. elegans DNA for
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long range ordering. There was no single technique used that would provide a full linkage 
of clones and as there was a level of redundancy between each technique, each technique 
complemented the next in a logical manner.
The C. elegans map consists of 17,500 cosmids and 3500 YACs. It was predicted that 
there were over 13,500 genes within the C. elegans genome. This was calculated by using 
EST (expressed sequence tag) data. The number of predicted genes in a given sequenced 
region was divided by the fraction of cDNA library for which exact matches found in that 
region. Even though there was only a quarter of the genes of the genome in the cDNA 
library, this made no difference to the calculation as the figure calculated rested solely on 
the assumption that the expression of the genes in the sequenced region is typical of the 
genome as a whole.
The C. elegans project was a project that had data published from its work over a number 
of years and as a result, a number of independent studies were initiated using the 
information as it was published during the project. The University of Leeds project 
involved collecting expression data by using transgenic reporter constructs of the 
predicted genes (Hope 1994; Lynch, Briggs and Hope 1995); Kohara of the National 
Genetics Institute at Mishima, Japan used the map to continue to gain information and 
collect data for his set of sequence tagged cDNAs and is using the information to 
determine the expression patterns by in situ hybridisation and Baillie at the Simon Fraser 
University and Rose at the University of British Columbia used the map to generate 
transgenic strains incorporating sequenced cosmids. This will allow the rescue of lethal 
and visible mutants to determine a precise correlation of the genetic map with the 
sequence (Howell and Rose, 1990; Schein et al, 1993). Each one of these laboratories and
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projects makes use of the map extensively. But the main use of the map and sequence 
have been for the study of specific C. elegans genes and for comparative genomics, 
which may involve up to 150 laboratories around the world.
Initially, it was thought that a whole genome shotgun for the A. fumigatus project would 
be logistically far too difficult because of the scale and cost. So the pilot project was set 
up to assess the viability of a complete genome sequencing project based on a 
methodology very similar to that that was being employed by the Human Genome Project 
and that of the Mouse Genome Project, a BAC based physical map. It was estimated that 
the pilot project would sequence no more than 1MB by choosing a BAC contig from this 
map centred around the niaD gene. The region of the genome surrounding niaD was 
chosen for this study as it is a well studied gene in A. nidulans within a gene dense 
region, and is thus a good choice for synteny studies.
3.2 Materials and Methods
3.2.1 Identification of the niaD gene 
Materials and Equipment
• Thick polythene sheet
• Small sandwich box
• Shaking incubator
• Perkin Elmer Cetus PCR machine
• QuikHybe (Stratagene)
• Guys buffer (see appendix 2)
114
• 5mM d(ATG) (Amersham Biosciences, lOOmM)
• AmpliTaq DNA polymerase (Applied Biosystems, 5U/pl)
• a-32P-dCTP (Amersham Biosciences, 3000Ci/mmol)
• (CA)n =(lmg poly dA-dC poly dG-dT in 1ml TO.IE, Pharmacia Biotech)
• 20xSSC (see appendix 2)
• 2xSSC
• 0.2xSSC
• Total Human Placental DNA (10.8mg/ml, Sigma)
• 0.5x SSC/1% sarkosyl (BDH Laboratories)
The niaD gene in the nitrate reduction gene cluster was used as a starting point for the 
mapping. The library had to be screened for the gene by radiation hybridisation with a 
niaD probe, which was generated using DNA from the previously sequenced niaD gene, 
supplied in the pGEM-T Easy vector (Promega), by Michael Anderson of Manchester 
University. 32P-radiolabelled probes were produced by PCR using gene specific primers 
(see below) to perform a hybridisation experiment against the library. Any spots that lit 
up designate both the plate number from the original library and also the position on that 
plate where the clone was located.
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3.2.1.1 Array probing
1. The filters were robotically gridded according to the manufacturers guidelines as 
shown in Figure 20
H12
3631
Figure 20. Diagram o f gridded filter. From top left to bottom right, each position shows position o f  clone 
on the original library plate. O f the 36 dots found in each grid position, this shows the plate number.
2. The filter was pre-hybridised in a small sandwich box, immersed in QuikHyb 
with a small piece of polythene placed over the top to slow evaporation, for 3 
hours at 65°C with shaking at 40 r.p.m. on a flatbed shaker.
3. To make the radiolabelled probe, 2pl niaD template DNA was pipetted into a 
sterile 0.5ml eppendorf tube and 0.2pl of each primer. The primers were 
sequences supplied by Anderson and represent the ends of the fragment that was
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supplied. (3 ’ :GCCCCAATAACGCTAGTGTG;
5’: CGTTCATCGCGCCACCACAT) (Tm: 60°C). A drop of mineral oil was 
added to each mix. A pre-mix of lpl lOx Guys Buffer, 0.4pl d(ATG), 5.7pl sterile 
H2O, 0.1 pi Taq DNA polymerase and 0.4pl a-32P-dCTP was made. 7.6pl of this 
pre-mix was added to the DNA/primer mix.
4. PCR was performed as follows (radioisotope shielded):
94°C 5min 1 cycle
93°C 30 seconds
55°C 30 seconds 35 cycles
72°C 30 seconds
72°C 5 min 1 cycle
5. Following the PCR reaction, a competition mix of 235pl DDW, 5pi (CA)n, 125pl 
total human placental DNA and 125pl 20x SSC were added to a screw capped 
eppendorf tube. The PCR was pooled into the competition mix and the cap 
screwed on. It was then placed in to a boiling water bath for 5min then quenched 
on ice for 2min.
6. The plastic was removed from the pre-hybridising filter and the filter removed. 
The probe/competition mix was added to the QuikHyb (plus a little more 
QuikHyb if some evaporation had occurred) and mixed. The filter was returned to 
the box, covered with the plastic and placed in a shaking incubator at 65°C 
overnight.
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7. 2 litres of 0.5x SSC/1% sarkosyl were pre-heated to 65°C in an incubator. In a 
large sandwich box, 1 litre of cold 2x SSC added and the filter transferred to the 
solution. The filters were “swirled” in the solution and the solution discarded. The 
process was repeated and the solution discarded. Then 1 litre of pre-warmed 0.5x 
SSC/1% sarkosyl was added to the filter and the box was placed in a shaking 
incubator at 65°C for 30min. The solution was discarded and the process 
repeated. The filter was then rinsed twice using 1 litre of 0.2x SSC. The filters 
were then placed face down on some pre-flattened cling film and the whole 
package placed into an autoradiograph cassette face up, a film placed on top with 
“Glo-gos” (Stratagene) in the cassette to mark the correct position of the film 
when developing. The cassette was left at -70°C overnight (or longer with fresh 
film if needed) and then developed.
8. When developed, the film was then placed back over the top of the filters in the 
cassette and correctly positioned using the “glo-gos” as a guide. Any spots that 
were “illuminated” on the film could then be scored to the correct position on the 
filter, giving the correct plate number from the library and the correct position on 
the plate.
3.2.1.2 Colony PCR 
Materials and Equipment
• TYE Agar plates (see appendix 2) containing 20pg/ml chloramphenicol and 5% 
sucrose
• TO.IE (see appendix 2)
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• 40% sucrose/creosol red (see appendix 2)
• lOxNEB PCR buffer (New England Biolabs)
• 1 OOxBovine Serum Albumin (BSA) (1 Omg/ml, New England Biolabs)
• P-mercaptoethanol (Sigma)
• Taq Polymerase (AmpliTaq 5U/ml, Applied Biosystems)
• dNTPs (Amersham Biosciences, lOOmM)
This was used as a confirmation that the “hits” that were found on the gridded array were 
true positive hits and not anomalies that were picked up by the process.
1. A small inoculum of each “hit” was taken from the original glycerol stock plates 
from the library and was streaked out onto TYE Agar plates containing 5% 
sucrose and 20pg/ml chloramphenicol and was grown overnight.
2. A single colony was then picked from each plate and transferred to a microtitre 
plate containing 150pl TO.IE.
3. A premix of 5.425pl sucrose/creosol red, 1.5pl PCR buffer, 0.495pi of a 1:10 
dilution of BSA, 0.21 pi of a 1:20 dilution of p-mercaptoethanol, 0.12pl Taq 
polymerase and 1.5pl dNTP’s.
4. The colony inoculum (5pl) was used as template, 0.75pl of the premix was added 
and PCR was carried out using the same conditions according to the above 
conditions set out for the array probing.
119
3.2.2 End Sequencing 
Materials and Equipment
• 48 well, deep well boxes (Beckman)
• Plate sealers
• 2xTY (see appendix 2)
• lm M T rispH 8.5
3.2.2.1 Template DNA preparation
1. Two deep well boxes were filled with 2.5mls of 2xTY media containing 20pg/ml 
o f chloramphenicol. These were inoculated from the original library, in the 
correct order of the plates.
2. The deep well boxes were then sealed with plastic, self-adhesive plate sealers and 
small holes punched into the tops.
3. The boxes were grown for 24 hours at 37°C in a shaking incubator at 220rpm.
4. The boxes were spun at 3800rpm at room temperature for lOmin.
5. The supernatant was then poured off and the box was dried upside down on a 
paper towel.
6. To extract the DNA, the REAL96 kit from QIAGEN was used in accordance to 
the manufacturers specifications
(http://www.qiauen.com/literature/Handbooks/PDF/Plasmid DNA isolation/INT/ 
Miniprep/PLS REAL Prep 96/1019510 OPREALHB pi 8 22.pdf)
7. The DNA was re-suspended in 22pl of Tris.
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3.2.2.2 Sequencing the DNA 
Materials and Equipment
• MJ Research PTC-225 Peltier Thermal Cycler
• BigDye© Terminator sequencing reagent (ABI Prism)
• T7 or SP6 30pmol/pl (120,000pmol/ml, Sigma)
• Precipitation mix (see appendix 2)
1. A sequencing reaction was set up as follows in 96 well PCR plates:
lOpl DNA 
lpl primer 
12pl BigDye©
2. The reaction conditions were set up as follows:
95°C 5min
95°C 30secs"
50°C 20secs >- X40 cycles
60°C 4min J
10°C hold
3. After the reaction had finished, 50pl of precipitation mix was added to each well.
4. The plates were then spun at 4000rpm at 4°C for 40min.
5. Supernatant was poured off, dabbed dry upside down on paper towel and 200pl of 
70% ethanol was added.
6. The plates were spun for 5min at 4000rpm at 4°C. Supernatant was poured off; 
the plates were dabbed dry and the process repeated.
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7. The plates were then spun briefly at 500rpm upside down to remove residual 
supernatant. The plates were air-dried and then they were loaded onto an ABI 
Prism 3700 sequencing machine.
3.2.3 Fingerprinting
An enzyme had to be chosen for fingerprinting that would restrict approximately 20 times 
in each BAC to provide sufficient data for map construction. The only dataset that was 
available to use for enzyme determination was the BAC end sequences. This data was 
analysed using a program called EmbossRestrict, which can be found at 
http://www.hgiup.mrc.ac.uk/Software/EMBOSS/Apps/restrict.html. Restrict uses the 
REBASE database o f restriction enzymes to predict cut sites in DNA sequence. The 
program will display a number of enzymes showing the number o f cuts for that sequence 
and the starting and finishing point of recognition. From the BAC end sequence that was 
inputted into the program, the enzyme that was chosen was Pstl. Although this enzyme 
was not ideal as the number of cuts it achieved was nearer the lower end o f the acceptable 
range, there was no other reasonable alternative. It was calculated that Pstl would cut a 
BAC clone to be fingerprinted between 20 and 30 times.
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3.2.3.1 Micro-prepping ofBACs.
Materials and Equipment
• 96 well, deep well boxes (Beckman)
• 2xTY (see appendix 2)
• 10% w/v glycerol
• Solutions I, II and III (see appendix 2)
• Isopropanol
• 4.4M lithium chloride
• 70% ethanol
• TO. 1E (see appendix 2)
1. Growth media (500pl of 2xTY containing 80pl of 25mg/ml chloramphenicol) 
was dispensed into 1ml deep well Beckman 96 deep well plates.
2. Using a “hedgehog” 96 pin inoculating tool, the medium was inoculated from the 
BAC library stock glycerol storage plate.
3. The plates were sealed with a microtitre plate cap and incubated at 37°C on a 
rotary shaker for 18 hours at 300rpm.
4. 250pl of each overnight culture was transferred to a new microtitre plate and 
centrifuged at 2500rpm at room temperature for 2min.
5. The supernatant was then decanted.
6. The remainder of the culture was stored at -70°C after adding glycerol.
7. Solutions (I, II and III) were made up
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8. To each well, 25pl of Solution I was added and the plates were tapped gently to 
resuspend the pellets.
9. Then 25pl of Solution II was added and this was mixed by again tapping the 
plates. They were left at room temperature for 5min.
10. Finally, 25pl of Solution III was added and mixed by gently tapping the plates. 
This too was left at room temperature for 5min. The plates were then covered 
with plate sealers and vortexed vigorously for 10 seconds.
11. The plates were then centrifuged using a microtitre plate rotor for lOmin at 
3400rpm and 4°C.
12. 75pl of the supernatant was transferred to a new microtitre plate that contained 
lOOpl of isopropanol in each well.
13. The plates were re-sealed and then placed at -20°C for 30min to 1 hour.
14. The plates were then centrifuged again at 3400rpm, 4°C for lOmin. The 
supernatant was decanted and the plates were drained upside down with care not 
to dislodge the pellets.
15. Water (25pl) was added and the pellets were resuspended by tapping the plates 
again. Then to this, 25pl of lithium chloride was added and mixed gently by 
tapping the plates. This was left for 1 hour at 4°C.
16. The plates were then again centrifuged at 3400rpm at 4°C for lOmin.
17. The supernatant from each well was transferred to another plate containing lOOpl 
in each well.
18. These were then put into a -20°C freezer and left either for 1 hour or overnight.
19. The plates were centrifuged at 3400rpm at 4°C for lOmin.
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20. The supernatant was decanted; the pellet washed with 200pl of 70% ethanol and 
the previous step was repeated. The pellet was then air dried. The pellet should 
dry to transparency.
21. Each pellet was resuspended in lOpl of T1.0E. To help the resuspension, the TE 
was pipetted up and down gently at the base of the well. The resuspended DNA 
could then be either used straight away for fingerprinting or could be stored for up 
to 2 weeks at -20°C.
3.2.3.2 Fingerprint digestion 
Materials and Equipment
• Pstl restriction enzyme (New England Biolabs, 20U/pl)
• Buffer 3 (New England Biolabs)
• 6X Buffer II dye (see appendix 2)
Digestion mixes were made up according to the number of plates that were to be loaded 
on to gels.
1. The enzyme of use, Pstl, was used with its supplied buffer. Premixes of the 
appropriate volume were first constituted on ice (Table 11)
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Table 11
x l well 1 plate 2 plates
Pstl enzyme 0.5pl 55pl llOpl
Buffer 3 0.9pl 99(4.1 198(4.1
Water 2.6pl 286pl 572pl
2. Then 4pl of this mix was added to each of the wells of the resuspended DNA 
using a combitip dispenser set to 1 with 0.2ml tips.
3. The plates were covered with plate sealers and agitated gently with a vortex to 
mix and were centrifuged briefly to lOOOg to bring the residue to the bottom of 
the well.
4. The plates were then incubated at 37°C for 2 hours.
5. The plates were again briefly centrifuged to lOOOg and the reaction terminated by 
adding 2pi of 6X Buffer II dye using a Hamilton pipette.
6. The plate was again centrifuged briefly to lOOOg. The plates could then be either 
stored for up to two weeks at 4°C with plate sealers covering them or used 
straight away.
3.2.3.3 Gel electrophoresis for fingerprinting 
Materials and Equipment
• Each gel was made using SeaKemLE agarose (FMC BioProducts).
• lxTAE (see appendix 2)
• Promega ladder (see appendix 2)
• Vistra Green (Amersham Life Sciences)
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Each gel required 5 litres of lxTAE. It was ensured that each buffer that was made up to 
make the gels was also the buffer that went with that gel in the electrophoresis tank. This 
prevents any contamination and also helped ensure straight running of the gels and to the 
correct distance.
1. For each gel, 4.5g agarose and 450ml lxTAE was heated in a microwave to melt 
the agarose for approximately 5min and allowed to cool for 5min in a cold room 
at 4°C.
2. The agarose was then poured into an gel bed with the ends sealed with plastic end 
sealers. A divider was put at approximately half way to separate the gel into two. 
A 121-well comb was placed in both halves of the gel at the same ends and the 
gel was allowed to set for at least 3-4 hours. The remaining buffer was also left to 
equilibrate at 4°C.
3. Once the gel had set, the sealers at each end were removed and the gel was placed 
into the gel tank and 3-4 litres of the buffer was poured in. The divider and the 
combs were then removed.
4. All reagents were stored on ice as the Promega ladder is particularly sensitive to 
temperature changes.
5. To the first well, 0.8pl of marker was added and then to every fifth well (see 
appendix 2).
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6. To the wells in between the markers, lpl of sample was added, starting from A1 
on the plate and working across the row. This was also done for the second lot of 
wells with another plate.
7. Once all 121 wells were loaded the gel was run at 90V for 15 hours at 4°C.
8. Once the gel had run, the gel, in its gel mould, was removed from the tank. The 
gel and mould was placed into a suitable plastic tray, placed onto a shaker then 
stained with Vistra Green.
5ml Tris (pH 7.4)
500pl 0.1MEDTA
Made up to 500ml with ddWater
50pl of Vistra Green
9. This was poured over the gel and it was checked that the gel was floating in the 
stain to ensure even staining of the gel. The gel was covered with a tray to prevent 
light exposure and the whole thing was stained for 45min at a very slow shake.
10. The gel was drained and then rinsed with 500ml of water, drained and this was 
repeated to remove any excess stain. The gel was then ready to be scanned into 
the computer.
11. The scanning was carried out using a Phosphoimaging Scanner and bespoke 
software.
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3.2.3.4 Data Capture
Data from the gel image was processed from the scanner and stored in a computer 
database. The database is a network accessible database that is part o f the editing 
program called Image (http://www.sanger.ac.uk/Software/Image/). Image is a program of 
algorithms for processing gel images o f restriction fingerprints. The raw information was 
then used to continue with the analysis.
Firstly, the captured image was visualised on screen within Image (Figure 21)
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Figure 21. This is an example of how a gel image looks at the first step o f the image analysis before any 
manipulation.
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Image takes the normalized banding patterns from each clone (lane) on a gel image and 
the program performs several procedures in turn. Firstly, the lane tracking has to be 
performed. The program has a facility to recognise the lanes itself and can superimpose a 
grid over each lane on the gel image. This is so the program can recognise what is a band 
or clone. It does this for all 121 lanes on a gel (the 96 wells from the plate and the 25 
marker lanes) (Figure 22)
3.10 . 112 Edit Ldnetnchim
- | - | J00%| L a n e s  la n e  u p  la n e  do v /n  g re y  ram p  too l
P roject 'te s tp io je c r  Gel 'le s tg e r  [Lanes 4 9  H ones 15
Figure 22. Here the test image has had the lanes tracked by the computer. The tracks in red show where the 
marker lanes are. The very small, indistinguishable bands have been removed from the image.
Once the lane tracking had been completed, the next step was to call the bands. The 
program looked along the tracks that has just been laid over every lane o f the gel and
130
looked for bands by making comparisons with the background and foreground contrasts. 
This step required frequent human intervention, as there were always artefacts on gel 
images that could not be completely eradicated. If something that was not DNA was 
stained and illuminated when being scanned, the scanner picked up the artefact and 
processed it with all the other band information. The gel image would transfer these 
artefacts and they would have to be eliminated by eye, as the program would recognise 
them as bands (Figure 23)
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Figure 23. A screenshot o f a test gel representing the band calling procedure.
The next step was to lock the markers for the program to have a reference to measure the 
band sizes. In order for the program and me to compare banding patterns from different
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gels, the band positions had to be normalized to one “master “gel. DNA marker 
fragments of a known size were loaded onto the gel at every 5th lane, with the samples in 
between the markers. This pattern of bands was then matched to the “master” pattern. 
The program was then used to get the best match between two sets of bands between the 
master pattern and the banding pattern o f the gel under analysis. (Figure 24)
Figure 24. Here the standard lane is “locked” with all the bands in the correct pattern and number. This is 
compared against a “standard” pattern within the program to ensure that the markers on all o f the gels are 
standardized to the “standard” pattern. Human intervention is inevitably needed at this stage to ensure that 
there are no bands missing, or there are no extra bands that the program may have called. The upper part o f 
the figure shows the central trace and the bands in the marker lanes. The triangles in the lower part o f the 
plot corresponding to the bands in the standard lane.
Once the marker lane patterns were locked onto the standard lane, then band positions of 
the samples were then normalized against the locked marker. Each gel would then appear 
to have been run on the “master” gel with all the distortions due to temperature
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differences, voltage discrepancies and so on metered out. The program was used to 
calculate the correct sizes for the bands by comparing the distances between the locked 
bands of the normalized marker and those of the sample banding pattern.
Once the bands had been sized in Image, the data were then processed into a database 
called FPC, which is an automated comparison tool that clusters the fragments from the 
clones together under certain stringency conditions. FPC uses more algorithms to 
automatically join clones into contigs by using a scoring system based on the probability 
of similarity between clones. For each contig, FPC created a “consensus” band (CB) map 
that had a lot of similarities to the restriction map, but had none of the errors that a 
restriction map can introduce. The CB map was used as a template to assign coordinates 
to the clones based on map alignment and generated a detailed visual picture of the clonal 
overlaps. I used the tools within FPC to adjust coordinates to fit and also remove any 
badly fingerprinted clones from the system. As new clones were fingerprinted, FPC also 
had the function of being able to integrate the new data into the system, ready to be used 
when needed. Contigs could then be split, merged and deleted as the analysis continued 
(See results). Clonal markers could also be displayed in the program, along with the 
appropriate contig that the clone was in, making matching the clones much easier. All of 
the data from the fingerprints was entered into the FPC database and the construction of 
the initial assembly started using the autonomous facility of the program. This was fine 
tuned to make the assembly as consistent and complete as possible before undertaking the 
manual work that was required to complete the task.
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The sequence from individual clones as they were sent for sequencing after initial 
identification of overlaps with other clones was completed could be viewed in a program 
called Gap4. This allowed the identification of overlaps in clones and was especially 
useful when the initial clones to start contig building were identified.
3.3 Results
3.3.1 Identification of niaD gene
Probes were generated and hybridised to the filters, as described in 3.2.1.1. After 
overnight exposure the film was developed and the image was analysed. 5 spots were 
illuminated on the film. The “hits” were designated 5C11, 8D5, 4H9 33H12 and 34H12 
(Figure 25). One hit (33H12 and 34H12) was slightly ambiguous as it was not clear that 
the hit was covering either one or two spots and whether it really was two spots very 
close together, or just an anomaly in the processing. The information was clarified by 
performing a colony PCR to confirm the hits were the correct clones. This was also to 
ensure that the probing had actually worked correctly and that the hits were not just 
artefacts on the grid.
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Figure 25. Although the illuminated spots can be clearly seen, they are a little diffuse. This becomes less o f 
a problem when the original filter is placed underneath so “scoring” can be performed. The filter spots can 
then be seen through the film and the spots can be matched to those on the filter.
135
3.3.2 Colony PCR
Colony PCR was carried out according to the method set out in 3.2.1.2.
IliPfff :>■ ■ i z ~ -
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5C11 4G9 34H12
8D5 33H12
Figure 26. The bands produced from the colony PCR correspond exactly to the spots on the filter. The 
strong spots on the filter gave by far the best products from the PCR. O f the 5 possible hits, 3 were positive.
If the colony PCR gave bands of good clarity and the correct size, then it could be 
assumed that the array probing actually worked and that the bands could be confirmed as 
the niaD gene. As can be seen from figure 26, three out o f the five hits tested showed 
positive and strong bands. When building contigs, 5C11, 4G9 and 34H12 were strong 
candidates to “walk” from. The clone 8D5 only gave a positive on the array probing and 
not on the colony PCR, but although the hit was not a strong one it was significantly 
visible, so on this evidence alone, it was sent for sequencing anyway, along with the other 
three hits. Hit 33H12 would need further confirmation and is discussed in a later section.
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3.3.3 End sequencing
The radiation hybridisation identified three clones that were candidates for a starting 
position and these clones had the end sequences compared against the rest in the database 
and the best candidate was picked on the grounds of greatest overlap and closest 
sequence homology. Using the BAC end sequences, the strategy was to “walk” from the 
starting BAC in either direction to construct contigs that way. Selected BACs were either 
skimmed (minimal sequencing to generate sequence for use in clone location) or 
“shotgunned” (further random shattering of the BAC inserts for ease of sequencing and 
put into pUC vector to create a “mini-library” of that clone) to 8-fold coverage for 
finishing (knowing the lengths of the selected BACs, by fingerprinting, was helpful in 
deciding how many plates to shotgun sequence). The fingerprints would then confirm 
that the clone to be sequenced was correct from the size information and the banding 
homology. Of the 6912 reads in the database that were produced from the end sequencing 
((36 plates x 96 wells per plate) x 2 for read pairs), there were 5685 useful reads. Of these 
5685 reads, it could be seen that 4468 reads were actually pairs. This left 1217 reads 
unaccounted for. These reads were seen as either single reads (there were approx. 300 
single end reads) that were still of some use as they were designated to one end of a 
particular clone, or that they were repeats that were of no use at all.
Which meant that from the 3456 read pairs that were predicted, 2234 read pairs were of 
use. This is 64.6% of the total complement from the library.
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3.3.4 Fingerprints
The fingerprint data were first to be edited. Fragments on the gels that were less than 
600bp were discarded as they gave false indications of information to the database and 
the database would predict very low estimates of clonal overlaps. Another problem was 
the incidence of “doublet” bands, where two bands of similar or exactly the same size 
travel though the gel at the same rate and are in approximately the same position when 
the gel run is over. There was a need for reliability in determining the correct overlaps 
between clones, so registering them as only one band in the fingerprint effectively 
eliminated the “multiple” bands. The reliability was increased accordingly.
There also had to be a tolerance threshold to accept two bands from different clones as 
being the same. If the stringency is too high then bands that are very close on the gel 
might not be seen as the same band size. Too low and bands on the gel that have high 
distances between them will be seen as the same band when they are clearly not. The 
stringency was a fairly fluid parameter due to the high number of variables that can 
happen with the gel runs. This had to be taken into account when collating this data in the 
database and the stringency was adjusted at all times, within its own set parameters, to 
allow discrepancies in gel run distances, as well as manually putting clones together 
when the program has made obvious mistakes. These parameters also were applicable to 
the datasets that were in the FPC software and data manipulation described in section
3.3.5 (Figure 27).
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Figure 27. Image o f one of the gels generated at different stages o f the process. This gel is designated 
B2825 (B28 is the library designation and 25 is the plate number)
a) Image capture
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With this image, indistinguishable fragments towards the bottom of the gel are visible. In 
the analysis, these fragments would be discounted. The gel has run relatively straight, but 
some lanes are still not completely straight and this needs to be compensated for.
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b) Lane tracking
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Here, the lane tracking has been completed. Each lane has been locked onto by the 
imaging software and has picked out what it thinks are the correct lanes. Some manual 
intervention is required the majority of the time at this stage as the software does not 
always get it 100% right every time. Some track may be off the middle of the lane or may 
well have kinks in them due to artefacts that are on the gel showing up more brightly and 
the software detecting it as a band. The tracks can be moved by the operator to give a 
more accurate representation.
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c) Band calling
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This image shows the band calling step. The software detects each band by comparing 
the contrast o f background and foreground. Unfortunately, this can lead to some artefacts 
being picked up, adding extra “bands” or can also lead to some bands missing if  the 
contrast is too faint. Again, operator intervention is required to make sure all the correct 
bands are called and no artefacts are picked up.
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d) Marker locking
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This image shows the last step of the editing process before the image is stored for the 
information to be used at a later date when comparing clones for contig building. Here, 
the marker standard is being locked so the software knows the correct distances to call 
the clone bands to. There should be a total of 37 bands for the marker. For each of the 
bands, it is up to the operator to make sure that the peaks correspond to the bands on the 
image and make sure they are accurately picking up the correct band. For the first 30 
bands this needs to be very accurate, as this is where the majority o f the clone bands 
migrate between on the gel. The accuracy needed for the last seven bands is not so 
important as the software rarely uses the information from fragments that small.
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As with the end sequencing, all 3456 clones were fingerprinted from the AfB28 library. 
Assuming an insert size of 74kb and an estimated genome size of around 30-35Mb, then 
this would give genome coverage between 7.5 and 8 times. The pilot project proposed to 
only do 1Mb, so the overall coverage was more than adequate.
In total, the B28 library had a total o f2635 fingerprints put into the database. But this 
was combined along the way with a further library, AfB46, which was needed to fill gaps 
and enhance the data. This was not the original intention, but as the second library had 
been constructed, it was thought that it might be valuable to integrate its data. Therefore, 
figures for the B28 library alone are difficult to obtain. The combined data, made up in 
the majority of the B28 library gave the following:
104 contigs in total (4180 clones)
1507 Singles (clones not in contigs)
Total genome length 30.032Mb 
Longest Contig 1.786Mb
30 BACs were picked in total in the project and 16 of these were “shotgunned” (i.e. 
broken down again into smaller fragments and sequenced again to attain a higher level of 
detail) to at least 8-fold coverage and 14 were “skimmed” (i.e. Sequenced to a level so 
detail could be seen, but not completely. Used only as an indicator as to whether it is 
worth sending the clone for full “shotgun” sequencing. Usually done on the number of 
plates, not overall coverage of the clone), (see Supplementary Figure 1).
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A total o f 166x96 well plates were sequenced and the total length of the 30 shotgunned 
BACs was 1880500bp. 31872 (166x96) attempted reads gave 25500 passed reads (at 
80% pass rate) and a total o f 12750000bp (at 500bp/read). This works out at an average 
o f 6.8-fold coverage o f 1880500bp.
The finished status was 16 finished BACs that cover a region o f 921536bp. The aim was 
to cover 1Mb.
3.3.5 Data capture
When the sequence was viewed in a sequence editor (3.2.3.4), it could be seen that all 
four of the hits had significant overlaps with each other, showing that 8D5 also had 
overlaps (Figure 28). Supplementary Figure 2 in the next chapter also shows where in 
relation to the clones indicated below the niaD gene is.
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Figure 28. This shows the sequence overlap between the clones 8D5, 34H12 and 5C11 in a viewing 
program called Gap4 (Bonfield et al 1995). a) This is a graphical representation of the overlaps and their 
sizes between the clones that were sequenced from the original four. Note that one of the clones, 4G9, is 
not there. In its place is 5C5, which came from BLASTing the sequence against the end sequences in the 
database that had already been completed for the library. 4G9 turned out to be a sequencing failure in that 
region, but 5C5 was a match. The numbers under the arrows represent the number of kilobases from the left 
end of the clone 8D5 that the overlaps occur, b) This shows the sequence alignment between 8D5 and 
34H12. The empty gap represents the cloning vector and where the sequence of the insert starts. It can be 
seen when in comparison with a) where the overlap occurs. The figures at the top of the window show the 
number of kilobases from the left end of the clone, as in a), c) This shows the sequence alignment at the 
other end of the clone where 5C11 starts the overlap. Again, with comparison to a), it shows nicely the 
distance from the left end of the clone and the good sequence alignment confirmation, d) These are known 
as “traces” which are the raw data that is produced by the sequencing machines. The peaks and colours 
represent the four different bases. Here, it can be clearly seen that there is good sequence matching with all 
three clones.
As can be seen from the images above, 4G9 clone was not seen in the final sequence 
alignment, but another clone, 5C5, was found to match the closest. 5C5 was found by 
comparing its end sequence from a BLAST search of an internal database which had all 
of the end sequences available on it and pasting in sequence from three of the clones to 
see if there were any matches in the database. 4G9 did not have any matches, but 5C5 
did. This was the clone that was used to continue the work.
FPC was used to build the contigs. There were a number of clones that were initially not 
included in the original build, but after careful manipulation of the data and stringencies, 
some of these clones were incorporated into the build. Figure 29 shows and example of
146
an intermediary build with a number of clones. Once this build with this group was done, 
it was joined with other contigs that were built at overlaps that were identified by either 
the software or myself.
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Figure 29. a) This screen shot shows a number o f fingerprints side-by-side so visual comparison can be 
made.
b) The fingerprint in blue is the clone that is being compared to the fingerprints the computer estimates is 
closest in match. Screen shot from FPC showing possible merge o f a contig. Clones in purple are 
overlapped.
The data from the fingerprint gels was visualised in the first part o f the FPC software 
(Figure. 29 (a)) by lining up the banding of each clone side by side to compare the sizes 
of each band in that clone. The software then determined the overlaps in the clones by the 
number o f bands that were in common with each clone. The higher the number o f bands
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in that were the same size, the higher the likelihood that the clones overlapped. It was 
inevitable that although a number of clones would have overlaps the software would not 
pick up the connection of the band number between the clones because the bands were 
not sized exactly as they should be. Hence stringencies had to be altered to allow for any 
running error on the gels that would stop the software from recognising the banding sizes. 
Once the clones had overlaps, the contigs could then be built in the second part of the 
software. This linked the clones by overlapping them by using information from both the 
end sequences in the database and the clones that overlapped from the FPC software. By 
looking at both sets of information, the clones could contiguated as seen in Figure 29 (b). 
The software and I combined the data generated so that “best-fit” overlaps could be 
made. Each type of information was used against the other to ensure that the clone that 
was thought to overlap was actually the correct clone.
3.4 Discussion
The identification of the niaD gene using the probes and the fragment supplied turned out 
to be a relatively easy process. The only complication that arose was after the clones 
identified were sent for sequencing. One clone, 4G9, did not show in the database as 
having overlaps with the other clones, even though it had been detected on the array and 
also by colony PCR. This may have been due to 4G9 being a very small clone and 
although detectable on a hybridisation experiment, the sequencing did not produce 
enough data to give positive matches. It is also possible that 4G9 was still in the niaD 
region, but not directly linked to the other clones in the gene i.e. either to the left or to the
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right of the other clones in the gene, but with no overlaps. 5C5 on the other hand showed 
up in the database as having significant overlaps with the other clones. The identification 
of this clone failed in the array probing and this was possibly down to a failed PCR, 
hybridisation or that the clone only had a small amount of sequence that was compatible 
with the probes to bind to but had high levels of overlap at the opposite end. The reason 
could be identified more clearly at a later time when there is more information in the 
databases and the clones could be placed more accurately.
The colony PCR also gave good confirmation on the hits on the array. The technique did 
clear up the confusion of the ambiguous hit of 33H12 and 34H12. When both were 
tested, it was easy to see that 33H12 was not a positive and proved that there was only 
one hit in that area and the confusion was brought about by highly dispersed radioactivity 
from the 34H12 hit in that area. The labelled probe had obviously not adhered completely 
to 34H12 and had spread too far into the surrounding area, which exposed the film more 
and made it look like there was the possibility of two hits instead of one. The would not 
have been too much of a problem once the clone had been sent for sequencing as it would 
have been immediately apparent that the clone did not have any overlaps with the other 
hits, but it would have been a waste of resources and time to have let the process go this 
far for one clone. Luckily, the colony PCR technique is usually reliable and identified 
that the hit was in fact false and prevented any further work from being done on this 
clone at this stage. But as proven above, the reliability of the technique is still not 100%, 
as it identified and confirmed the 4G9 hit which consequently did not have significant 
overlaps with the other clones. But for the purpose of identifying clones from an array, it 
was a very useful tool.
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As discussed in section 3.3.3, the number of read pairs produced from the end sequencing 
that were of use was 64%. Although this figure is not optimal (other BAC end sequencing 
projects aim for 80-85% pass rate), it was still more than useful as the read pairs there 
were of confirmed good quality. This confirmation is done on a scoring system produced 
by the software indicating the quality of the read pairs that have come through the 
system. Also, if the sequencing reactions have just not worked, then there will be no data 
to score. As the end sequencing was relatively new on a project like this, there were 
initially some mistakes in database nomenclature that may account for some lost reads, 
some miscalculations from reads and so on. This itself bought down the overall pass rate. 
But what was important was the quality of the sequence from the reads and this was of a 
very high quality, ensuring that the lower pass rate would not be too much of a problem. 
As it was a 1MB contig that was to be sequenced and not the whole genome at this point, 
then a 64% pass rate was more than enough to ensure coverage for a 1MB contig 
construction. Ideally, all of these would have passed and each read would be a clean, 
mistake-free sequence covering every clone in the library. But this is not so and there are 
inevitably some failures.
As with the end sequencing, all 3456 clones were fingerprinted from the AfB28 library. 
Assuming an insert size of 74kb and an estimated genome size of around 30-35Mb, then 
this would give genome coverage between 7.5 and 8 times. Although the library had 
smaller inserts than envisaged, it was known that the library was of high quality, with few 
non-recombinants and relatively uniform insert sizes. This was confirmed by the excision 
of the insert by Notl digestion, showing the good quality of the insert size and also by the
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end sequencing, which as already explained gave good results for DNA quality, even if 
the actual pass rate was less that ideal. The insert size reduction could be due to a number 
of factors such as a library bias of smaller fragments that were generated when removing 
the fragments from the gel. The clones were digested and loaded on to gels with 121 
lanes. 25 lanes were taken up with “marker” DNA to help determine standards and 
calculate band sizes. Each plate of the library was digested at once and the whole plate 
was loaded on to the gels. This was time consuming and laborious, but this was slightly 
relieved when a revised method of tandem gels was introduced (described in section 
3.2.3.3), which halved the time it took to fingerprint the whole library and also did not 
degrade the integrity of the results regarding the accuracy of the clone tracking or the 
fragment sizes. The original method only used one gel per plate. There was no division of 
the gel into two distinct sections and there was only comb. The main problem of this 
method was the time it took to do each plate. When the one gel/two plate method came 
in, it became much quicker to fingerprint the whole library. There was an investigation to 
determine if this would have a detrimental effect on the running characteristics by some 
colleagues who concluded, after a little manipulation of a few of the minor preparative 
practices in making the gels that there should be no effect on the results produced by a 
tandem gel. Before the preparation protocols were changed and tandem gels were tried, 
the DNA tended to “bend” in the gel, with the outside lanes “drifting” out towards the 
edge of the gel and usually losing the smaller fragments from the bottom of the marker 
lanes. As already discussed, the smaller fragments are not that useful, but the tandem gels 
lost bands from the marker that were of larger size and these bands were required for 
band calling a sizing. The modifications to the preparation were very small, but effective.
153
Procedures such as leaving the gel to equilibrate at 4°C in a cold room for at least 2 hours 
before loading made a difference, probably due to the temperature being equal 
throughout the gel as opposed to some areas of the gel being warmer or colder than others 
and affecting the gel properties. Also, making sure the buffers were also equilibrated for a 
minimum amount of time at the same temperature all had small, but significant effects. 
Once these small problems were corrected, the time benefits were obvious over a single 
gel. This meant that we could start on the next processes much more quickly.
The data capture was more or less fully automated, with the software doing most of the 
work capturing images and interpreting and analysing them before human intervention. 
The main intervention was at the stage of contig building using FPC. Here, it was the 
number of single clones that were not integrated into the contigs from the first round of 
automated building by the software that was a slight problem. Stringencies within the 
software could be changed manually, which relaxed the guidelines and allowed more of 
the single clones to be added. This may seem like a haphazard method when the strict 
guidelines already posed by the software has not included the singles, but when the data 
from the fingerprints was visually analysed and the data were combined with both the end 
sequencing data (which was more useful for the walking) and the BLAST searches, 
which compared the sequence data with other clones in the database, an overall picture of 
the contig could be built up which integrated the single clones into the contig. The 
confirmation that the clones were the correct ones was the data from the end sequencing, 
which compared the ends of each of the clones and indicated that my intervention had 
actually picked out the correct clones.
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The physical map is and was a very useful tool in regards to deciding which clones were 
to be used for sequencing. A number of techniques were used to reduce the eventual 
number of clones that needed to be sequenced to cover the entire region to a minimum of 
16 clones. Overall, it was a painstaking process, but in hindsight, probably the most 
efficient and accurate way of confirming the clones. Supplementary figure 1, at the end of 
this chapter, shows the breakdown of how it was achieved. The original end sequenced 
clones marked out the clones and put each in relation to the next clone correctly by 
overlap of similar sequence. The choice of a starting point was done using the 
hybridisation of a known gene, niaD, and then using this to find the corresponding clone 
in the library. Each clone was “walked” out using the end sequencing data and further 
sequencing from each end of the original niaD containing clone and the map was slowly 
generated. Once a certain “tiling path” had been determined, each clone was sequenced 
much more accurately and the clones put together by their overlaps. This then reduced 
the number of clones covering the contig to 16. Supplementary figure 1 shows the “map” 
of the contig with the levels of coverage that were needed to obtain the final 16 clones. 
The map can and will still be used in the future as a good starting point for the whole 
genome sequencing project, as well as being useful for researchers who may want to look 
at particular genes or regions within the contig more closely. Genes can be identified and 
then located to a particular clone from the library using the map. The clone can then be 
studied much more closely.
The sequencing of the clones was done in accordance to the standard sequencing and 
subcloning protocols carried out at the Sanger Institute and the methods and outlines of
155
Supplementary Figure 1
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this can be found at http://www.sanger.ac.uk/Teains/Team53/methods/inethods.shtml and 
also at http://www.sanger.ac.uk/Teams/Team55. Once the clones had been sequenced, the 
sequence data was fed into a database that was accessible by a number of programs 
already described and will also be described in the next chapter.
4. A nnotation and the findings o f the sequence
4.1 Introduction
The final stage in the project was to annotate the DNA sequence that has been elucidated 
from the methodology described in Chapters 2 and 3. It is necessary to try and detect 
mobile elements, pseudogenes, repetitive elements and viral fragments as well as 
determining the most important regions, the areas of interest. At the nucleotide level, 
“landmarks” have to be identified such as detection o f tRNAs, rRNAs, other non­
translated RNAs, repetitive elements and duplications. Additionally, the genetic markers 
confirmed by experiments have to be found. This gives a “map” of reference points from 
which to work. Genomic landmarks then have to be identified, with PCR based genetic 
markers and restriction fragment length polymorphisms being good indicators. The 
identification o f open reading frames is a vitally important step to determine putative 
genes. Bioinformatic tools can provide context, near species matches and some 
information on possible function. Some o f the programs and databases used in the 
analysis are outlined below.
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Possibly the most difficult part o f the annotation is the process level annotation. How 
does the protein o f interest fit into the overall biology of the organism? What is its 
function? This was a very difficult process to begin with, as there was only comparison 
with experimental evidence to back up submissions and queries. But this has changed 
recently with the advent of Gene Ontology (GO). This “database” allows the annotator to 
pinpoint much more accurately the whereabouts and its function within the cell by 
allowing searches against other proteins and domains that have already been 
characterised. This is further described in 4.1.3.
This chapter will give an overview of some o f the techniques used to decode the 
information we gained from the sequencing of the 1Mb o f A. fumigatus DNA, as well as 
give an insight into what has been found within that sequence.
4.1.1 Artemis
There are a number of sequence viewers either commercially available or written 
specifically by various organisations, such as AceDB (http://www.acebd.oru). but these 
more often than not have limitations. Artemis (http://www.sanger.ac.uk/software/aitemis) 
on the other hand is freely available yet has many more capabilities than most 
visualisation tools. The Sanger Institute has used Artemis for many organisms to date and 
was custom built for the annotation and display of both prokaryotic and lower eukaryotic 
genomes, including the complete genome annotation o f the malaria parasite Plasmodium 
falciparum, Neisseria meningitides, and Campylobacter jejuni.
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Artemis can be used solely as a sequence viewer. A number of formats of sequence and 
annotation can be entered into the program including those taken directly from EMBL 
(European Molecular Biology Laboratory) (http://wwwl.embl-heidelberg.de/) and 
GenBank (Benson et al 2000) (http://www.ncbi.nlm.nih.gov/) format files. It displays 
stop codons in all frames, making visualisation of ORFs and possible genes much easier. 
Display of G+C content, an important identifier o f many genes, can be visualised as 
graphs and charts. But Artemis is mainly an annotation tool and was used to identify 
multiple or single features for further work with BLAST and FASTA. Artemis is 
currently the main annotation and visualisation tool used within the Pathogen Sequencing 
Group o f the Sanger Institute and will be continually updated as time and requirements 
move on. Artemis allowed the manual prediction o f genes and identification o f unusual 
features much more easily. It allowed the interactive prediction o f gene models whilst 
allowing the annotator to view the evidence at the same time, which in turn allows the 
highlighting of genes and exons that have been overlooked by the gene prediction 
programs. Very large sections of sequence can be annotated and analysed at the same 
time, which allows the identification o f unusual features from rearrangements or 
acquisitions.
4.1.2 Gene prediction and other tools
Used in conjunction with Artemis were other tools, many web-based, that allowed not 
just the ability to view the sequence, but to decipher the main features o f the sequence 
displayed. GlimmerM (Salzberg et al 1999), Phat (Cawley, Wirth and Speed 2001) and
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GeneFinder P (P.Green, unpublished) helped predict genes from the evidence such as 
G+C content or standard open reading frame views. The results of the outputs o f these 
programs could be adjusted to ensure that the predictions were correct, for example, 
splice sites. Percentage GC plots were also used in exon prediction, as this was the only 
tool to use when any o f the gene finding programs failed to find a number o f them, which 
could happen on a number o f occasions due to the complexity o f some sequence regions 
and the inability of the programs to decipher the code.
To identify genes and to make gene predictions, a number o f web based were used. 
Programs such as :
• TMHMM fhttp://www.cbs.dtu.dk/services/TMHMM/). Transmembrane proteins 
are seen as particularly important in that they are the gateways for cell secretions 
and could be used as drug targets. This program was used to predict 
transmembrane helices in proteins and gave links to literature on the nature of 
those particular proteins and their functions. It also helped the annotator designate 
function much more easily.
• SMART (Simple Modular Architecture Research Tool) 
nittp://smart.embl-heidelberg.de/help/smart about.shtml) (Schultz et al 1998) 
allowed the identification and annotation of genetically mobile domains and the 
analysis o f domain architectures, especially in signalling and extracellular 
proteins.
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• InterPro (http://www.ebi.ac.uk/interpro/) (Mulder et al 2003) is another external 
program and was used to identify protein families, protein domains and protein 
functional sites.
• Pfam (Protein Families) (http://www.sanuer.ac.uk/Software/Pfam/index.shtml) is 
a large collection of multiple sequence alignments and hidden Markov models 
that covers many o f the common protein families and domains. This was used to 
look at multiple alignments and to view protein domain structures. It also allowed 
the annotator to examine the distribution o f a family within species narrowing 
down the annotators searches.
• ExPASy (http://ca.expasv.org/enzyme/) identifies enzymes and allocates an 
Enzyme Commission (EC) number. The EC number can be fed into ExPASy, 
which pinpoints the enzyme and its function whilst the annotation is ongoing.
4.1.3 Gene Ontology (GO)
Gene Ontology is a relatively new process, but is a very useful tool and a good final point 
to the annotator’s main job. To make time consuming function searches easier and less 
confusing, as well as having a standard from which all work can then be set, the Gene 
Ontology (http://www.geneontology.org/) consortium was initiated in 1998. It is a 
collaboration of three different model organism databases;
FlyBase (http://f1ybase.bio.indiana.edu/). the Saccharomyces Genome Database 
(http://www.yeastgenome.org/) and the Mouse genome
Database (http://www.informatics.iax.org/). GO has now incoiporated a large number of
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databases into its fold, including some of the worlds biggest plant, animal and microbial 
genome databases.
The collaborators working on GO are developing three structured controlled 
vocabularies. These represent biological process, molecular function and the cellular 
component. The biological process component comprises of its function within the cell.
A general rule of thumb would say that the process must have more than one distinct step 
too. The types of functions would go from processes such as cell growth and maintenance 
to more complicated and focused processes such as pyrimidine metabolism. Molecular 
function on the other hand describes the function of a particular protein at molecular 
level, such as catalytic or binding activities. It does not specify when or where the 
process is taking place in the cell or in what context. It is purely a functional designation. 
Cellular component is stating that it is part of the cell and is also part of a larger object in 
the cell, whether that is anatomical (e.g. endoplasmic reticulum) or part of a gene product 
group (e.g. ribosome). These three categories help scientists by describing the protein of 
interest in a species independent manner. The vocabularies are structured so that it is easy 
to look at a certain protein in different ways. For example, you can search the databases 
for all of the gene products that are associated with signal transduction within the mouse 
genome or you can target in directly on something much more specific. Depending on 
what is known on a gene product, annotators can then assign function on a gene product 
at different levels but with a much greater degree of accuracy. GO is not a series of 
databases or catalogues nor is it a central unification of all databases in use. It is therefore 
also not a gold standard and should be seen and used only as a means to quickly and
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accurately assign a function to a gene product that has already had a certain amount of 
analysis performed on it.
GO annotation is usually one of the last processes to be completed before the entire 
sequence is submitted for viewing. The process can be quite complicated as a number of 
the terminologies can overlap or a product might have more than one molecular function 
in one or more places within the cell. But it is still more accurate and a lot less labour 
intensive doing this than by curating manually and assigning function without knowing 
the background to that gene product.
4.1.4 Other aspects of annotation
By the very nature of annotation and genome sequencing, annotation is not a finite 
process. As time goes on, even on supposed completed genomes, the annotations will 
need to be updated to include any new information that is gathered from various studies 
upon that organism. Experimental verification will confirm or deny annotation of 
particular predicted genes and this will have to be identified and corrected. Independent 
viewers may find mistakes or anomalies in the original annotation that needs to be 
discussed, agreed upon and confirmed. Even though a publication may go out and the 
annotation data go live on the Internet, it is still an ever-evolving situation that has to be 
refined and updated to reflect this situation. Annotation is done in very different ways by 
different laboratories and scientists, and it can be done either by a single individual or by 
an entire group or consortium. It can even be done by a whole community interested in a
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particular organism. This approach has both good points and bad points. One of the good 
points is that it spreads the work around which can be especially important on a large 
genome, such as the Human Genome Project and it can also bring a lot of expertise 
together. On the other hand, with so many people involved, it can also bring confusion 
and misunderstanding and errors can creep into the annotation. The annotation process 
for the A. fumigatus pilot project was a single effort of one institution, but a collaborative 
effort of three or four annotators. The proposed Whole Genome project that will come 
from this will be a collaborative effort by a number of institutions across the globe.
4.2 Methods
Annotation is a continuous, difficult and time consuming process and the screen capture 
images shown here are of the actual stages of the process. But they are not necessarily in 
the order that the process they were performed due to the very “fluid” nature of the 
process. Therefore, to explain the methods, I will be using the images in a rough 
“chronological” order, to show approximately the required steps that are needed for 
annotation. The images are from the actual A. fumigatus contig.
4.2.1 Method overview
1. Genes were identified by annotators within Artemis using the output of various 
gene finding programs as previously mentioned such as GlimmerM and 
Genefinder. These programs were “trained” to search for genes using a gene set 
from A. nidulans.
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2. Functions were assigned to the genes from the results of BLAST and FASTA 
searches of public databases. InterPro (Apweiler et al 2000), TMHMMv2.0 
(Krogh et al 2001), t-RNA scans (Lowe and Eddy, 1997) and SignalPv2.0 
(Nielsen et al 1999) searches were used to assign functions to the predicted genes. 
Where possible, GO terms were assigned manually to the predicted genes.
3. Initially, the possible GO terms were chosen by searching for sequence similarity 
in a database of protein sequences and their previously assigned GO terms. The 
database drew from the databases previously mentioned in 4.1.3.
4. Once sequence alignments had been agreed, GO terms were assigned from either 
the candidate list or directly from the ontology. If a previously characterised gene 
was identified, the GO terms were assigned as above. But the inferences were no 
longer based on sequence similarity; therefore alternative experimental evidence 
codes were used to relay this.
5. BLAST comparisons and the Artemis Comparison Tool (ACT) (Rutherford, 
unpublished) were used to view the comparison of the quinate utilisation gene 
cluster regions of A. fumigatus, N. crassa, Podospora anserina and A. nidulans.
4.2.2 Method used
The sequence was put through a gene finding program via Artemis, which predicted 
genes from the information that was on screen using the stop/start codons, codon usage 
within the genome, open reading from size, gene splice sites and many other 
algorithmical properties. At the moment, the Sanger Institute uses the two previously
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mentioned programs, GeneFinder and GlimmerM. Both of these gene finding programs 
initially had to be “trained” to look for genes in A. fumigatus by using a training set of 
genes from possibly a related genome or a different organism that carries a lot of 
similarities. These training sets helped the program to predict where genes were likely to 
be throughout the genome. Once the raw sequence was fed into Artemis and the gene 
finding programs had predicted where genes were likely to be, the annotator or I had to 
view and edit the predictions meticulously to ensure the predictions were correct.
Splicing had to be correctly altered; ORFs had to be joined if the prediction programs had 
missed splicing sites and stop end codons needed to be checked to ensure the gene was 
correctly aligned.
1. The sequence was fed into Artemis in the form of files that were compatible, such 
as those mentioned in 4.1.1. It displayed this sequence on screen with features in 
the genome already picked out, such as stop and start codons, open reading 
frames, amino acid sequences and so on.
2. Artemis was used to read features and sequence from a file and display the 
features on a six-frame translation of the sequence. Two views of the sequence are 
shown, both of which can be zoomed in to the base level, or zoomed out to 
display the entire sequence. Figure 30 shows a blank window with just the 
sequence file read into it, the start and stop codons and amino acid sequences 
displayed.
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Figure 30. This image shows the three frame read in each direction (top to the right, bottom to the left) and 
the stop codons are shown as small, vertical black lines. The three frame amino acid sequence is directly 
below this.
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3. Next, the gene finding programs were read into the sequence and the predicted 
genes and ORFs were displayed within the three frames, with the exons spread 
over the three frame plot, showing where the predicted splice sites were. Manual 
curation of this process was time consuming as each prediction had to have the 
correct splice sites and not all had been correctly predicted by the programs. 
Moving of the splice sites was a simple click and drag process o f the ORF to 
where the correct splice site was thought to be (Figure 31).
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Figure 31. The gene finding programs, GlimmerF and GeneFinder are read into the sequence and the 
results displayed. The red ORFs are the Glimmer results and the GeneFinder results are in blue. Note the 
differences in the predictions due to the differences in the programming algorithms. Both are needed 
though as to make accurate predictions on the correct ORFs.
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4. Artemis was also used to plot the results o f calculations on the sequence, or on 
any of the CDS (coding) features. This helped confirm ORFs and predicted genes 
by looking at %G+C plots, when usually there is a higher percentage o f G+C in a 
gene or ORF. Figure 32 shows the same sequence with a simple %G+C plot for 
the DNA sequence, and a plot o f amino-acid properties for one o f the CDS 
features.
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Figure 32. %G+C plots showing the increase in the G+C percentage where there are predicted ORFs. The 
line is the cut o ff by which the percentage is measured.
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5. Other tools, such as a GC frame plot also helped confirm the predictions and help 
with corrections o f splice sites. Figure 33 shows the three colour graphical display 
o f each %G+C frame plot.
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Figure 33. The frame plot shows the GC percentage for each part o f the gene, indicating whether the splice 
sites are correct and confirming that each part o f the gene predicted by the gene finding programs is correct.
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6. Next, the annotation programs and files were read into Artemis. These started the 
actual gene identification process and also helped identify specific features that 
would help confirm what the gene and its function was. Figure 34 shows a 
SignalP and a TMHMM file read into the sequence.
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Figure 34. SignalP and TMHMM have been read into the sequence and the results displayed. Note the 
new features that have appeared in the two middle grey lines at certain points. The small white features 
are SignalP results, usually indicating a signal peptide has been identified in that gene and the blue 
features are TMHMM results, usually indicating transmembrane helices at transporter sites within cell 
membrane. As there are usually more than one, the TMHMM shows the results for all o f the helices 
identified within that region.
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7. Further programs and files were then read into the sequence to identify other 
features. InterPro, Pfam and SMART scans all helped identify the genes and their 
function. Figure 35 shows a further step with a number of these files read in and 
the results displayed.
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F igure 35. More features have been edited in this window and the features themselves are indicated in 
text at the bottom o f the screen. Each ORF or feature can be clicked on and the information that has 
been entered by the annotator about that feature can be read or further edited as more information 
about it is found.
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8. Further files were read in and then web based databases and programs were used 
to finally come up with a gene model that was close to finishing. As analysis on 
the genome is a continuous process, the annotation cannot ever be said to be 
completely finished at this stage, but it is certainly in a form that can be submitted 
to various databases and to the web. Figure 36 shows annotation close to 
completion. This would have also gone through the GO function assignment 
process too, but the results of this are hidden in text, so do not show on screen.
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Figure 36. This is close to the final gene model with annotation and program file results fed in and 
displayed. Each one o f the features highlighted is clickable and all annotated information on that 
feature will be displayed in a window that can also be edited. The main features of each ORF are also 
displayed in the bottom window for quick and easy viewing o f what is in that particular region.
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9. Each one o f these checks verified what the predicted genes were likely to be. The 
genes usually come in a number of categories. There are hypothetical genes which 
are as the name suggests, possibly genes but have no direct, indisputable evidence 
to say otherwise. There are putative genes where the searches show that it has 
function analogous to that of other genes, but it is not definite. There are 
pseudogenes that look like genes but have little or no known function.
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10. Each gene was individually looked at by the annotator to ensure that the predicted 
gene had been identified as accurately as possible and that its sequence had been 
dealt correctly. The final annotation file was then written.
11. All of this information was fed into an “edit” box as the process proceeded and 
the information was saved at every point. Once all the genes had been edited and 
annotated, the whole section of the particular genome under scrutiny was saved as 
a large file that could be fed back into Artemis at any point, either to be viewed or 
to be edited at a later date.
4.3 Results
4.3.1 Annotation overview
From a sequence of 921,539bp, 54% was coding sequence with 50.6% as the GC content. 
There were a total 341 predicted putative protein coding genes and 8t-RNA genes (see 
Supplementary Figure 2 (a) & (b) and table 14 at end of this chapter). Gene density was 
calculated at an average of 0.37/kb of sequence. Each gene had 3 exons per gene on 
average. The mean gene length, excluding the introns, was 1462bp. This is comparable to 
1424 for S. cerevisiae (Goffeau et al 1996), 1673 for AZ crassa (Galagan et al 2003) and 
1626 for D. discoideum (Glockner et al 2002). It was predicted that 80% of the genes 
would have introns, which is similar to Arabidopsis thaliana at 79% and AZ crassa at 
72%. It is much higher than that found in S. cerevisiae, which only has 5% of genes with 
introns and is still considerably higher than Plasmodium falciparum that has 54%,
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Schizosaccharomyces pombe has 43% and still higher than D. discoideum, which has 
68%. There were also 8 predicted t-RNA genes, 5 of which contain a single intron and 
were arranged in an array. There were no r-RNA genes or arrays found in the small 
region that was sequenced or any transposable elements, even though there was one 
possible putative transposase gene. There were no telomeric or centromeric regions in the 
900kb sequence. Just 16% of the predicted proteins have been previously been described 
across the Aspergilli genus. From BLAST/FASTA searches, 44% have significant hits to 
other organisms in the database. Of the predicted proteins, 38% could not be assigned a 
function, but a significant proportion of these (25% approx) had conserved homologues 
in one or more organisms. These have been marked in the annotation as “hypothetical 
protein, conserved”. There were 1 or more transmembrane domains in approximately 
21% of the total of the predicted genes and there were also 20.5% predicted to have 
signal peptide or signal anchors. It was seen that the top five FASTA hits to functionally 
annotated and conserved hypothetical proteins have a number of homologues present 
only in bacteria and plants. Included in these are proteins involved in secondary 
metabolism. The proteins predicted in A. fumigatus were also compared to the proteome 
of N. crassa and 70% (238 from 341) were identified as putative orthalogues. When the 
whole proteome dataset o f A. fumigatus becomes available, a complete comparison with 
N. crassa is going to be of great interest. Table 12 shows a breakdown of the analysis.
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Table 12
F eature
A. fumigatus N. crassa. S. cerevisiae S.pombe D.discoidium
(G+C) content (%) 50.6 50 38.3 36 22.2
No. o f predicted
genes 341
Mean gene length*
(bp) 1461 1673 1424 1426 1626
Gene density
(bp per gene) 2702 1953 2088 2528 2600
% coding 54 40.2 70.5 57.5 56.3
%  coding (including
introns) 59.8 46.5 ND ND ND
Genes with introns
(%) 80 72 5 43 68
Exons
Number 1089
No. per gene 3 2.6 ND ND ND
(G+C) content (%) 53.8 55.9 28 39.6 29
Mean length (bp) 487 538 ND ND 711
Introns
(G+C) content (%) 46.5 ND ND ND 13
Mean length (bp) 78 134 82 81 177
Intergenic regions
(G+C) content (%) 46.5 ND ND ND 14
Mean length (bp) 997 ND 515 952 796
No. tRNA genes 8
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4.3.2 Functional classification of predicted gene products
From 153 predicted proteins, 187 Pfam domains were found. From these Pfam domains, 
the most abundant of them were Zinc-flngers and 9 proteins have been identified with 
either fungal Zn(2)-Cys(6) binuclear cluster domains or C2H2 type Zn-finger domain 
(Table 13). There were 74 putative proteins identified that were assigned Enzyme 
Classification (E.C.) numbers on the contig. This was approximately 22% from the total 
predicted proteins.
Pfam a n try hits In terPro  e n try G ene Ids
PF00172: Fungal Zn(2)-Cys(6) binuclear cluster domain 5 FRD01138 AfA24A6.035c; AfA5A2.050c; AfA34B6.070c; AfA10A1.045; AfA10A1.100c;
FFD0096: Zinc finger. C2H2 type 4 FFD00822 afa5c11.21c; afa35g10.15; AIA33H4.005; AfA19D12..065;
FF01488: Shikimate /q iina te 5-dehydrogenase 3 PR002907 AfA5A2.035; AfA5A2055; afa35g10.13;
FFD0501: AMR-binding enzyme 3 PRD00873 AfA24A6.045; AfA28D10.115c; AfA6E5.015;
PF00106: short chain dehydrogenase 3 FRD02198 AIA19D12.080; AfA10A1.040c; AfA10A1.050;
PFOOOS3: Sugar (and other) transporter 3 FR005828 AfA5A2.030c; AfA28D10.090c; afa35g10.20c;
FF00069: Protein kinase domain 3 FRD00719 AIA28D1.020; afa5c11.10; afa35g10.01;
PF00023: Ankyrin repeat 3 FR002110 AfA14B.12c; AfA5C5.015c; AfA10A1.125;
FF00005: ABC transporter 3 PR003439 AfA5C5.85c; afa5c11.08; AfA10A1.030;
PF02826: D-isomer specific 2-hydroxy acid dehydrogenase, NAD binding domain 2 FR002162 afa35g10.04c; AfA10A1.060;
FF02716: Isoflavone reductase 2 FR303866 Afa31G4.020; AfA31G4.040c;
FF01545: Cation efflux fanily 2 FP002524 Af A28D1.115; AfA10A1.085;
FF01487: Type 13-dehydroqiinase 2 FRD01381 AIA5A2.055; afa35g10.13;
PF01423: Smprotein 2 FRD01163 AfA28Dl0.010c; AfA10A1.010;
FF01360: Monooxygenase 2 FR000733 AfA14E5.32; afa35g10.06c;
PF01202: Shikimate kinase 2 FPD00623 AfA6E3.120; afa35g10.13;
PF00503: G-protein alpha subunit 2 FR001019 afa5c11.l0c; AfA6B3035c;
PF00400: WD domain. G-beta repeat 2 FFD01680 AfA14E5.29c;afa35g10.09c;
PFD0389: D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain 2 FP006139 afa35g10.04c; AfA10A1.060;
PF00155: Arrinotransferase class I and 1 2 FRD04839 AIA28D1.001; AfA33H4.060c;
Table 13. Pfam and InterPro entries from the initial annotation process. Note the high abundance o f  the 
Zinc finger Pfam hits.
From the total gene products, 177 were assigned GO terms (52%) manually. The 
annotation highlighted a tendency to have a slightly higher proportion of genes annotated 
to function as either enzymes (39%) or transporters (13%) compared to other organisms
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such as S. cerevisiae and Arabidopsis thaliana (36% and 30% enzymes respectively and 
8% transporters in both organisms). Compared to S. cerevisiae, the proportion of 
secondary metabolism proteins was higher in A. fumigatus (18% compared to 13%), but 
was significantly lower than A. thaliana and the worm C. elegans (both approx. 23%). 
However, it did not reflect the genome as a whole for A. fum igatus, as it suggested that 
the contig that had been analysed may just have contained more than one functional gene 
cluster, which would have biased the percentage o f proteins that had been annotated as 
enzymes or transporters.
4.3.3 Analysis and comparison of A  nidulans linkage group VIII and the qut/qa gene 
cluster synteny comparison
Analysis o f the degree o f synteny of the orthologous A. fumigatus genes and those 
mapped to the linkage group VIII in A. nidulans
(http://www.da.ac.uk/Acad/IBLS/molgen/asperuillus/index.html) was made and the 
results are illustrated below.
Figure 37 shows there was an inversion of two regions (facC  to veA; trpC  to hisC) with 
respect to the gene order could be observed in A. fum igatus. It was also seen that the galG  
and fw A  loci between the markers facC  and the qut gene cluster was missing when 
compared to A. nidulans. qut has a function in the utilisation o f quinate. As the loci brlA, 
pyrD, aldA and argC  all map to the linkage group VIII o f A. nidulans genetic map, it was 
not unreasonable to expect that the region or cluster was to be found elsewhere on the 
genome.
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Figure 37. Synteny shown in linkage group VIII between A. fumigatus and A. nidulans. Note the regions o f  
inversion at facC, veA, trypC to hisC.
The quinate utilisation gene cluster was compared between A. fumigatus and a number of 
other filamentous fungi, such as A. nidulans, N. crassa and Podospora anserina. This is 
known as the ‘quf genes in Aspergillus spp. and P.anserine and known as ‘qa’ in 
N. crassa. This cluster was looked at as the sequence to the qut and qa genes are already 
in public databases. The clusters are involved involved in the quinate utilisation pathway 
and the genes code for at least 5 structural genes and 2 regulatory genes. Artemis 
Comparison Tool (ACT) was used to perform the comparisons. In Figure 38,
A.fumigutus and A. nidulans showed that the gene order in the qut genes was completely 
conserved, but the orthologous qa genes in N. crassa and P. anserina show little or no 
order of conservation.
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Figure 38. Artemis Comparison Tool (ACT) showing degrees o f synteny o f  the qut cluster and its adjacent 
regions. The red stripes are regions o f synteny. The blank spaces are regions where no synteny occurs.
From the region, it is seen thatT . nidulans and A. fumigatus have high levels o f  synteny along nearly all o f 
the cluster, where other organisms show little or none across the region.
N. crassa and P. anserina showed synteny with complete conservation in orientation and 
order of the qutG, B, C and B genes, but in the two species the qutA, R and D  genes were 
inverted. The qutH  gene, which has an unknown function in the quinate utilisation 
pathway, codes for a gene with putative oxidoreductase activity. This gene is not found in 
N. crassa and P. anserina in the orthologous cluster. There was also a qutD -like
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permease gene found 57kb away from the qutD gene found in the cluster in A. fumigatus. 
The qutD-like permease is predicted to have nine transmembrane domains compared to 
the eleven in the qutD permease gene or twelve in the A. nidulans. The qutD-Wke, 
permease and the actual qutD permease gene have only 29% similarity compared to the 
76% similarity between the A. fumigatus and A nidulans qutD proteins. The three 
proteins are part of the sugar transporter family (MFS), which in turn is part of a major 
facilitator superfamily which is involved in the transport of organic alcohols, organic 
acids and carbohydrates. It is still unclear what, or if, the qutD-\\k& permease has a role in 
the quinate utilisation gene cluster in A. fumigatus.
4.3.4 Aflatoxin-related genes
A.flavus, A. parasiticus and A. nidulans have all had extensive studies with respect to the 
organisation and expression of the aflatoxin B1 gene cluster (Woloshuk and Prieto 1998). 
These were used for the basis of our comparison. In A. flavus and A. parasiticus, the 
aflatoxin producing genes are located in a 75-90kb cluster and the genes for the aflatoxin 
synthesis intermediate, sterigmatocystin, are also shown to be in a cluster (Prieto et al 
1996, Yu and Leonard 1995, Keller and Hohn 1997). The aflatoxin B1 biosynthesis gene 
cluster was not identified on the contig that was sequenced for A. fumigatus, but two 
genes with significant similarities to genes in the aflatoxin gene cluster were identified. 
The annotation assigned a ‘vesicolorin b synthase-like’ label to one which showed high 
similarity to the vbS gene of A. nidulans and the other as ‘q/ZT-like major facilitator 
superfamily’ which shows significant similarity to aflT (aflotoxin efflux pump) gene of
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A. nidulans. It is thought after extensive analysis that the aflatoxin biosynthesis cluster is 
located elsewhere in the genome of A. fumigatus, therefore the genes are not part of the 
aflatoxin B1 cluster and it is not known whether they have a role in aflatoxin B1 
biosynthesis.
Another interesting gene found in the contig is an aldo-keto reductase gene. It has a 42% 
identity to the human aflatoxin B1-aldehyde reductase (AFAR) and is thought to code for 
a protein very similar to the AFAR. Both proteins are part of the aldo-keto reductase 7 
family (AKR7), which in itself is part of the AKR superfamily (Jez et al 1997). There are 
a number of enzymatic systems that have evolved to deal with ketones and aldehydes, as 
these can present significant problems to cellular function. Members of the AKR1 such as 
aldose reductase and members of the AKR7 family are often found in mammalian 
systems, particularly humans and rats. A number of important amino acid residues, such 
as the highly conserved mammalian aflatoxin B1-aldehyde reductases and aldose 
reductases, can also be found in the A. fumigatus protein. The residues make up a 
catalytic triad and also bind to the co-factor NADPH (Wilson 1993, Ireland 1998). There 
is an orthalogue that can be found in N. crassa. There is 62% identity and the initial 
thought is that they may have a role in specific charged aliphatic and aromatic aldehyde 
detoxification, but there would need to be experimental verification that the AKR7 family 
has a similar substrate range.
4.3.5 Possible drug targets
The contig contains a gene called aroM, which codes for a 171kDa pentafunctional 
polypeptide. It has five functional domains, which is the same as other aroM orthologues.
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Bacteria, plants and microbial eukaryotes all have a system for synthesis of aromatic 
compounds and an intermediary compound in this system is shikimate. The five 
functional domains in AroM orthologues are known to catalyse consecutive steps in the 
shikimate biosynthetic pathway (Bentley, 1990). The protein is required in Salmonellae 
for virulence (Gunel-Ozcan et al 1997) and is potentially a target for anti-fungal and anti­
bacterial drugs (Kishore and Shah, 1988). The crystal structure of one of the five 
domains, dehydroquinate synthase, has been determined in A. nidulans (Carpenter et al, 
1998). The AroM sequence in A. fumigatus is 80% identical to the A. nidulans orthologue 
and therefore is a candidate for more modelling to look for potential inhibitors.
There are also a number of other enzymes that have similarity to homologous plant and 
bacterial proteins. Examples of these are a short chain dehydrogenase/reductase, a 
dioxygenase (which is involved in the cleavage of aromatic rings), a putative 4- 
coumerate-CoA ligase and a putative 3-oxoacyl-[acyl carrier protein] reductase, which is 
also a member of the short chain dehydrogenase/reductase family. It may be that these 
proteins are components of biochemical pathways not found in humans. If this is the case, 
then as long as they are part of the fungal mechanism for growth in human tissue, then 
they are good, viable drug targets.
4.3.6 Drug/toxin transporters
A. fumigatus produces a number of secondary metabolites that are toxic to its own cells. 
Therefore the fungus has a number of transporters to remove the toxins from its cells. In 
the contig, there were a total of twenty putative transporters identified. Fortuitously, some 
of these transporters can pump anti-fungal drugs from the cells. Therefore, efflux is
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probably the major mechanism of azole drug resistance in Aspergilli (Moore et al 2000). 
Three genes in the contig, AfA35C 10.20c, AfA5C5.050 and AfA24A6.065 code for 
proteins related to a group found in the MFS class, which is involved in the efflux of 
drugs. Also, interestingly, another gene, AfA5C5.085c, is already previously 
characterised as mdr4. This is known to be highly over expressed in A. fumigatus mutants 
that confer high level itraconazole resistance. Its product is a member of the ABC 
transporter superfamily (Nascimento et al 2003). Afal0A1.030, whose product is also 
part of the ABC transporter superfamily, but it is known to have a role in itraconazole 
susceptibility (Mosquera et al 2002). The A. nidulans orthologue, atrG, has also been 
characterised and is known to have a similar role in the resistance of azoles (Andrade, 
2002).
4.3.7 Transcription factors
The fungal specific zinc-finger domain, Zn(2)-Cys(6) binuclear cluster domain has 
already been shown to be the most abundant Pfam domain seen in the contig. This is an 
N-terminal region DNA-binding protein found in transcription regulators. There have 
been 17 proteins predicted to function as transcription factors. This equates to 8% of the 
functionally annotated proteins. Of these, the activator QutA and repressor QutR, of the 
quinate utilisation cluster; AfA14E5.23c, the Jumonji family transcription factor 
(Balciunas and Ronne 2000) and the acetate regulatory FacB orthologue are of most 
interest.
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4.3.8 Putative host interaction molecules
Host interaction genes are likely to be of high interest to investigators and a number of 
interesting candidate genes have been identified in the contig. A gene identified as 
AfA10A1.015 encodes for a 580 amino-acid-long protein predicted by Pfam to contain 2 
fascilin domains. It is thought that this might represent ancient a cell adhesion domain 
and usually proteins have 2 or 4 copies of this domain and are GPI-anchored to the 
membrane. The A. fumigatus protein has a predicted signal peptide, but there is no 
prediction of a GPI-anchor.
There is a very obvious N. crassa orthologue, AfA.33H4.165, which encodes for a 1236 
amino acid protein. The C-terminal half of this protein has 26% identity over 644 amino 
acids to the TGF-P receptor associated protein. But it may not be expressed on the cell 
surface as it is not predicted to have a signal peptide.
Also, AfA5A2.010 has been found to have 35% over 318 amino acids similarity to 
human integrin beta 1 protein 2 and has been annotated as a chord containing protein 
homologue. It is still not known whether A. fumigatus expresses an integrin beta 1 
binding domain-containing protein to mediate interactions with the host, but this gene 
also has a very strong N. crassa orthologue and has no prediction to be secreted at the cell 
surface.
4.4 Discussion
This pilot project was designed to give a possible whole genome sequencing project a 
head start and to determine if sequencing the entire genome would be possible. Before
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the project had started, there had only been one protein structure that has been deciphered 
in the A. fumigatus genome. This is the Mn-dependant superoxide dismutase (Fluckiger et 
al 2002). There are only 44 A. nidulans proteins known. To have only 16% of the 341 
annotated genes identified in other Aspergilli so far shows the possible scale of the task 
ahead. Another indicator of the size of this undertaking is that there is one third of the 
proteins still not found to have an orthologue in N. crassa.
On detailed analysis, the sequence so far shows a gene density in A. fumigatus that is 
comparable to the fission yeast, S. pombe. It also shows that the majority of the genes are 
spliced. Significantly and interestingly, the percentage of spliced genes found so far is 
much higher than that of S. pombe and N. crassa. But it does compare favourably with 
A.thaliana. There have been other genes and proteins that have been reported for 
A. fumigatus, such as the retrotransposons Afutl and Afut2 (Class I) (Glayzer et al 1995, 
Neuveglise 1996, Paris 2001) but they have not been found in the region that has so far 
been sequenced. In fact, this region has not shown any signs of any degenerative 
transposable elements. But other filamentous fungi have had both Class I and Class II 
transposable elements found and identified, so it is expected that these will be identified 
in other regions of the genome that have not yet been sequenced or analysed. They can be 
seen as important as they are natural causes of genetic instability in fungi and therefore 
they could be used for identification and manipulation of the fungus.
Drug targets are an obviously important area for further study and research and there 
have been a number of genes that have been identified that will facilitate the search for 
possible drug targets and allergens. The pilot project has identified a number of genes 
that are involved in diverse functions and as a number of genes are involved in secondary
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metabolite metabolism, it is thought that A. fumigatus will have a large catalogue of 
transcriptional control points and export mechanisms. Within the contig, several 
transcriptional control proteins and transporters have already been identified and translate 
into about one fifth of the functionally annotated proteins. These could possibly give an 
indication of what may be found in the rest of the genome, but so far it is not known 
whether this is a localised property of the contig sequenced so far or whether it is an 
indicator into what will be found in the whole A. fumigatus proteome. But it is possibly a 
very good indicator to the A. fumigatus proteome content and therefore with the trend for 
a large number of transcriptional control mechanisms so far identified, will show why 
A. fumigatus is such a highly opportunistic pathogen of man.
There is a very high likelihood that A. fumigatus has evolved to produce a number of 
transporter pumps to remove the secondary metabolites that it produces that are toxic to 
its own cells. Although the contig represents only a small fraction of the genome, it does 
indicate that there could be a high number of transporters within the rest of the genome, 
which will become of great interest with the increase into drug resistance in the fungus 
(Del Sorbo et al 1997, Warris et al 2002). Regions of synteny will indicate and identify a 
number of significant factors, such as evolutionary significant genes, potential regulatory 
elements and ORF identification and annotation. As more sequences from different 
genomes become available, there has been a sharp increase in the amount of interest in 
these syntenic regions, including filamentous fungi (Seoighe et al 2000, Hamer et al 
2001, Pederson 2002). This study has shown that A. fumigatus and A. nidulans show high 
levels of synteny in the quinate utilisation gene cluster. The study also showed that in 
other Ascomycetous fungi, evolution has kept the genes located in the quinate utilisation
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cluster as a cluster, but there have been a number of genetic rearrangements within the 
cluster. As other genomes and annotation become available for Ascomycetous fungi, it 
would be interesting to study the levels of synteny of other metabolically related gene 
clusters.
The project also showed that there is a high similarity in the putative aldo-keto reductase 
gene in A.fumigatus and the mammalian aflatoxin B1-aldehyde reductase and this could 
prove highly significant. This protein may provide a role in the detoxification of aromatic 
and aliphatic aldehydes including aflatoxin B1 catabolism. In humans, the aflatoxin B1 
protein (afbl) is metabolised by aflatoxin B1 aldehyde reductase and has been shown that 
it may have some function in the protection of the liver against acute and long term 
carcinogenic effects of aflatoxin B1 (Neal et al 1998; Kelly et al 1997). It is known that 
G-T transversions in the p53 tumour suppressor gene at codon 249 (Eaton and Gallagher 
1994) is caused by aflatoxin B1 and therefore A.fumigatus having an aflatoxin B1 
detoxifying gene will make this a very good candidate for further study into aflatoxin 
metabolism.
Identification of the fungus encoded molecules that influence the outcome of infection 
during invasive aspergillosis has become an interesting focus of attention (Muhlschlegal 
et al 1998; Latge and Calderone 2002). A significant number of specific interactions 
between A.fumigatus conidia and host molecules have already been described (Sturtevant 
and Latge 1992; Mendes-Giannini et al 2000; Clemons et al, 2000; Allen, Voelker and 
Mason, 2001; Robinson et al, 2001; Monod et al, 2002; Tronchin et al 2002). This study 
has identified a number of genes that may be involved with host molecule interaction, 
such as the integrins. There are more than 75 IgE -binding allergen molecules produced
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by A.fumigatus and to understand the patho-physiology of allergic bronchopulmonary 
aspergillosis, further identification of these molecules needs to done (Kurup et al 2000; 
Baneijee et al 2002; Kodzius et al, 2003).
Further comparison of invasive A.fumigatus isolates and non-invasive isolates or non- 
pathogenic A. nidulans strains will be able to be carried out when the whole genome 
sequence of both organisms becomes available and the various comparisons will 
hopefully be a pointer to why A.fumigatus has become so much more of varied pathogen 
and is capable of much more varied and extremes of infection, from allergies to invasive 
diseases. Hopefully, the further comparisons will also allow A.fumigatus specific 
pathogenic pathways and increase the identification of new and novel drug targets.
5. Summary
With the ever-increasing prevalence of Aspergillus fumigatus infection and invasion 
threatening to become a major problem in the coming years, the sequencing of the 
genome is taking on a much greater importance in the medical community. This pilot 
project was prompted and designed in a way as to determine whether the sequencing of 
the genome was a feasible objective by carrying out a small-scale sequencing project to 
sequence just 1Mb of the A.fumigatus genome. What I hope that this thesis has proven is 
that not only was it feasible, but also that it went beyond expectations in proving what 
could be done in the constraints of time and budget but also, more importantly, what can 
be found within the genome.
188
Many people are at risk from this opportunistic pathogen. Healthy and 
immunocompromised people are exposed to the airborne spores of this fungus 24 hours a 
day and can be infected, resulting in symptoms ranging from skin lesions and eye 
infections to lethal lung and central nervous system debilitation. It’s the most common 
mould causing infection across the globe and is almost impossible to treat sufficiently. 
There have been some genetic studies on this or organism, but most are small-scale, 
specialised studies into specific areas of interest. This pilot project was devised to 
determine whether this understanding could be increased significantly and allow this 
genetic information to be available to all who could use this information in the fight 
against infection. This information could and will be used in virulence, pathogenicity and 
metabolic studies in order to help understand its workings and design anti fungal drugs to 
combat infection. The information could be used in comparative and post genomic 
studies in order to better understand its biology and metabolism and determine if 
anything useful could be taken from what the sequence holds.
The initial attempts at the construction of a genomic library good enough for sequencing, 
following a rough guideline from the Osoegawa paper, were dotted with problems and it 
took over a year to get a good, viable library. There were a number of reasons for this but 
after some serious thought and some consultation with collaborators, it was eventually 
resolved. There needed to be a high yield of clean, good quality DNA and some 
experimentation to remove the smaller fragments of DNA from the process that could 
detrimentally affect downstream procedures by DNA “trapping” were carried out, with 
differing levels of success. When the consultations with collaborators provided greater
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quality DNA, it was found that the experiments to remove the smaller fragments and 
cellular debris were not required, which became a turning point as it was not long after a 
viable library was made. Techniques such as “pre-electrophoresis” and electroelution 
helped us further in refining the techniques, removing smaller fragments of DNA and 
helping keep the DNA in tact to optimise the process to give the best viable library we 
could make with the resources available to us.
For us to use a library, the insert sizes had to be consistently large and above an 
arbitrarily picked size of about 60kb. Many attempts gave deleted inserts, inserts of 
inferior quality and size. The overall insert size that was eventually generated was not 
ideal, being just over 70kb, but it was more than good enough to cover the genome and 
be a usable, working library for sequencing.
The next step was to find a starting place for the sequencing and mapping process using 
radiation hybridisation. The niaD gene was used as it was one of the few well 
characterised gene in A. fumigatus, as well as Aspergillus nidulans. Once the “starting” 
point had been identified as a clone on the array, it was a simple case of “walking” out 
from this clone by a combination of end sequence matching and fingerprint information. 
Good overlaps between clones were found, few were mismatched, most clones were 
intact; it could be said that the A.fumigatus genome was almost the “model” genome to 
assemble.
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The only slight problem encountered was the less than ideal read pair pass rate figure of 
64% from the 3456 clones the end sequencing produced when normally a pass rate of 
around 80-85% is the target aimed for. This is a 7.5-8.0-fold coverage of the genome.
The fact that the quality of the clones that had passed meant that the programs used to 
“fit” the pieces back together (FPC, BLAST etc) had no problem achieving this and the 
lower than expected pass rate could be overlooked to a certain extent as there was still 
more than enough coverage to complete the goal. The reasons for the reduced pass rate 
were numerous, such as sequencing reactions not working, database mismatching and 
wrong nomenclatures.
The project ended with an overall 16 “super-contigs” covering just under 1Mb of the 
genome, centred around the niaD gene and its associated cluster genes. This information 
was fed into a central, purpose built database that could be accessed by a number of other 
programs for use further downstream. The map was also useful for the whole genome 
shotgun that has continued on since this project has come to an end, being used primarily 
as a good anchor and starting point for that project.
Before the pilot project started, only the Mn-dependant superoxide dismutase protein had 
been characterised and deciphered from th q A.fumigatus genome. In comparison, only 44 
proteins were identified in A. nidulans at that time. What emphasised the importance of 
the pilot project was finding that only 16% of the 341 genes found in the 1Mb were 
identified in other Aspergilli. The fact that this figure is so low, even in such a small 
proportion of the estimated 30Mb genome size showed the scale of the whole genome
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project. The pilot project sowed the seeds for this to continue, as it showed that the 
practicalities could be overcome.
The analysis of the 1Mb region shows a gene density comparable to that of the S. pombe. 
There is also a high degree of gene splicing, much higher than S. pombe. Some genes, 
such as the retrotransposons Afutl and Afut2 that have been reported are yet to be 
identified in the 1Mb region, but these may be found elsewhere in the genome with the 
whole genome project underway.
Possible drug targets are obviously important to identify (if possible) and a number of 
genes were found in the 1Mb that could help with this search. The aroM gene was 
identified, which is involved in the synthesis of aromatic compounds and is part of the 
shikimate pathway. Identified in Salmonellae for virulence, it is potentially a target for 
anti-fimgal and bacterial drugs. Further searches on the whole genome would hopefully 
highlight more of these genes. A number of genes coding for enzymes homologous to 
plant proteins were also found, such as the putative 4-coumerate-CoA ligase that may be 
a component in the pathway involved in fungal growth, which make them highly 
conducive to drug target studies. A number of secondary metabolism genes have been 
identified, which indicates that there could be a high number of transcriptional control 
point and export mechanisms. About one fifth of the functionally annotated proteins from 
the 1Mb are already identified as such. If the whole proteome is found to follow this 
trend, it could indicate why A.fumigatus is such a highly opportunistic pathogen.
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Transporter genes seemed to be relatively prevalent in the 1Mb, indicating more to be 
identified in the whole genome studies. These could give good indicators to the 
mechanisms involved in the organism’s drug resistance, further increasing interest in 
studies to exploit these findings further downstream as the data from the whole genome 
sequence is unravelled.
Synteny studies will also become important in searching for evolutionary significant 
genes as studies on other filamentous fungi highlight areas for comparison. For instance, 
it has already been shown that A.fumigatus and A. nidulans show significant synteny in 
the quinate utilisation cluster. Interestingly, the studies have also shown that evolution in 
ascomycetous fungi has kept the location of these genes in a cluster across a number of 
other fungi, although there have been some genetic rearrangements. Comparison studies 
from these findings help further in the understanding at a molecular level for not just A. 
fumigatus, but a number of other fungi too.
Further genes, such as the putative aldo-keto reductase genes and the 75+ IgE-binging 
allergen molecules will all give rise to further study due to the importance of them in 
aflatoxin metabolism and the patho-physiology of allergic bronchopulmonary 
aspergillosis, two highly significant areas of interest. The former is thought to be one of 
the most important factors in fungal virulence and the latter focuses on a very important, 
specific illness that can arise from the infection. Comparing these two here shows the 
diversity of the experimentation and studies that are likely to come from the whole 
genome sequencing, from the interaction of a single molecule with the host to identifying
193
and combating the processes involved with one of the more prevalent and dangerous 
forms of infection.
Further work on this organism will continue unabated now that the pilot project has been 
a significant success in pointing the way for the whole genome sequence. It has also 
shown that there is still plenty of information and data that can and will be taken from the 
rest of the genome. Comparison studies will hopefully highlight why A.fumigatus is such 
a highly virulent organism compared to its close relatives and why it infects in such 
varied ways.
The whole genome sequencing project for A.fumigatus started towards the end of the 
pilot project as preliminary results from this were first appearing. It was clear from the 
outset that the whole genome project would be feasible and that work should start 
immediately. This has now been going for almost two years now, with results published 
on the Sanger Institute web pages every day (www.sanger.ac.uk). The annotation process 
has not been completed as yet, so figures and indications of what has been found in the 
genome are few and far between. But there is preliminary annotated data in GeneDB 
(www.genedb.org).
Other groups within the fungal study community have done further complimentary work. 
One such study is the “optical” map of the genome by the company OpGen 
(www.opgen.com). Using the information from 19 contigs of the whole genome 
sequence, they have completed a whole genome map for the international consortium in
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order to complete the genome sequence. The data from the OpGen optical map has 
allowed the contigs to be ordered and orientated on what is now believed to be a 
confirmed eight chromosomes. This has allowed the size, location and number of gaps 
remaining to be finished on the project. The map corresponded to over 300 times 
coverage of the genome and has showed that the optical map is extremely powerful and 
versatile. Not only that, it has helped the international consortium immensely in being 
able to identify areas of the genome that are not complete and therefore speeding up the 
process to completion and ready for the annotation stage. An explanation of this 
ingenious process can be found on their website.
Recently, The Institute of Genome Research (TIGR) have announced that they are 
selecting A.fumigatus for the development of functional genomics resources and reagents 
via their Pathogen Functional Genomics Resource Centre. This will study a number of 
organisms using microarrays for in depth genomic comparison and study 
(http://pfgrc.tigr.org/).
As the sequence data is relatively new and there is little of it, direct genomic studies on A. 
fumigatus are few and far between. This will increase as the sequence data increases on 
various databases. This will open up the door to many types of experimentation. One 
important area to look at would be comparison studies using microarrays for expression 
studies. Using clinical isolates from patients and a cultured laboratory strain, a 
comparison of the two across its genome would be able to highlight the genes that are 
being expressed at various stages of infection in the host. Further studies, such as gene 
knockouts, could then be carried out to determine which genes are causing the infection
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and what effect they have on the host. This would hopefully lead to the development of 
novel drugs, either targeted specifically to the host or to the organism to help combat the 
infection.
A full study of the organism’s proteome would help understand its expression patterns, to 
better understand its biology and to help identify novel drug and vaccine targets. 
Proteomic profiles of the organism at different stages of its life cycle could be decoded, 
enabling scientists to leam more about its development, its host interaction and its general 
biology. It would also help scientists understand the continuing process of increased 
resistance to the already largely ineffective and toxic chugs that are on the market to 
combat the organism. It would help understand the mechanisms of how and why it 
becomes resistant, helping scientists to be one step ahead in their fight against infection.
Putative genes have usually been seen to be good starting points for developing drug 
targets. As annotated sequence becomes more available, putative genes would be 
highlighted, with their possible function being identified and experiments designed 
around this. With the information available to everyone, there is opportunity for many 
laboratories to tackle many different putative regions and functions.
Other studies, such as Single Nucleotide Polymorhism experiments can show the 
evolutionary divergence of the organism over time and how this divergence has affected 
its interaction with humans. This may lead to the identification of epidemiological 
patterns that can help scientists reduce areas of risk.
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As the Plasmodium falciparum sequencing project has shown, the sequencing of the 
genome may not lead instantly to the answers of eradication or combat to diseases due to 
technology, funding and infrastructure, but at least the sequence is as good a starting 
point as any and will hopefully lead the way for a better understanding of the fungus.
This project and the ongoing whole genome sequencing project has been a huge 
undertaking, but one that ultimately will pay dividends when the genome releases its 
secrets to the world. With the rapidly increasing prevalence of this lethal fungus, work 
will continue on in the search to help either eradicate infection, help the symptoms of 
those who are already infected and also to fully understand the workings of the 
innocuous, yet highly dangerous mould.
Table 14
The 341 annotated genes from the 922kb contig oi Aspergillus fumigatus
A. fumigatus CDS AfA34E6.080 hypothetical protein
A. fumigatus CDS AfA28D 10.085c transporter, putative
A. fumigatus CDS AfA24A6.120c bgtl, beta-l,3-glucanosyltransferase
A. fumigatus CDS AfA31G4.020 isoflavone reductase, putative
A. fumigatus CDS AfA28D1.090c n-acetyltransferase, putative
A. fumigatus CDS AfA14E5.18c NADH-ubiquinone oxidoreductase, putative
A. fumigatus CDS AfA28Dl0.005c hypothetical protein, conserved
A. fumigatus CDS AfA28D 1.050c hypothetical protein
A. fumigatus CDS AfA5A2.030c qutD, quinate permease, putative
A. fumigatus CDS AfA8D5.035 hypothetical protein
A. fumigatus CDS AfA34E6.065c tktA, transketolase, putative
A. fumigatus CDS AfA28D1.010c hypothetical protein
A. fumigatus CDS AfA6E3.195 DCGl-like protein, putative
A. fumigatus CDS AfA33H4.065c hypothetical protein
A. fumigatus CDS AfA24A6.115c myosin heavy chain-like protein, putative
197
A. fumigatus CDS AfA.34E6.105 spindle-related protein, putative
A. fumigatus CDS A£A14E5.17c nucleoporin, putative
A. fumigatus CDS AfA8D5.025 adenylyl cyclase-associated protein, putative
A. fumigatus CDS A£A24A6.090c esterase/lipase/thioesterase family protein, putative
A. fumigatus CDS AfA34E6.060 spermidine synthase, putative
A. fumigatus CDS AfA6E3.170c DUF6-like integral membrane protein, putative
A. fumigatus CDS AfA28D1.125 hypothetical protein
A. fumigatus CDS AfA6E3.130c esterase/lipase/thioesterase family protein, putative 
A. fumigatus CDS AfA14E5.20c gab A, GabA permease, putative 
A. fumigatus CDS AfA28D1.005c hypothetical protein, conserved 
A. fumigatus CDS AfAlOAl.llOc hypothetical protein, conserved 
A. fumigatus CDS AfA28D1.085 hypothetical protein
A. fumigatus CDS AfA5C5.015c suppressor protein spt23-related, with ankyrin repeats 
A. fumigatus CDS afa35gl0.09C hypothetical protein, conserved 
A. fumigatus CDS AfA28D 1.080 hypothetical protein 
A. fumigatus CDS AfA24A6.140 14-3-3-like protein, putative
A. fumigatus CDS AfA34E6.055 ubiquinol-cytochrome c reductase complex ubiquinone- 
binding protein qp-c precursor, putative
A. fumigatus CDS AfA33H4.080 nuclear segregation protein, putative 
A. fumigatus CDS AfA8D5.010 hypothetical protein, conserved 
A. fumigatus CDS AfA28Dl.l 15 cation transport protein 
A. fumigatus CDS afa35gl0.12C transport protein, putative
A. fumigatus CDS AfA28D 10.110c mitochondrial processing peptidase alpha subunit, 
putative
A. fumigatus CDS AfA24A6.045c 4-coumarate-coa ligase, putative
A. fumigatus CDS AfA14E5.15c hypothetical protein, conserved
A. fumigatus CDS AfA28D 1.070 hypothetical protein
A. fumigatus CDS AfA24A6.135 phosphoesterase, putative
A. fumigatus CDS AfAlOAl.OOlc hypothetical protein
A. fumigatus CDS AfA33H4.170c dioxygenase, putative
A. fumigatus CDS AfA.34E6.045 hypothetical protein
A. fumigatus CDS AfA24A6.095 ubiquitin-conjugating enzyme e2, putative
A. fumigatus CDS AfA34E6.040 hypothetical protein
A. fumigatus CDS AfA6E3.200 mipA, gamma tubulin, putative
A. fumigatus CDS AfA33H4.130c possible epimerase
A. fumigatus CDS AfA6E3.165 actin-like protein, putative
A. fumigatus CDS AfA28D1.105 possible glycine cleavage system h protein
A. fumigatus CDS afa35gl0.11C isoleucyl-tma synthetase, putative
A. fumigatus CDS AfA5Cl 1.03 cmA, nitrate permease, putative
A. fumigatus CDS AfA6E3.060c hypothetical protein
A. fumigatus CDS AfA33H4.105 hypothetical protein
A. fumigatus CDS AfA10A1.040c 2-deoxy-D-gluconate 3-dehydrogenase, putative
A. fumigatus CDS afa35gl0.07C hypothetical protein
A. fumigatus CDS AfA14E5.14c hypothetical protein, conserved
A. fumigatus CDS AfA28D 1.062 hypothetical protein
A. fumigatus CDS AfA33H4.100 hypothetical protein, conserved
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A. fumigatus CDS AfA24A6.125 endosomal p24b protein precursor, putative
A. fumigatus CDS AfA28D1.060 hypothetical protein
A. fumigatus CDS AfA6E3.020c hypothetical protein
A. fumigatus CDS AfA31G4.010c cipA, CipA protein, putative
A. fumigatus CDS AfA34E6.035 hypothetical protein
A. fumigatus CDS AfA8D5.001c hypothetical protein
A. fumigatus CDS AfA24A6.085 cytochrome p450, putative
A. fumigatus CDS AfA5A2.055 qutR, quinate repressor, putative
A. fumigatus CDS AfA28Dl.l 10c possible RING finger protein
A. fumigatus CDS AfA6E3.155 possible transcription factor
A. fumigatus CDS A£A31E11.010c diphthine synthase, putative
A. fumigatus CDS afa35gl0.10C hypothetical protein
A. fumigatus CDS AfA6E3.150 GTP cyclohydrolase ii, putative
A. fumigatus CDS AfA33H4.125c mitochondrial processing Peptidase beta subunit,
mitochondrial precursor, putative
A. fumigatus CDS A£A28D10.040c hypothetical protein
A. fumigatus CDS afa35gl0.06C phenol 2-monooxygenase, putative
A. fumigatus CDS afa35gl0.05b hypothetical protein
A. fumigatus CDS AfA8D5.040c hypothetical protein
A. fumigatus CDS AfA10A1.035c freA, metalloreductase, putative
A. fumigatus CDS AfA24A6.110 RNA export mediator glel homologue, putative
A. fumigatus CDS AfA34E6.025 ao-I, copper amine oxidase 1, putative
A. fumigatus CDS AfA33H4.050 hypothetical protein
A. fumigatus CDS A£A24A6.075 vbS, versicolorin b synthase, putative
A. fumigatus CDS AfA5A2.045 qutE, catabolic 3-dehydroquinase, putative
A. fumigatus CDS AfA31G4.005c hypothetical protein
A. fumigatus CDS A£A6E3.145 hypothetical protein, conserved
A. fumigatus CDS AfA33H4.060c histidinol-phosphate aminotransferase
A. fumigatus CDS AfA.34E6.020c hypothetical protein
A. fumigatus CDS AfA6E3.140 putative secreted protein
A. fumigatus CDS AfA28D1.045 hypothetical protein, conserved
A. fumigatus CDS afa35gl0.05C hypothetical protein
A. fumigatus CDS AfA3 IE 11.005c hypothetical protein
A. fumigatus CDS AfA14E5.12c ankyrin repeat protein, putative
A. fumigatus CDS AfA24A6.105 hypothetical protein
A. fumigatus CDS AfA5A2.060c cytosolic cu/zn superoxide dismutase-related protein, 
putative
A. fumigatus CDS AfA24A6.065 transporter, putative
A. fumigatus CDS AfA5C5.090c hypothetical protein
A. fumigatus CDS AfA5A2.035 qutB, quinate 5-dehydrogenase, putative
A. fumigatus CDS AfA34E6.010 hypothetical protein
A. fumigatus CDS AfA19D 12.060c DNA repair helicase, putative
A. fumigatus CDS AfA28D 1.040c dynamin-related protein, putative
A. fumigatus CDS AfA5A2.020c qutC, 3-dehydroshikimate dehydratase, putative
A. fumigatus CDS AfA33H4.055c integral membrane protein, putative
A. fumigatus CDS AfA6E3.095 hypothetical protein
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A. fumigatus CDS AfA5C5.010c hypothetical protein, conserved
A. fumigatus CDS AfA28D1.035 pyridine nucleotide-disulphide oxidoreductase family
protein, putative
A. fumigatus CDS A£A34E6.015c phosphotyrosyl phosphatase activator protein, putative
A. fumigatus CDS afa35gl0.04C glycerate dehydrogenase, putative
A. fumigatus CDS AfA6E3.090 cytochrome p450 (E-class), putative
A. fumigatus CDS AfA.14E5.llc hypothetical protein
A. fumigatus CDS AfA28D 1.030 hypothetical protein
A. fumigatus CDS AfA34E6.005 hypothetical protein
A. fumigatus CDS AfA24A6.055 gluconolactonase precursor, putative
A. fumigatus CDS AfA5A2.025 qutH, QutH protein, putative
A. fumigatus CDS AfA19D12.095c hypothetical protein
A. fumigatus CDS AfA28D1.075c hypothetical protein, conserved
A. fumigatus CDS AfA24A6.050 2-dehydro-3-deoxyphosphoheptonate aldolase, putative
A. fumigatus CDS AfA6E3.125 hypothetical protein
A. fumigatus CDS AfA5C5.085c mdr4, ABC transporter, putative
A. fumigatus CDS AfA24A6.080c integral membrane protein, putative
A. fumigatus CDS AfA6E3.120 l-phosphatidylinositol-4,5-
bisphosphatephosphodiesterase 1, putative
A. fumigatus CDS AfA6E3.160c hypothetical protein
A. fumigatus CDS AfA6E3.085 nucleobase permease, putative
A. fumigatus CDS afa5c 11.22c regulator of nonsense transcripts, putative
A. fumigatus CDS AfA24A6.040c hypothetical protein
A. fumigatus CDS AfA6E3.080 conserved hypothetical protein
A. fumigatus CDS afa35gl0.03C oligonucleotide transporter
A. fumigatus CDS AfA19D 12.015c hypothetical threonine-rich protein
A. fumigatus CDS AfA14E5.10c nadA, NADH oxidase, putative
A. fumigatus CDS AfA28D 1.020 serine/threonine-protein kinase, putative
A. fumigatus CDS afa5c 11.18c sagA, sagA protein
A. fumigatus CDS AfAlOAl.lOOc transcriptional regulator, putative
A. fumigatus CDS AfA5A2.015 ethanolamine kinase, putative
A. fumigatus CDS AfA6E3.115 hypothetical protein
A. fumigatus CDS AfA5A2.010 chord containing protein homologue, putative
A. fumigatus CDS AfA6E3.110 hypothetical protein
A. fumigatus CDS AfA19D12.085 hypothetical protein with DUF292 domain, putative
A. fumigatus CDS afa5c 11.21c possible zinc finger protein
A. fumigatus CDS AfA6E3.070 hypothetical protein
A. fumigatus CDS AfA19D12.080 short-chain oxidoreductase, putative
A. fumigatus CDS AfA28D10.100c mitochondrial import receptor subunit tom22
homologue, putative
A. fumigatus CDS AfA33H4.015 hypothetical protein
A. fumigatus CDS AfA24A6.035c aflR, possible aflatoxin regulatory protein
A. fumigatus CDS AfA.5A2.005 2,4-dihydroxyhept-2-ene-l,7-dioic acid aldolase
A. fumigatus CDS AfA31G4.001c hypothetical protein
A. fumigatus CDS AfA24A6.030 oxidoreductase, putative
A. fumigatus CDS AfA5A2.001 hypothetical protein
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A. fumigatus CDS AfA19D12.075 SUN family protein, putative
A. fumigatus CDS afa5cl 1.20c dual specificity protein phosphatase 3, putative
A. fumigatus CDS AfA31El 1.001c clathrin coat assembly protein, putative
A. fumigatus CDS AfA19D 12.070 hypothetical protein, conserved
A. fumigatus CDS A£A6E3.050c geranylgeranyl pyrophosphate synthetase, putative
A. fumigatus CDS A£A28D 1.001 serine palmitoyltransferase 2, putative
A. fumigatus CDS AfA33H4.005 possible zinc finger protein
A. fumigatus CDS afa5c 11.16c hypothetical protein
A. fumigatus CDS AfA31G4.040c isoflavone reductase, putative
A. fumigatus CDS AfA19D12.105 hypothetical protein
A. fumigatus CDS AfA14E5.32 salicylate hydroxylase, putative
A. fumigatus CDS AfA28D1.100c mitochondrial 40s ribosomal protein mrpl7, putative
A. fumigatus CDS AfA14E5.31 hypothetical protein, conserved
A. fumigatus CDS AfA33H4.155c outward-rectifier potassium channel tokl homologue,
putative
A. fumigatus CDS AfA6E3.055 cell division control protein cdcl4, putative
A. fumigatus CDS AfA19D 12.065 zinc finger protein, putative
A. fumigatus CDS AfA33H4.115c possible NOL1/NOP2/SUN family protein
A. fumigatus CDS AfA14E5.03c guanosine-diphosphatase, putative
A. fumigatus CDS AfA8D5.030c hypothetical protein
A. fumigatus CDS AfA24A6.015 peptidase, putative
A. fumigatus CDS AfA31G4.035c veA, veA protein
A. fumigatus CDS AfA14E5.29 hypothetical protein, conserved
A. fumigatus CDS AfA33H4.090c hypothetical membrane protein
A. fumigatus CDS AfA10A1.125 Ankyrin repeat protein, putative
A. fumigatus CDS AfA6E3.005c trpC, anthranilate synthase component ii, putative
A. fumigatus CDS AfA34E6.050c prohibitin, putative
A. fumigatus CDS AfA10A1.120 hypothetical protein
A. fumigatus CDS AfA33H4.0120 hypothetical protein, conserved
A. fumigatus CDS AfA14E5.21 hypothetical protein
A. fumigatus CDS AfA6E3.045 smr family protein, putative
A. fumigatus CDS AfA10A1.085 possible cation efflux protein
A. fumigatus CDS AfA19D12.055 DNA-directed RNA polymerase i, putative
A. fumigatus CDS AfA10A1.080 possible secreted cellulose-binding protein
A. fumigatus CDS AfA24A6.100c protein phosphatase ssdl homologue, putative
A. fumigatus CDS AfA33H4.010c hypothetical protein
A. fumigatus CDS afa5c 11.14c hypothetical protein, conserved
A. fumigatus CDS AfA5C5.001c odeA, oleate delta-12 desaturase
A. fumigatus CDS AfA8D5.065c niaD, nitrate reductase, putative
A. fumigatus CDS AfA24A6.005 3-hydroxy-3-methylglutaryl-coenzyme a reductase,
putative
A. fumigatus CDS AfA19D12.090c possible transporter-like protein 
A. fumigatus CDS AfA5A2.050c qutA, quinic acid utilization activator, putative 
A. fumigatus CDS AfA5C5.080c GTPase activator protein, putative 
A. fumigatus CDS AfA34E6.085c GTP-binding protein, putative 
A. fumigatus CDS AfA14E5.13 peptide transporter, putative
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A. fumigatus CDS AfA28D10.095 possible transcription factor Illc-like protein 
A. fumigatus CDS AfA19D12.050c u4/u6 small nuclear ribonucleoprotein hprp3-related 
protein, putative
A. fumigatus CDS AfA.33H4.085c hypothetical protein
A. fumigatus CDS AfA10A1.075 hypothetical protein
A. fumigatus CDS AfA19D12.045 hypothetical protein, conserved
A. fumigatus CDS AfA.5C5.040c la protein homolog, putative
A. fumigatus CDS afa35gl0.21 hypothetical protein
A. fumigatus CDS AfA.10Al.070 hypothetical protein
A. fumigatus CDS AfA6E3.030 hypothetical protein
A. fumigatus CDS AfA33H4.045c hypothetical protein
A. fumigatus CDS AfA14E5.01c possible translation initiation factor
A. fumigatus CDS afa5c 11.09c glpV, glycogen phosphorylase 1, putative
A. fumigatus CDS AfA14E5.09 hypothetical protein, conserved
A. fumigatus CDS AfA14E5.08 hypothetical protein, conserved
A. fumigatus CDS AfA10A1.105 hypothetical protein
A. fumigatus CDS AfA.14E5.07 hypothetical protein, conserved
A. fumigatus CDS AfA14E5.05 translation elongation factor tu precursor, mitochondrial
A. fumigatus CDS afa35gl0.19 hhtA, histone h3, putative
A. fumigatus CDS AfA14E5.04 infC, translation initiation factor 3, putative
A. fumigatus CDS afa35gl0.18 hypothetical protein
A. fumigatus CDS AfA.6E3.190c aflatoxin bl aldehyde reductase, putative
A. fumigatus CDS AfA28D1.065c hypothetical protein, conserved
A. fumigatus CDS afa35gl0.17 transposase, putative
A. fumigatus CDS AfA14E5.02 hypothetical protein
A. fumigatus CDS afa35gl0.16 hypothetical protein
A. fumigatus CDS afa35gl0.15 zinc finger protein, putative
A. fumigatus CDS AfA10A1.065 60S ribosomal protein 117, putative
A. fumigatus CDS AfA.6E3.025 hypothetical protein
A. fumigatus CDS afa35gl0.13 aroM, pentafhnctional arom polypeptide [includes: 3-
dehydroquinate synthase], putative
A. fumigatus CDS AfA24A6.070c oxidoreductase, putative
A. fumigatus CDS afa35gl0.12 dhpl, 5'->3'exoribonuclease, putative
A. fumigatus CDS AfA28D10.080 flavin-containing monooxygenase, putative
A. fumigatus CDS AfA10A1.060 NAD-dependant D-isomer specific 2-hydroxyacid
dehydrogenase, putative
A. fumigatus CDS AfA28D 1.025c ribosomal protein 115 homologue, putative
A. fumigatus CDS AfA19D 12.030 hypothetical protein
A. fumigatus CDS afa5cl 1.12c culA, scf complex protein, putative
A. fumigatus CDS afa35gl0.08 hypothetical protein
A. fumigatus CDS afa35gl0.07 hypothetical protein
A. fumigatus CDS AfA6E3.015 4-coumarate coa-ligase, putative
A. fumigatus CDS AfA19D12.025 hypothetical protein
A. fumigatus CDS AfA28D 10.070 possible bhlh transcription factor
A. fumigatus CDS afa35gl0.02 proline-rich SH3 domain protein, putative
A. fumigatus CDS afa35gl0.01 cell division protein kinase, putative
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A. fumigatus CDS AfA6E3.185c malate permease, putative
A. fumigatus CDS AfA6E3.010 hypothetical protein
A. fumigatus CDS AfA.5C5.075 hypothetical protein, conserved
A. fumigatus CDS AfA.10Al.050 3-oxoacyl-[acyl-carrier protein] reductase, putative
A. fumigatus CDS AfA24A6.025c hypothetical protein
A. fumigatus CDS AfA.6E3.001c brct domain protein, putative
A. fumigatus CDS AfA28Dl0.065 possible nucleoside hydrolase
A. fumigatus CDS AfA.33H4.150c hypothetical protein, conserved
A. fumigatus CDS AfA10A1.045 nirA, nitrogen assimilation transcription regulator,
putative
A. fumigatus CDS AfA.34E6.110c hypothetical protein
A. fumigatus CDS AfA33H4.110c lacA orthologue, beta-galactosidase precursor, 
putative
A. fumigatus CDS afa5c 11.10c ganB, G-protein alpha subunit, putative 
A. fumigatus CDS AfA.5C5.060 hypothetical protein, conserved 
A. fumigatus CDS AfA31G4.030c hypothetical protein 
A. fumigatus CDS AfA10A1.020c hypothetical protein, conserved 
A. fumigatus CDS AfA19D12.005 hypothetical protein 
A. fumigatus CDS AfA28D 10.050 hypothetical protein
A. fumigatus CDS AfA5C5.055 mnn4, possible mannosylphosphorylation protein mnn4 
protein
A. fumigatus CDS AfA10A1.030 atrE, ABC transporter, putative
A. fumigatus CDS AfA28D10.060c hypothetical protein
A. fumigatus CDS AfA.10Al.095c hypothetical protein
A. fumigatus CDS AfA5C5.050 aflT, aflatoxin efflux pump AflT, putative
A. fumigatus CDS AfA34E6.001c hypothetical protein, conserved
A. fumigatus CDS AfA.6E3.075c hypothetical protein
A. fumigatus CDS AfA33H4.001c hypothetical protein
A. fumigatus CDS AfA10A1.055c zinc-dependent alcohol dehydrogenase, putative
A. fumigatus CDS AfA28D 10.020c 60S ribosomal protein 11-b, putative
A. fumigatus CDS AfA14E5.29c transcriptional regulator, putative
A. fumigatus CDS AfA14E5.29b hypothetical protein, conserved
A. fumigatus CDS AfA8D5.020c PfkB family carbohydrate kinase, putative
A. fumigatus CDS AfA6E3.035c fadA, guanine nucleotide-binding protein, putative
A. fumigatus CDS AfA31G4.025c hypothetical protein
A. fumigatus CDS AfA.10Al.025 UBX-domain protein, putative
A. fumigatus CDS AfA5C5.047 hsp88, heat shock protein Hsp88, putative
A. fumigatus CDS AfA5C5.045 chsD, chitin synthase d
A. fumigatus CDS AfA24A6.130c hypothetical protein
A. fumigatus CDS AfA.19D12.001c hypothetical protein
A. fumigatus CDS AfA28Dl0.055c surfeit locus protein 4 homologue, putative
A. fumigatus CDS AfA28D 10.015c basic proline-rich protein
A. fumigatus CDS AfA28D10.035 adp-ribosylation factor, putative
A. fumigatus CDS AfA5A2.040c qutG, QutG protein, putative
A. fumigatus CDS AfA8D5.015c possible ribonuclease III
A. fumigatus CDS AfA10A1.015 fasciclin I family protein, putative
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A. fumigatus CDS AfA5C5.070c hypothetical protein 
A. fumigatus CDS AfA34E6.075c SET domain protein, putative 
A. fumigatus CDS AfA28D10.030 hypothetical protein, putative 
A. fumigatus CDS AfA19D12.040c glycosyl transferase, putative 
A. fumigatus CDS AfAlOAl.OlO u6 snma-associated sm-like protein, putative 
A. fumigatus CDS AfA33H4.075c DNA-directed RNA polymerase, putative 
A. fumigatus CDS AfA5C5.030 ligatin-like protein, putative 
A. fumigatus CDS afa5cll.04C hypothetical protein
A. fumigatus CDS AfA14E5.27c possible pathogenesis-related protein precursor 
A. fumigatus CDS AfA28D1.095c peroxisomal acyl-coenzyme a thioester hydrolase, 
putative
A. fumigatus CDS AfA28D10.025 hypothetical protein
A. fumigatus CDS AfA.10Al.005 hypothetical protein
A. fumigatus CDS AfA6E3.180c hypothetical protein
A. fumigatus CDS AfA5C5.025 endoglucanase, putative
A. fumigatus CDS AfA28D1.055c oligouridylate binding protein, putative
A. fumigatus CDS AfA28D 10.093c hypothetical protein
A. fumigatus CDS AfA5C5.065c 3-ketoacyl-coA thiolase, putative
A. fumigatus CDS AfA24A6.060c hypothetical protein
A. fumigatus CDS AfA19D12.035c hypothetical protein, conserved
A. fumigatus CDS AfA28D1.015c SH3-homology domain protein
A. fumigatus CDS AfA24A6.020c hypothetical protein
A. fumigatus CDS AfA6E3.100c adenosine deaminase, putative
A. fumigatus CDS AfA28D10.015 hypothetical protein
A. fumigatus CDS afa5c 11.23 imp4 protein, putative
A. fumigatus CDS AfA31El 1.015 transcription factor spt3, putative
A. fumigatus CDS afal4e5.22C possible transcription factor
A. fumigatus CDS AfA6E3.175c transporter, putative
A. fumigatus CDS afa35gl0.18C histone h4, putative
A. fumigatus CDS AfA14E5.25c facC, carnitine acetyl transferase, putative
A. fumigatus CDS AfA6E3.135c manA, mannose 6 phosphate isomerase, putative
A. fumigatus CDS afa5c 11.19 hypothetical protein
A. fumigatus CDS AfA28Dl0.001 flavin-containing monooxygenase, putative
A. fumigatus CDS afa5c 11.17 possible swi2/snf2-like protein
A. fumigatus CDS afa5c 11.16 hypothetical protein, conserved
A. fumigatus CDS A£A33H4.070c hypothetical protein
A. fumigatus CDS AfA33H4.140c hypothetical protein, conserved
A. fumigatus CDS afa5cl 1.13 hypothetical protein
A. fumigatus CDS afa5c 11.11 hypothetical protein, conserved
A. fumigatus CDS afa5c 11.10 osml, osmotic sensitivity map kinase, putative
A. fumigatus CDS AfA34E6.100c HMG-like protein, putative
A. fumigatus CDS AfA10A1.090c exgO, exo-l,3-beta-D-glucanase, putative
A. fumigatus CDS AfA.8D5.060 hypothetical protein
A. fumigatus CDS AfA31G4.045 rad57 protein, putative
A. fumigatus CDS AfA28D 10.115c acetoacetyl-coa synthetase, putative
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A. fumigatus CDS AfA33H4.165 tgf beta receptor associated protein 1 homologue, 
putative
A. fumigatus CDS afa5cl 1.08 ABC transporter, related to N. crassa 
adrenoleukodystrophy-related protein 
A. fumigatus CDS afa5c 11.07 hypothetical protein 
A. fumigatus CDS afa5cl 1.06 60S ribosomal protein 15, putative 
A. fumigatus CDS afa5c 11.05 epoxide hydrolase, putative 
A. fumigatus CDS AfA28D1.120c hypothetical protein 
A. fumigatus CDS AfA34E6.095 hypothetical protein 
A. fumigatus CDS afa5cl 1.02 niiA, nitrite reductase, putative 
A. fumigatus CDS AfA28D 10.090c qutD-like transporter, putative 
A. fumigatus CDS AfA34E6.090 hypothetical protein
A. fumigatus CDS afa35gl0.20C mdR, mfs-family multidrug resistance protein, putative
A. fumigatus CDS AfA31El 1.020c Bli-3 protein, putative
A. fumigatus CDS AfA19D12.100c hypothetical protein, conserved
A. fumigatus CDS AfA8D5.050 isocitrate dehydrogenase, putative
A. fumigatus CDS AfA33H4.135c fibrillarin, putative
A. fumigatus CDS afa35gl0.16C hypothetical protein
A. fumigatus CDS AfA 14E5.23 c jumonj i family transcription factor, putative
A. fumigatus CDS AfA28D 10.010c u6 snma-associated sm-like protein, putative
A. fumigatus CDS AfA14E5.19c acyl CoA binding protein, putative
A. fumigatus CDS AfA.34E6.070c facB, acetate regulatory DNA binding protein FacB,
putative
A. fumigatus CDS AfA31G4.015c hypothetical protein
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Appendix 1
Year Author Report
1729 Micheli First description o f  
Aspergillosis
1815 Mayer Air sac and pulmonary infection 
in a jackdaw
1842 Bennett Aspergilloma complicating 
tuberculosis with Aspergillus 
sputum
1842 Rayer Pleural aspergillosis
1844 Fresenius Clear species description o f  A. 
fumigatus (isolated from air sacs 
and bronchi o f  a great bustard)
1879 Leber Aspergillus keratitis following 
chaff entering the eye
1886 Bostroem Cutaneous aspergillosis
1887 Popoff Allergic pulmonary disease 
caused by Aspergillus
1890 Wheaton Aspergillus tracheobronchitis
1891 Zamiko Maxillary sinus aspergillosis
1897 Oppe Sphenoid sinus aspergillosis
1931 Just Cerebral aspergillosis
1936 Shaw and Warthen Aspergillosis o f  the bone
1947 Cawley Invasive aspergillosis (probable) 
complicating chronic 
granulomatous disease (with 
meningitis)
1950 Zimmerman Native valve aspergillus 
endocharditis
1952 Hinson, Moon and Plummer Allergic bronchopulmonary 
aspergillosis, definition o f  
disease
1953 Rankin Invasive pulmonary 
aspergillosis as an opportunistic 
infection (during neutropenia)
1955 Zimmerman Invasive aspergillosis in infancy
1959 Finegold, Will and Murray Classification o f  invasive 
aspergillosis
1964 Newman and Coredell Post operative aspergillus 
endocarditis
1966 Milosev et al Paranasal aspergillus granuloma 
in Sudan
1970 Young et al Comprehensive description o f  
pathology o f  invasive 
aspergillosis, with clinical 
correlation
1983 Katzenstein, Sale and Allergic aspergillus sinusitis
Greenbereger
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Appendix 2
Materials and solutions
• GTE: 227ml 20% glucose, 494ml of 0.1M EDTA, 128.5ml 1M Tris-HCl pH 7.4
to 51 with Double De-ionised Water (DDW)
• Solution 2:
• LB Broth: lOg Tryptone, 5g Yeast Extract, 5g Sodium Chloride made to lltr with 
DDW
• TE (10:10): lOmM Tris-HCl pH8.0, lOmM EDTA
• TO.IE: lOmM Tris-HCl pH8.0, ImM EDTA
• TBE: Tris-Borate pH8.4, ImM EDTA pH8.0
• lxTAE (Tris, 0.1M EDTA, Glacial Acetic Acid)
• Ficoll Loading Dye: 5mg Bromophenol Blue (BDH), 0.5g Ficoll 400 (Sigma), 
0.5ml lOxTBE, 4.5ml DDW.
• SDS/NaOH (4N Sodium Hydroxide (BDH, AnalaR Grade) 25ml, 20% SDS 
solution (lOOg Sodium Dodecyl Sulphate in 500ml DDW)
• 10% SDS (50g Sodium Dodecyl Sulphate in 500ml DDW)
• Guys buffer (1M KC1,1M Tris-HCl pH8.3, 1M MgCk, double deionised water 
(DDW))
• 20xSSC (1 Ltr=175.3g NaCl, 88,lg Hydrated Trisodium Citrate made to 1 ltr with 
DDW)
• TYE Agar plates (15g Agar, 8g NaCl, lOg Bacto Tryptone, 5g Yeast Extract 
made to 1 ltr with DDW)
• 40% sucrose/creosol red (40g sucrose made to 100ml with DDW, creosol red 
(Sigma) to a final concentration of 0.147mg/ml, filter sterilised)
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• 2xTY (16g Tryptone, lOg Yeast Extract, 5g NaCl made to lltr with DDW)
• (T7: TAATACGACTCACTATAGGG; SP6: ATTTAGGTGACACTATAG) 
(Sigma Genesis 120,000pmol/ml) (Tm: 55°C)
• Precipitation mix (95% Ethanol, 0.1M EDTA, 1M Sodium Acetate)
• Solution 1: 4.504g of Glucose (50mM final conc.), 10ml of 0.5M EDTA (lOmM 
final conc.), 12.5ml of 1M Tris pH8.0 (5mM final conc.), made up to 500ml with 
double distilled (dd) water and filter sterilised.
• Solution II (made fresh each time): 8.6ml of (dd) water, 400pl of 5M NaOH (2N 
final conc.), 1ml of 10% SDS (2N final conc.)
• Solution III: 3M KOAc pH5.5 (stored at 4°C)
• Fingerprint marker ladder: TO.IE 19.2pl, Promega ladder 1.5j.il, Boehringer- 
Mannheim Molecular Weight V 0.1 pi, 6X Buffer Dye 4.2pl.
• 6X Buffer II Dye: 0.25% bromophenol Blue, 0.25% xylene cyanol, 15% Ficoll 
(Type 400: Pharmacia}
Equipment
• BioRad Clamped Homogenous Electric Field gel apparatus. Gels usually run with 
1.0% high gelling temperature agarose and 0.5xTBE
• New Brunswick Scientific Innova 4300 shaking incubators
• Eppendorf 581 OR centrifuge
• Sorval RT-6000D centrifuge with microtitre plate rotor
• Sorval RT7 centrifuge
• Owl Scientific Gator Wide Format System A3-1 gel tank and bed
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• Molecular Dynamics Phosphoimaging Scanner and NT Fragment software 
supplied with machine
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Appendix 3
Disease
Allergic Bronchoplumonary 
Aspergillosis (ABPA)
Extrinsic Allergic Alveolitis 
(EAA)
Aspergilloma
Acute Invasive Pulmonary 
Aspergillosis
Central Nervous System 
Infection
Chronic Necrotising 
Aspergillosis
Infection o f  the paranasal 
sinuses
Sym ptom s
Recurrent fever, coughing, 
sputum plugs infested with 
Aspergillus
No previous allergic history 
in patient, but patient exposed 
to high levels o f  conidia. 
Rapid onset o f  fever, dyspnea 
and depression 
Usually develops in old, 
tubercular or disease caused 
cavities. Chronic cough, 
weight loss and lethargy
Bronchopneumonia, fever, 
haemorrhagic pulmonary 
infarction, thromboembolism
Mood swings and behavioural 
changes, confusion and 
reduces consciousness. Can 
disseminate into cerebrospinal 
fluid (CSF)
Patient usually been treated 
for previous lung disease or 
already have chronic lung 
disease. Chronic cough, fever, 
weight loss and lethargy 
Nasal discharge, fever, facial 
pain and headache. Facial 
disfigurement can occur after
Prognosis 
Broncho-spasm and 
Atelectasis. Airway 
obstruction and alveolar 
collapse
Basis o f  “Farmers Lung”. 
Pulmonary fibrosis may 
occur
Com m ents
Close relationship to 
asthma (5% pop.) 
Found in 10-11% 
cystic fibrosis 
patients
Misc. inform ation 
Due to Type I, III and 
IV allergic reactions
Usually symptoms 
set in with a few 
hours o f  exposure.
Haemoptysis is main 
complication (50-80% o f 
patients)
10% patients show 
spontaneous lysis in 
lungs. Fungal ball 
evident on X-ray
Lack o f  response to Mortality o f  about
treatment. Also can lead to 95%. Can be seen in
massive Haemoptysis various forms
50% patients with CSF 
infection appear healthy
Can lead to mental 
impairment
Massive haemoptysis 
can be fatal. Starts 
with granuloma 
(solid grouping o f  
inflammatory cells 
Main infection o f 
immunocompromised 
patients. Can go on to 
infect other organs 
Damage usually 
irreversible and can 
lead to death
Usually in middle -aged  or Can be sometime
older men before diagnosis is 
made while 
symptoms persist
Most common infection is 
aspergillosis. Aspergillus 
sinusitis is extremely
Four groups: allergic Have clinical
aspergillus sinusitis, pulmonary parallels
fulminant invasive such as ABPA,
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Cerebral Aspergillosis
Occular infections
Osteomyelitis
Otomycosis
Endocarditis and 
Myocarditis
Skin Infections
Infections o f  the 
Gastrointestinal tract
Liver and Spleen infections
AIDS patients and invasive
necrotic lesions have taken 
hold. Brain and eye orbit also 
susceptible
Cerebral infarction and 
thrombosis
Corneal ulcers, 
endopthalmitis and orbital 
aspergillosis
Spinal infection and paralysis 
Infection o f  the auditory 
canal.
Embolism usually common
Lesions on skin, become 
hardened, blue and violet in 
colour, covered by scab
Intestinal ulcers, internal 
bleeding and perforation
common around world. 
Bone marrow transplant 
patients contracting sinus 
aspergillosis have 100% 
mortality
High prevalence and highly 
fatal
Causes three types o f  eye 
infection
Rare infection 
Usually chronic, but can be 
cleared with sporadic 
recurrence
Myocarditis is found in 
15% o f  patients dying with 
disseminated aspergillosis
Cutaneous Aspergillosis 
occurs with local or general 
immunodeficiency e.g. 
scalds or bums. Has 
mortality rate o f  50% in 
these types o f  infections 
Oesophagus most common 
site for infection
Most patients do not report Seen in 30% o f  patients
symptoms, but some with disseminated
observation o f jaundice, liver aspergillosis
and abdominal pain has 
occurred
60-80% patients present Most present with
aspergillosis, 
saprophytic 
aspergillus 
colonisation and 
chronic sinusitis 
Disseminated from 
other infected regions 
o f  the body 
25% cases reported, 
spreads to brain and 
causes death
Usually occurs in 
open heart surgery 
patients, but also 
drug users 
Reported as two 
defined types.
Found in 40-50% 
patients dying from 
disseminated 
infection
Complications
Aspergilloma etc
Usually spreads from 
paranasal sinuses, 
described earlier
Can lead to
disseminated
aspergillosis
AIDS is a very
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aspergillus infection
Solid Organ Transplant 
susceptibility to 
Aspergillosis
Invasive pneumonia
pulmonary infection. Small pulmonary disease, but 10- always lead to more
skin lesions are also very 15%  have no lung than one eventual
common. Disease can be seen involvement at all. Central presentation. Any
in all organs o f  body in Nervous System is the most treatment is only
various forms. Due to the common infected site useful in prolonging
nature o f  the disease, the outside the heart and lungs the inevitable
patient can present with one, a
few or all o f  the types o f
infection, causing multiple
symptoms
Sub-dermal legions, skeletal Infections o f  the pulmonary More non-specific
damage and infection o f  the tracts dominate. than other infections.
CNS. Fever, cough, chest pain Symptoms tend to be
and dyspnoea. Can cause observed with other
peritonitis o f  the kidney in symptoms from both
kidney transplant patients. infectious and non-
Gut and paranasal sinuses are infectious illnesses.
also targets leading to
catastrophic dissemination
Respiratory failure, fever Does not respond to Most feared by
antibiotics and gives rise to doctors. Almost
classic symptoms o f always fatal,
pneumonia particularly when in
severe neutropenia
complex disease that 
can embrace all o f 
the above diseases in 
various forms.
Disease CAN be 
treated, but has to be 
caught very early in 
onset, with treatment 
o f  high doses o f 
AmB
Aspergillus is also known to be virulent pathogen in other vertebrate animals, as well as 
non-vertebrates. These diseases can present themselves as pulmonary and air sac 
infections in many birds, especially those kept in captivity and in new hatched chicks. 
Long nose dogs are also prone to sinusitis and pregnancy termination and horses are 
known to be prone to catastrophic haemorrhaging due to guttural pouch aspergillosis 
infection. Infections can occur in other animals such a whales and dolphins. A. fumigatus
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is thought to be the contributor to most of these diseases, with the exception of sinusitis, 
which is often caused by A.flavus, but this does not mean to say that they do not cause 
the disease in any form.
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